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ABSTRACT 
 
INVESTIGATION OF CYTOTOXICITY AND ION FLUX INDUCED BY VARIOUS 
AGGREGATION STATES OF AMYLOID-BETA PEPTIDES 
 
by 
 
Panchika Prangkio 
 
 
Chair: Michael Mayer 
 
 
The pathological feature of Alzheimer’s disease (AD) involves accumulation of 
amyloid-beta (Aβ) peptides into plaques in brain tissues.  Two species of Aβ peptides, 
Aβ1-40 and Aβ1-42, have been identified as the major components of the amyloid plaques.  
Most studies have reported that the intermediate oligomeric forms of Aβ are responsible 
for neurodegeneration; the exact mechanisms of neurotoxicity, however, are still unclear.  
An increasing number of evidence indicates that Aβ peptides can form pores in neuronal 
membranes and cause uncontrolled ion flux through cellular membranes, leading to a 
disruption of the ion homeostasis.  
In this thesis, with regard to a controversy on the mechanism of Aβ-induced ion 
flux: ion channel formation versus thinning membrane hypotheses, we provided an 
 xxi 
 
evidence that Aβ can form pores which permit ion flux through the artificial lipid and 
neuronal membranes, while the proposed membrane thinning effect was due to the 
residual amounts of the solvent hexafluoroisopropanol, which was used in the 
preparation procedure.  In addition, we used planar lipid bilayer recordings to study the 
formation of ion channel, and cytotoxicity assays to determine the toxicity of Aβ from 
various preparation methods of Aβ.  We characterized the aggregation states of Aβ 
using biochemical and biophysical techniques to correlate the relative abundance of 
aggregated Aβ species with pore formation and cytotoxicity.  Our statistical analyses 
revealed that pore formation was correlated most strongly with tetramers to hexamers, 
while cytotoxicity correlated with tetramers to 18 mers.  The partial overlap of Aβ 
oligomers that induced the highest probability of pore formation with those that were 
most toxic suggests that pore formation is likely a contributing mechanism to the toxicity 
of Aβ.   
In the second part of this research, we characterized two synthetic molecules 
containing oligo(ethylene glycol), which self-assemble to form ion channels across lipid 
membranes.  We found that these molecules also exhibited antibacterial activity against 
gram-positive bacteria, which might be appealing as a starting material for the 
development of antibiotics. 
 
 
 1 
 
 
 
Chapter 1 
Introduction to Alzheimer’s Disease and Amyloid beta (Aβ) Peptides 
 
 
1.1 General overview of Alzheimer’s disease (AD) 
Alzheimer’s disease (AD) is the most common neurodegenerative disorder which 
is associated with loss of memory and cognitive abilities.  It was discovered in 1906 by 
Dr. Alois Alzheimer, a German psychiatrist, who examined the post-mortem of the brain 
tissues of a 51-year-old woman who died after suffering from memory impairment and 
abnormal behaviors (1).  After a few years of investigation, he revealed that the brain 
tissues of his patient contained abnormal fibrillar structures, and numerous deposits 
(lesions) within the cerebral cortex.  Since then, these two abnormal structures, known 
as neurofibrillary tangles (NFT) and amyloid plaques, have been considered as the 
hallmarks of AD.  The major components of amyloid plaques are amyloid-β (Aβ) 
peptides, while the NFT are mainly composed of hyperphosphorylated tau proteins, 
which are crucial for microtubule assembly and axonal transport (2, 3).  The progression 
of AD results from an injury and loss of nerve cells in the brain, especially in the cerebral 
cortex which is associated with learning, memory, and behaviors. 
Currently, AD affects more than 35 million people worldwide and 5.5 million in the 
United States, mostly above the age of 65 (2).  As of 2011, AD is the 6th leading cause of 
death in the U.S with an estimated cost of 183 billion dollars per year (4).  The 
occurrence of AD doubles every 5 years and the number of AD patients is expected to 
 2 
 
approach 13.2 to 16 million cases in the U.S. by 2050 (2).   Despite the extensive 
studies on AD in the past century, the exact mechanisms of AD pathogenesis are still 
unclear.  Increasing evidence supports a causative role for amyloid beta peptides (Aβ) in 
AD pathogenesis as Aβ triggers neurotoxicity in brain cells via several mechanisms.  
The work presented here focuses on the so-called “ion channel formation” 
mechanism, which states that Aβ induces the neurotoxicity by forming pores in cellular 
membranes, which disrupts ion homeostasis (5-8).  We examined the relationship 
between aggregated species, pore formation, and cytotoxicity and determined the 
aggregation conditions of Aβ that are most likely to form pores through the lipid 
membranes as well as induce cytotoxicity.   
 
1.2 Amyloid-β peptides and their roles in AD pathology 
1.2.1 Amyloid cascade hypothesis  
With regard to pathology of AD, two major hypotheses have been postulated to 
explain the molecular mechanisms of AD: the cholinergic hypothesis and amyloid 
cascade hypothesis (9).  As demonstrated in Fig. 1-1, the cholinergic hypothesis, which 
preceded the amyloid cascade hypothesis, suggests that a decline of choline 
acetyltransferase (ChAT) and acetyl cholinesterase (AchE), which leads to a deficit of 
acetylcholine neurotransmitter, causes an impairment of cognitive and memory functions 
(10).  The amyloid cascade hypothesis, which has received considerable support from a 
number of research groups (11-16), states that the neurodegenerative process is 
initiated by the overproduction of Aβ, leading to aggregation and accumulation of Aβ 
plaques.  Along the cascade, there are multiple neurotoxic pathways that may contribute 
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to the pathogenesis of AD, including disruption of Ca2+ homeostasis, free radical 
production, excitotoxicity, inflammation of neurons, progressive synaptic activity, and 
hyperphosphorelation of tau (12, 17). 
 
Figure 1-1.  Major hypotheses of AD pathogenesis.  The cholinergic hypothesis states a 
reduction of neurotransmitters causes a dysfunctional cholinergic system, which leads to 
a memory loss.  In the amyloid cascade hypothesis, AD pathogenesis is initiated by an 
overproduction of Aβ, which accumulates and forms amyloid plaques, resulting in a 
series of subsequent events that leads to cell death (9). 
 
Currently, there is no treatment for AD that can stop the deterioration of brain 
cells and prevent dementia; however, treatments that can alleviate the symptoms of AD 
Hypotheses of pathogenesis mechanism in AD
Cholinergic hypothesis
Reduction in ChAT and AchE
Decline in neurotransmitter
Impairment in 
neurotransmission
Amyloid cascade hypothesis
Increase of Aβ1-40/Aβ1-42 production 
and accumulation
Disruption of Ca2+ homeostasis
Free radical production
Excitotoxicity
Neuroinflammation
hyperphosphorylation of tau
Accumulation of 
intracellular NFT
Destabilize microtubules
neuronal 
damage/dysfunction
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have become available, including acetylcholine esterase inhibitors, antioxidant agents, 
nonsteroidal anti-inflammatory drugs (NSAIDs), amyloid-β-peptide vaccination, 
secretase inhibitors, Aβ aggregation antagonist, Cu+ and Fe2+ chelators, neurotrophic 
factors, lipid-modulating agents, antidepressants, and cholesterol-lowering drugs (2, 9, 
18-20).  
Nevertheless, these treatments cannot rescue patients from loss of cognitive 
abilities and memory in the long run, because these treatments cannot modify the 
pathogenesis of disease, and some treatments have negative side effects (9).  Hence, it 
is critically important to increase our understanding of pathways and the mechanisms of 
AD and to seek new strategies for treatment of this fatal neurodegenerative disease.  An 
understanding of AD pathogenesis may shed light on the development of therapeutic 
treatments for other protein-misfolding diseases, such as Parkinson’s disease (PD), type 
II diabetes, Huntington’s disease, rheumatoid arthritis, and spongiform encephalopathies 
(or “mad cow” disease). These diseases are characterized by the aggregation of 
proteins that share common biophysical characteristics or similar biochemical properties 
with Aβ, including α-synuclein, islet amyloid polypeptide (IAPP or amylin), polyglutamine, 
serum amyloid A (SAA), and prion peptide 106-126 (21, 22). 
 
1.2.2 Molecular properties of amyloid β 
Amyloid β peptides (Aβ), which consists of 39-43 amino acids, are natural 
products of metabolism typically produced in nerve cells by cleavage of a 
transmembrane protein called amyloid precursor protein (APP).  Studies have shown 
that APP is expressed in various neuronal and non-neuronal cells but the function of 
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APP is not fully understood (23).  APP can undergo proteolytic processing via two 
pathways: the non-amyloidogenic and amyloidogenic pathways.  The more common 
pathway, non-amyloidogenic pathway is mediated by α-secretase and γ-secretase and 
yields two non-pathogenic peptide fragments called sAPPα and C83.  The cleavage of 
APP by α-secretase occurs within the domain of Aβ, thereby precluding the production 
of Aβ (see Figure 1-2).  Some studies have demonstrated that sAPPα has neurotrophic 
functions (24).  The generation of Aβ is a result of the amyloidogenic pathway that 
involves cleavage of APP by β-secretase and γ-secretase.  Although Aβ is a normal 
product of APP proteolysis and is found in plasma and cerebral spinal fluid (CSF), an 
imbalance between production and clearance of Aβ leads to Aβ accumulation and 
formation of insoluble deposits called “senile plaques” or “amyloid plaques,” which are 
hallmarks for AD (25, 26).  On the other hand, the density of amyloid plaques in the 
cerebral cortex showed a weak correlation with severity of dementia in Alzheimer’s 
patients (20, 27). 
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Figure 1-2. Amyloid β (Aβ) peptide is produced via proteolysis of a transmembrane 
protein called APP, which consists of 696-770 amino acids.  APP undergoes two 
enzymatic pathways: the non-amyloidogenic pathway and amyloidogenic pathways. In 
the amyloidogenic pathway, APP is cleaved by β-secretase and γ-secretase and 
released Aβ into extracellular matrix.  In healthy people, most APP proteolysis is 
processed via the non-amyloidogenic pathway, which precludes the generation of Aβ. 
Figure adapted from reference (23). 
 
The major components of amyloid plaques are Aβ1-40 and Aβ1-42.  Both species of 
Aβ exist in plasma and CSF at nanomolar concentrations (28, 29).  Despite a small 
difference in the number of amino acids (i.e., Ile41 and Ala42), Aβ1-40 and Aβ1-42 exhibit 
different neurotoxicity and biophysical behavior.  Aβ1-42 is more hydrophobic and prone 
to aggregation than Aβ1-40.  Toxicity studies revealed that Aβ1-42 is more toxic than Aβ1-40.  
In addition, some research groups have revealed that Aβ1-42 is more physiologically 
relevant than Aβ1-40, while Aβ1-40 is the predominant Aβ species found in vivo (30). 
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In general, Aβ peptides exhibit stochastic mechanisms of aggregation as 
demonstrated by several biophysical and biological studies, especially with the less 
soluble and more pathogenic Aβ1-42 (31).  Aβ peptides are initially secreted as soluble 
monomers and readily assemble into dimer, trimer, and multimeric complexes in a 
nucleation-dependent process which further aggregate into protofibrils, and eventually 
insoluble amyloid fibrils (32, 33).  The aggregation of Aβ varies considerably even 
between samples in the same preparation as it is influenced by a number of parameters 
(34), including the species of peptides, solvent hydrophobicity, ionic strength, pH, 
temperature, solvent history, peptide concentration, initial aggregation state, buffer type, 
peptide counter ions, and the presence of partially oxidized or pre-aggregated forms 
(seeds) of the peptide.  The major difficulty for conclusive studies relates to the tendency 
of Aβ to aggregate in aqueous solution, forming heterogeneous Aβ assemblies, that 
makes it difficult to obtain reproducible results of functional experiments (34, 35).  It is; 
therefore, important to obtain a well-defined initial aggregation state and to characterize 
the aggregation states of Aβ in the molecular studies. 
To date, monomeric Aβ and fibrils appear to have a minor contribution to 
neurotoxicity, whereas increasing evidence implicates the prefibrillar intermediate 
species that contain 2 to 50 Aβ subunits collectively referred to as “small oligomers” or 
“low-molecular-weight oligomers” (16), are responsible for the neurotoxicity and memory 
impairment in rat and mouse models (16, 22, 36-38). 
Table 1-1 summarizes the findings of defined size of Aβ species and their 
relevance in memory loss and neurotoxicity in several research groups (14, 36, 37). 
. 
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  Table 1-1.  Specific assemblies of Aβ and their relevance in neurotoxicity 
Aβ assembly Characteristics Neurotoxicity Ref. 
Monomer small globule that is ~ 1.3 nm in height as 
revealed by AFM 
neuroprotective under trophic deprivation; fails to 
evoke Ca2+ influx across cell membrane 
 
(39, 40) 
Dimer stabilized by SDS; found in both human AD 
patients and rat Cerebral Spinal fluid (CSF) 
activates glial cells; leads to nerve cell death; 
abolishes long-term potentiation (LTP) completely 
 
(38, 41-
44) 
 
Trimer 
 
 
 
Tetramer 
extracted from Chinese hamster oocytes (CHO) 
that expressed human APP 
 
 
separated by size-exclusion chromatography 
from synthetic Aβ1-42 and characterized by 
western blotting 
fully inhibits hippocampal LTP in vitro and in vivo; 
transiently impairs the recall of complex learned 
behavior in rats 
 
yields the highest toxicity in neuroblastoma cells and 
primary hippocampal neurons, but does not 
necessarily inhibit LTP 
 
(45) 
 
 
 
(46, 47) 
Pentamer/ 
Hexamer 
early observable assembly of Aβ1-42, that self-
associates into larger oligomers 
considered stable oligomeric species that are 
neurotoxic 
(48) 
  
 
9 
 
Prefibrillar 
oligomer (PFO) 
 
spherical particle of 3-10 nm; appears at early 
incubation time; considered as precursor of 
annular protofibrils (APFs) 
 
showed higher toxicity and membrane-permeabilizing 
activity than APFs 
 
(49) 
Aβ-Derived 
Diffusible 
Ligands 
(ADDLs) 
synthetic Aβ oligomers with a smaller molecular 
weight than an annulus; between 17-42 kDa 
(corresponding to tetramers to 12 mers) 
affects neural signal transduction pathways 
 
(50, 51) 
 
Aβ globulomer 
 
pure, highly water-soluble globular 60-kDa 
oligomeric form of Aβ1-42; persistent structural 
entity formed independently of fibrillar 
aggregation pathway (corresponding to 13 mer) 
 
 
binds specifically to dendritic processes of neurons in 
hippocampal cell cultures; completely blocks LTP in 
rat hippocampal slices 
 
 
(52, 53) 
Aβ*56 Aβ1-42 with molecular weight of 56 kDa; detected 
in the endogenous brains of an APP transgenic 
mouse line (corresponding to 13 mer) 
 
correlates with memory loss of transgenic mice (54) 
 
Protofibril (PF) 
 
 
intermediate of synthetic Aβ fibrillization with 
diameter of ~ 6-8 nm and length up to 200 nm 
from AFM; apparent mass > 100 kDa 
 
alters hippocampal synapse physiology and learning 
behavior of rats 
 
 
(33, 55, 
56) 
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Insoluble 
amyloid fibrils 
 
highly aggregated forms of Aβ 
 
 
impairs the late phase of LTP; toxic in rat hippocampal 
culture; promotes toxicity in primary cortical neurons 
via interaction with APP 
 
 
(24, 57, 
58) 
 
Lipid induced 
oligomers 
obtained from co-incubation of mature Aβ fibrils 
with membrane particles, resulting in reversion 
to an oligomer 
causes cytotoxicity in hippocampal primary neurons;  
causes significant cognitive decline in mice 
(59) 
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The inconsistent results of neurotoxic forms of Aβ across the different 
laboratories could arise from different preparation methods of Aβ that affect the 
aggregation state of the protein (14, 34).   
 
1.3 Studies of ion channel hypothesis 
1.3.1 Ion channel hypothesis 
Since the amyloid cascade hypothesis have proposed that multiple neurotoxic 
pathways may lead to cell death (12, 17), a number of subsequent studies have 
emerged.  One aspect this thesis focuses on is the Aβ-induced-ion channel hypothesis 
which states that non-fibrillar Aβ interacts with cell membranes and induces aberrant ion 
channel formation in neuronal membranes, leading to excessive Ca2+ influx and 
disruption of Ca2+ homeostasis (5-8).   
In 1993, Arispe et al. discovered that Aβ can form cation-selective channels when 
incorporated into planar lipid bilayers in electrophysiological studies (60).  The 
characteristics of these ion channels including ion conductance, kinetic behavior, ion 
selectivity, and pharmacological properties suggest diverse types of Aβ ion channels 
(21, 61).  On the other hand, some research groups reported difficulty in observing 
channel activity of Aβ1-40 or Aβ1-42 in electrophysiological studies (62). Most research 
groups have observed discrepancies in the toxicity of Aβ, likely due to the variability in 
initial aggregation state of peptides from different suppliers or the same supplier with 
different batches (63, 64).  Aβ-induced ion flux was also observed in various biological 
membranes, including lipid membranes, and cellular membranes —in both neuronal and 
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non-neuronal cells (21).  Some studies have revealed that Aβ channel activity could be 
blocked by various agents such as Congo red (65), Zn2+, Al3+, Tris (66, 67), and the 
other synthesized molecules, such as the short peptide, NA7 which contains 7 amino 
acids that are complementary to the sequence of Aβ peptides (68), and two small 
molecules, MRS2481 and MRS2485 (69). 
The ability of Aβ to form pores in biological membranes and discovery of specific 
blockers provide strong evidence supporting the ion channel hypothesis.  In addition, 
evidence of pore-like structure of Aβ oligomers has been revealed by atomic force 
microscopy (AFM), and electron microscopy (EM).   AFM images demonstrated that 
tetrameric to hexameric Aβ oligomers reconstituted in DOPC lipid bilayers can form 
annular pores with inner diameter of roughly 2.0 nm diameter and outer diameter of 8-12 
nm (28, 70).  EM revealed that the outer diameter of the annular pores was in the range 
of 7 to10 nm and inner diameter was between 1.5 to 2 nm (36, 71, 72).  These pore 
structures were also observed in neuronal cell membranes and mitochondria-like 
organelles from brain tissue of AD patients, but the size of pores was larger than those 
observed in vitro, with outer and inner diameters of 16 nm and 10 nm, respectively (73).  
Recently, Schauerte et al. reported by single-molecule spectroscopy that the smallest 
oligomer that can permeabilize lipid membranes is a hexamer, while 12-14 mers yield 
the highest conductivity (74). 
Using molecular dynamics (MD) simulations, Jang et al. demonstrated the 
possible arrangement of Aβ oligomeric pores in lipid bilayers, which is in agreement with 
experimental data (75, 76).  The studies revealed that the “preferred” size of ion channel 
ranged from 16 to 24 mers.  Other research groups independently reported by MD that 
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the plausible structure of Aβ pores may consist of the tetramer (77) and hexamer (77, 
78) 
Despite strong supports for the ion channel formation hypothesis, other 
mechanisms by which Aβ alters cellular Ca2+ homeostasis have been proposed.  Glabe 
and co-workers demonstrated that soluble oligomers of Aβ disrupt lipid membrane 
integrity by thinning the membrane and causing non-specific leakiness without the 
formation of the defined pore structures (79-81).  Other research groups proposed that 
Aβ directly and indirectly modulates the existing ion channel proteins, receptors (82-88), 
transporter and pumps (89, 90).  Figure 1-3 illustrates the proposed mechanisms in 
which Aβ oligomers triggers neurotoxicity by inducing Ca2+ influx. 
 
 
 
 
14 
 
 
 
 
Figure 1-3. Schematic illustration of Aβ aggregation and the proposed mechanisms for 
Aβ-induced disruption of Ca2+ homeostasis.  Aβ monomers aggregate into β-sheet 
oligomers, and eventually fibrils, which compose amyloid plaques.  The intermediate Aβ 
oligomers are considered to be the toxic species that associate with cellular membranes 
and evoke the unregulated influx of Ca2+ through plasma membranes via several 
possible mechanisms, including pore formation, membrane thinning, and modulation of 
native Ca2+ channels.  An increase in intracellular concentration of Ca2+ can lead to other 
neurotoxic pathways such as apoptosis and alteration of ATPase functions.  Figure 
adapted from references (5, 7, 16). 
 
It is widely accepted that Aβ causes the dysregulation of intracellular Ca2+, yet 
the exact mechanism of Aβ toxicity is still not fully understood.  The controversy 
regarding how Aβ interacts with the lipid membrane and the disrupts Ca2+ homeostasis 
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has been going on for decades, which has slowed the progress toward understanding 
the mechanism of neurotoxicity induced by Aβ.  In chapter 2 of this thesis, we address 
this controversy and provide evidence that Aβ is able to induce a stepwise ion flux 
across planar lipid bilayers as opposed to thinning of membrane.  We show that the 
previously reported gradual increase in transmembrane current arises from the residues 
of the solvent, hexafluoroisopropanol (HFIP) used in the preparation.  
 
1.3.2 Membrane model systems and techniques to study the Aβ-lipid membrane 
interaction 
1.3.2.1 Membrane models 
Natural cell membranes, widely referred to as plasma membranes, are 
composed of a lipid bilayer embedded with transmembrane proteins, ion channels, 
receptors, and glycoproteins (36).  The structural complexity of biological membranes 
reflects their diverse functions, including selective transport of molecules between the 
intra-and extracellular compartments.  
With regard to the complexity of biological membranes, researchers have created 
simplified membrane models for in vitro studies of the physiological behavior of cell 
membranes.  The development of membrane models made it possible to investigate 
electrical properties of lipid membranes, transport phenomena, protein-membrane 
interactions, and other membrane characteristics in a systematically controlled 
environment (91). 
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 In this thesis, two major membrane models that we employed are 1) planar lipid 
bilayers (PLBs), also referred to as black lipid membranes or bilayer membranes 
(BLMs), which are lipid films separating two aqueous solutions, and 2) liposomes or 
vesicles, which are enclosed spherical bilayer lipid membranes.  These model 
membranes provide a simplified system for examining the ability of molecules (e.g. Aβ 
peptides in different aggregation states) to form pores on lipid membranes.  PLBs are 
among the oldest membrane models and are the standard for ion channel recording 
experiments (36, 92).  Liposomes or vesicles are spherical lipid bilayers of various sizes 
internally filled with water or aqueous solution. There are three major classes of vesicles: 
1) small unilamellar vesicles (SUVs), with diameters in the range of 20-50 nm, 2) large 
unilamellar vesicles (LUVs), with diameters of approximately 100 nm, and 3) giant 
unilamellar vesicles (GUVs), with diameters in the range of 1-10 μm (36).  Due to the 
similarity in shape and size of cells, liposomes are considered to be most biologically 
relevant mimic of natural cell membranes, and have been used in a number of 
applications, including dye-leakage assays, vehicles for drug delivery, and gene therapy 
(36).   
 
1.3.2.2 Electrophysiological technique for studying ion channel  
A cell derives its electrical properties mostly from its membrane, which is 
composed of lipids and proteins, such as ion channels and transporters (93).  An 
electrical potential difference (∆V) exists between the intracellular and extracellular 
compartments of the lipid membrane.  Conductance (G) is a measure of the ability of 
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ions or charged particles to move between two compartments with an electrical potential 
difference.  Conductance is also written as the reciprocal of resistance (R) (94).  When 
ion channels are formed in the membrane, the flux of ions between the intra-and 
extracellular compartments, typically known as current (I) can be measured which is 
described by Ohm’s law, Eq. (1-1): 
   
    ܫ =  ∆௏ோ = ܩ∆ܸ    (1-1) 
  
Typically, the electrophysiology experiments can be performed on cellular and 
artificial membranes, which behave similarly to an insulator or capacitor.  Capacitance 
(C) is a measure of how much charge (Q) can be stored on the membrane for a given 
potential difference across it, as defined by Eq. (1-2): 
    
     ܥ = ொ Δ௏     (1-2) 
 
The capacitance depends on the dielectric constant and surface area of the membrane, 
as shown in the following relationship in Eq. (1-3): 
             ܥ = ఌఌబ஺ௗ              (1-3) 
   
where  ε  is the dielectric constant of the membrane 
ε0 is the dielectric constant of free space (8.8542 x 10-12 C V-1 m-1)  
A is the surface area of the membrane, and 
d is the thickness of the membranes 
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In our studies, we will sometimes refer to the conductance term as the 
measurement of ion flux through the membrane, since voltage was held constant 
throughout the electrophysiological recordings.  Capacitance is an important quantity 
used to determine the existence and the stability of the lipid bilayer in the 
electrophysiological studies, as the values of capacitance depend on the surface area 
and the thickness of the membrane. 
Single-channel recordings technique with planar lipid bilayer (PLB) has been 
extensively used to measure biophysical properties of molecules that conduct ions 
across the membrane.  There are two primary techniques for PLB formation that have 
been used, the “painted” (95), and the “folded” (96) techniques, but the fundamental 
characteristics of the bilayers in both methods are the same (91).  Figure 1-4 illustrates a 
conventional experimental setup for bilayer recording, consisting of two compartments 
which are separated by a lipid bilayer located across an aperture in a hydrophobic film or 
material, such as Teflon.  Each compartment is filled with an electrolyte containing the 
ions of interest and is connected to the amplifier by electrodes.  An ion channel or pore-
forming agent is typically inserted into the membrane by addition to the chamber, 
followed by vigorous mixing.  The current due to the conductivity of ion channels is 
measured as a function of time.  
 
 
 
 
19 
 
 
 
 
Figure 1-4.  A conventional PLB setup consists of a chamber with two compartments, 
electrodes, and a membrane support.  A lipid membrane is formed on an aperture of 
~50-250 μm size between the cis and trans compartments of the chamber by various 
techniques, such as “painting” or “folding” techniques.  Magnetic stirrers are generally 
required for mixing of added compounds. 
 
The advantages of the PLB technique are high sensitivity in measuring ionic 
current flowing through a single ion channel, and the possibility to modify the 
environment of ion channel (e.g. ionic composition, pH, lipid composition).  However, the 
limitations of this technique include the instability of the PLB in response to vibrations 
and hydrostatic pressure gradients, as well as the noise during recording.  
Another powerful electrophysiological technique is patch-clamping, which was a 
breakthrough in 1970s and has been adopted by a number of laboratories in various 
applications (93). This technique provides a sensitive measurement of the current 
flowing through a single ion channel within the membrane of a living cell.  One 
application of patch-clamping is to examine the ability of Aβ peptides to form ion 
channels in the cell membrane.  It has been shown that Aβ peptides can induce current 
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flux in living cells such as rat cortical neurons (97), hNT cells (6), and gonadotropin 
releasing hormone (GnRH) secreting neurons (98).  Yet, in practice, there are several 
limitations of this technique such as difficulties in controlling the intracellular 
environment, manual manipulation of an individual cell, selection of the cells, and 
specialized equipment and expertise are necessary (93).   
In part of this thesis, we adopted a semi-automated patch-clamp device that is 
commercially available, the so-called “Port-a-Patch” (Nanion Technologies, Munich, 
Germany), to study Aβ-induced ion channels on cell membranes.  We examined the 
ability of Aβ to form pores in membranes of neuroblastoma cell line (SH-SY5Y), and in 
primary cortical neurons from transgenic mice that express human amyloid precursor 
protein (hAPP) and human presenilin 1 (hPS-1).  
 
1.4 Summary of thesis 
The main work of this thesis focuses on the ion channel hypothesis with regard to 
the question of which aggregation states of Aβ are likely to form pore across the lipid 
membrane and yields the highest toxicity in mammalian cells.  In the initial phase of the 
research, we explored several preparation methods of Aβ and optimized for ion channel 
recordings in PLBs and cytotoxicity assays in a human neuroblastoma cells.  Along the 
process of the developing the ion flux and cytotoxicity assays, we discovered that one of 
the common preparation methods of Aβ oligomers, which requires HFIP to break up the 
large Aβ aggregates, yielded a gradual increase in transmembrane current 
independently from the presence of Aβ.  We proved that the “thinning membrane” 
mechanism as previously reported was due to the residues of HFIP from the 
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preparation.  In chapter 2, we show that Aβ induces ion flux through membranes of 
artificial lipid and neuronal cells by pore formation rather than non-specific membrane 
thinning.  This finding strengthens the ion channel hypothesis.  
In chapter 3, we compare several preparation methods of Aβ as reported in the 
literatures with regards to the likelihood of pore formation in the PLBs.  We characterized 
the aggregation states of both Aβ1-40 and Aβ1-42 from different preparations by using 
biochemical and biophysical techniques in order to correlate the aggregation states of 
Aβ with pore formation and cytotoxicity.   
We further investigated the effect of Aβ at various aggregation states on the 
membrane permeabilization in the liposomes by using proton leakage and dye leakage 
assays.  We found the effect of aggregation states on leakage of protons or dyes was 
different from the results obtained via electrophysiological studies.  We discuss the 
results with regard to liposome influx assays in chapter 4. 
In searching for inhibitors of Aβ-induced ion flux and neurotoxicity, we examined 
the inhibitory effect of a number of small molecules that have high binding affinities to 
Aβ. These small molecules were designed and studied by our collaborators in Professor 
Yang’s laboratory.  We did not find molecules which could reduce Aβ-induced ion flux 
completely.  Unexpectedly, we discovered that two synthesized molecules, which are 
derivatives of benzothiazole (BTA) attached to oligo(ethylene glycol), which we called 
BTA-EG4 and BTA-EG6, could form well-defined channels independent from the 
presence of Aβ.  In chapter 5, we investigated the characteristics of these self-
assembled ion channels.  We found that these molecules also exhibited the anti 
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bacterial activity against gram-positive bacteria, Bacillus subtilis, which might be 
appealing for development of antibiotics.  
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Chapter 2 
 
Amyloid-beta (Aβ) Ion Channels in Artificial Lipid Bilayers and  
Neuronal Cells1 
 
Understanding the pathogenicity of amyloid-beta (Aβ) peptides constitutes a 
major goal in research on Alzheimer’s disease (AD).  One hypothesis entails that Aβ 
peptides induce uncontrolled, neurotoxic ion flux through cellular membranes.  The exact 
biophysical mechanism of this ion flux is, however, a subject of an ongoing controversy 
which has attenuated progress towards understanding the importance of Aβ-induced ion 
flux in AD.  The work presented here addresses two prevalent controversies regarding 
the nature of transmembrane ion flux induced by Aβ peptides.  First, the results clarify 
that Aβ can induce stepwise ion flux across planar lipid bilayers as opposed to a gradual 
increase in transmembrane current; they show that the previously reported gradual 
thinning of membranes with concomitant increase in transmembrane current arises from 
residues of the solvent hexafluoroisopropanol, which is commonly used for the 
preparation of amyloid samples. Second, the results provide additional evidence 
suggesting that Aβ peptides can form ion channels in cellular membranes that are 
                                                
 
1 This chapter contains a content of publication, Capone, R., Quiroz, F. G., Prangkio, P., Saluja, 
I., Sauer, A. M., Bautista, M. R., Turner, R. S., Yang, J., and Mayer, M. (2009) Amyloid-beta-
Induced Ion Flux in Artificial Lipid Bilayers and Neuronal Cells: Resolving a Controversy, 
Neurotox. Res. 16, 1-13. My contributions in this study include performing a portion of bilayer 
recordings, characterizing the cytotoxicity of HFIP on neuroblastoma cells. 
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independent from the postulated ability of Aβ to modulate intrinsic cellular ion channels 
or transporter proteins. 
 
2.1 Introduction 
One of the current hypotheses for the pathology of Alzheimer’s disease (AD) 
proposes that amyloid-beta (Aβ) peptides induce aberrant, neurotoxic ion flux across 
cellular membranes (1-20).  The resulting difficulty of neurons to regulate their 
intracellular concentration of ions, in particular calcium ions, has been associated with 
cell death (9, 21) and may thus contribute to cognitive impairment typical for AD. 
Understanding the underlying mechanisms that cause Aβ-induced ion flux may hence be 
crucial for developing new strategies to reduce the toxicity of Aβ in AD. 
Increasing evidence shows that exposure of cells to Aβ leads to elevated 
concentrations of intracellular calcium ions  (1, 9, 15, 21-29); the predominant cellular 
mechanism for this disruption of Ca2+ homeostasis remains, however, a focus of intense 
studies.  The four mechanisms that have been proposed are: 1) Aβ assembles into 
oligomers to form Aβ  ion channels in cell membranes (1-20, 22, 30-35), 2) Aβ interacts 
with membranes in such a way that it generally lowers the dielectric barrier for ions to 
cross the membrane (e.g. by thinning the membrane) (23, 36-39), 3) Aβ modulates, 
directly or indirectly, the activity of existing ion channel proteins or receptors (14, 25, 27, 
40-57), or 4) Aβ  modulates, directly or indirectly, the activity of cellular ion transporters 
and pumps (58, 59).  Experimental evidence for each of these mechanisms has been 
provided and it is possible that several mechanisms act together to disrupt Ca2+ 
homeostasis. 
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The work presented here examined the first three mechanisms. It employed 
electrophysiological techniques to measure ion flux by current recordings across bilayer 
lipid membranes (using BLM recordings) or across cellular plasma membranes (using 
whole-cell patch clamp recordings).  This approach excluded the study of ion flux by 
transporter proteins or ion pumps because the ion flux generated by these proteins is too 
slow to be detectable by current recordings (60). Instead, we asked if Aβ can form ion 
pores in artificial lipid bilayers, in membranes of a human neuronal cell line (SH-SY5Y), 
and in primary neurons from transgenic mice that express human amyloid precursor 
protein (hAPP) and human presenilin 1 (hPS-1). 
 
2.2 Results and discussion 
Recently, three articles highlighted an ongoing controversy with regard to the 
exact biophysical characteristics of Aβ-induced transmembrane ion flux across artificial 
lipid membranes (61-63).  These articles debate two mechanistic hypotheses.  On the 
one hand, the “Aβ ion channel hypothesis” suggests that Aβ assembles into pore-like 
structures in lipid membranes, leading to stepwise (or spike-like) fluctuations of 
transmembrane current that is typical for ion channels (1-20, 22, 30-35).  On the other 
hand, the “Aβ membrane thinning hypothesis” postulates a generalized and gradually 
increasing ion flux as a result of Aβ-induced reduction of the dielectric barrier of 
membranes, for instance, by thinning of membranes (37-39). 
Here, we examined, in detail, the two pivotal protocols for measuring Aβ induced 
conductance through artificial lipid bilayers to resolve this controversy.  The protocol that 
leads to ion flux by gradual membrane thinning involves solubilizing Aβ1-40 or Aβ1-42 in the 
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solvent hexafluoroisopropanol (HFIP), followed by dilution in water, and purging of HFIP 
by a stream of nitrogen gas (23, 36-39, 64).  Figure 2-1A shows the gradual increase in 
ion flux through a planar lipid bilayer upon exposure of membranes to these Aβ samples.  
Figure 2-1A is consistent with previous reports that used the same HFIP-based 
experimental procedure (37-39).  Figure 2-1B, however, shows a similar gradual 
increase in conductance following the exact same protocol but in the absence of Aβ.  
This control experiment thus shows that Aβ was not required for the observed gradual 
increase in transmembrane conductance but that residues of HFIP alone could be 
responsible for the observed ion flux.2  
 
                                                
 
2One of the previously reported results that supported the hypothesis of Aβ-induced gradual 
thinning of membranes was the observation that an anti-Aβ antibody could reduce the observed 
transmembrane ion flux caused by these Aβ preparations.  These experiments were carried out 
with Aβ samples that were also prepared with an HFIP purging protocol (23, 37-39).  We 
repeated this experiment with the modification that we added bovine serum albumin (BSA) 
instead of adding an anti-Aβ antibody.  In approximately half of these trials, we found a reduction 
in transmembrane ion flux by adding BSA to the bilayer chamber.  The results were thus similar 
to the effect attributed previously to the anti-Aβ antibody.  Furthermore, when we induced 
transmembrane ion flux by adding HFIP only, we observed again a reduction in conductance by 
addition of BSA to bilayer chambers that did not contain Aβ.  These results suggest that a specific 
anti-Aβ antibody was not required to reduce gradually increasing ion flux that was induced by 
samples containing HFIP. 
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Figure 2-1. Ion flux across lipid bilayers upon exposure to samples with 1 μM amyloid-β 
peptides (Aβ), which were prepared by two different protocols.  A) Gradual increase in 
transmembrane ion flux upon addition of an Aβ sample that was prepared by purging the 
solvent hexafluoroisopropanol (HFIP) for 10 min (37, 39).  The “noisy” part of the current 
trace is a result of mixing.  B) Gradual increase in transmembrane ion flux following the 
exact same protocol as in (A) but in the absence of Aβ.  Inset, gradual increase in ion 
flux across the membranes of SH-SY5Y cells upon addition of HFIP (final concentration 
~6 mM).  C) Transmembrane ion flux upon addition of an Aβ sample prepared according 
to previous reports (37, 39) but with 18 h instead of 10 min of purging to remove HFIP.  
D) Stepwise fluctuations in transmembrane ion flux after incorporating a proteoliposome 
preparation of Aβ that was prepared without using HFIP (1).  The applied voltage 
was -150 mV in all recordings.  Membranes were prepared from DOPC:DOPE lipids at a 
1:1 (w/w) ratio by the “folding method” over a pore (diameter 150 μm) in a Teflon film 
that was pretreated with 5% squalene in pentane. 
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To investigate whether this gradual increase in conductance could be reproduced 
by exposure of membranes to defined concentrations of HFIP (in the absence of Aβ), we 
examined the effect of HFIP on cell membranes (Fig. 2-1B inset) and on planar lipid 
bilayers of various lipid compositions (Fig. 2-2A and 2-2B).  We found that, in all of these 
membranes, solutions containing 1-6 mM (corresponding to 0.01-0.06% v/v) 
concentrations of HFIP induced a gradual increase in ion flux similar to the results 
shown in Fig. 2-1B and similar to results described previously (37-39).3   
                                                
 
3 These results together with previous work (65) show that even low concentrations of HFIP can 
adversely affect membranes and alter their permeability for ions. Unlike other short chain 
alcohols, HFIP affects membranes similarly as long chain alcohols (66-68).  
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Figure 2-2. Transmembrane ion flux induced by samples containing well-defined 
concentrations of HFIP as well as removal of HFIP from Aβ samples as a function of the 
time of purging with nitrogen gas.  A) Current versus voltage curves of transmembrane 
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conductance as a function of HFIP concentration (Aβ was not present in these 
experiments).  The slopes of the linear best fits represent the conductance (in Siemens, 
S = Ω-1) of ions across a planar lipid bilayer made from a 1:1 (w/w) mixture of DOPS and 
POPE.  The absolute magnitudes of these conductance values varied between repeated 
experiments and between different membrane compositions; however, the relative dose-
response effect of increasing concentration of HFIP on the conductance remained the 
same.  B)  Transmembrane conductance induced by 1 mM HFIP (equivalent to 0.01% 
v/v) in planar lipid bilayers of various lipid compositions and by ~6 mM HFIP in cell 
membranes.  All indicated lipid mixtures were prepared in a 1:1 (w/w) ratio.  All 
experiments were repeated at least three times, the error bars represent the standard 
deviation from the mean conductance.  C) Removal of HFIP from samples containing 
100 μL of HFIP and 900 μL of water (concentration of HFIP ~1 M) as a function of 
purging time with nitrogen gas.  The data indicated by red circles correspond to a flow 
rate of N2 gas of ~30 mL min-1.  The data indicated by black squares correspond to a 
flow rate of 2-3 mL min-1.  All points represent average values (± standard deviation) 
from 2-6 repeated experiments.  Note, for purging times longer than 10 min with a flow 
rate of ~30 mL min-1, we observed that significant amounts of the foam that formed 
during purging escaped the microtube, thus rendering this flow rate impractical for 
purging times longer than 10 min. 
 
Since HFIP induced a significant, gradual increase in transmembrane ion flux in 
all tested membranes, we investigated its toxicity on SH-SY5Y cells using the MTT 
viability assay.  We found that HFIP was toxic to SH-SY5Y cells in a dose-dependent 
manner: a concentration of HFIP of ~30 mM (~0.3% v/v) reduced the viability of SH-
SY5Y cells to 50% (Fig. 2-3).  At HFIP concentrations above ~60 mM (~0.6% v/v), we 
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observed a 90% reduction in viability of these cells.4  Based on these results, we 
emphasize that it is critically important to remove HFIP completely before attempting to 
investigate the effect of Aβ or other samples prepared with HFIP, on cytotoxicity or on 
bilayer membranes.  
 
 
Figure 2-3. Viability of human SH-SY5Y neuroblastoma cells as a function of overnight 
exposure to increasing concentrations of HFIP.  Data are represented relative to control 
cells that were treated the same way but without HFIP (corresponding to 100% viability).  
The solid line represents a best fit to a first order exponential decay function of the form:  
Viability (%) = 100% × e-([HFIP] in mM / (41.2 ± 1.2) mM), N = 13, R2 = 0.91.  
                                                
 
4 For comparison, the ethanol concentration necessary to achieve similar cell toxicity is higher 
than 200 mM (69)  
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In order to examine the contribution of HFIP to the reported transmembrane ion 
flux across lipid bilayers in detail, we determined the residual concentration of HFIP after 
purging Aβ samples (Fig. 2-2C).  In the previously described protocol of preparing Aβ 
samples by purging of HFIP (23, 36-39, 64), the Aβ samples were subjected to a gentle 
stream of N2 gas for 5-10 min.  We found by gas chromatography and mass 
spectrometry (GC-MS) analysis of Aβ samples prepared in the same fashion that the 
residual concentrations of HFIP exceeded 200 mM in the Aβ samples (Fig. 2-2C) even 
after purging for 30 min at a flow rate of 2-3 mL min-1 or after purging for 10 min at a fast 
flow rate of ~30 mL min-1 (purging times longer than 10 min at this fast flow rate were not 
practical since they led to loss of Aβ by excessive foam formation).  Addition of these Aβ 
samples to planar lipid bilayers or to cell membranes led to a gradual increase in 
transmembrane ion flux that was similar to the one shown in Fig. 2-1B (the final 
concentration of HFIP in the bilayer chamber ranged from 5 to 20 mM).  These results 
suggest that the reported gradual increase in conductance (37-39) was due to 
incomplete removal of residual HFIP in these Aβ samples.  In contrast, when we purged 
HFIP from Aβ samples for 18 h, we found that 1) the residual concentration of HFIP in 
the Aβ samples was consistently below 10 mM and 2) that addition of these Aβ samples 
to membranes (which resulted in a final concentration of HFIP below 0.2 mM) did not 
result in a gradual increase in ion flux.  Instead, we observed in ~75% of these 
experiments a stepwise ion flux as reported previously by several research groups (Fig. 
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2-1C) (1-20, 22, 30-35).5  These ion channel-like current fluctuations were reminiscent of 
the originally reported Aβ-induced transmembrane ion flux that led to the Aβ ion channel 
hypothesis in AD (1, 22).  For comparison, Fig. 2-1D shows such stepwise current 
fluctuations through planar lipid bilayers using the original protocol for preparation of Aβ 
samples (1) that did not employ HFIP (or using a protocol for preparation of Aβ samples 
that removed HFIP completely by lyophilization for two days prior to dissolving Aβ in 
aqueous solution). 
The results presented here, along with evidence from other groups (1-20, 30-34, 
70-72), clearly demonstrate that Aβ peptides are indeed capable of forming ion pores in 
artificial membranes.  They also show that stepwise ion flux is the predominant mode of 
ion flux across artificial bilayers provided that the samples of Aβ are free of organic 
solvent.  If gradual thinning would be the predominant mechanism of Aβ-induced ion 
flux, then we would have expected to detect a gradual shift of the recorded current 
baseline under the same conditions where we observe measurable stepwise ion flux.  
Since all solvent-free Aβ preparations that we tested did not lead to gradual shifts in 
current baseline, we conclude that the postulated effect of Aβ to lower the dielectric 
barrier by gradual thinning of membranes – if existent – is small compared to the ion flux 
induced by Aβ pores.  We also note that, to the best of our knowledge, all reports that 
observed gradual membrane thinning employed Aβ samples that were prepared with 
HFIP in combination with relatively short durations of purging (< 30 min) by a gentle gas 
                                                
 
5 In the remaining ~25% of the trials, we observed a flat baseline without any detectable 
transmembrane current. 
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stream (37-39).  We, therefore, attribute the reported gradual increase in ion flux to 
residual HFIP in Aβ samples. This conclusion resolves the controversy with regard to 
Aβ-induced ion flux across artificial lipid bilayers; the results presented here confirm that 
Aβ can form ion pores in bilayer membranes. 
After establishing the stepwise nature of Aβ-induced ion flux through planar lipid 
bilayers, two questions remain: 1) can Aβ form ion pores in cellular membranes and 2) 
what is the predominant mechanism of Aβ-induced ion flux across these cellular 
membranes?  These questions are difficult to answer definitively because of the many 
direct and indirect pathways that can lead to ion flux in living cells.  Here, we provide 
additional evidence in support of the hypothesis that Aβ is capable of forming 
independent pores in cellular membranes (8). 
In order to compare ion flux induced by Aβ in artificial lipid bilayers with Aβ-induced 
ion flux across cellular membranes, we performed whole-cell patch clamp recordings on 
a human neuroblastoma cell line (SH-SY5Y cells) that we exposed to an exogenously 
introduced Aβ preparation (prepared after completely removing HFIP by lyophilization for 
two days).  In addition, we carried out whole-cell recordings from transgenic, primary 
neurons that produced Aβ endogenously.  In both cell types, we performed all recordings 
close to the resting membrane potential of the cells (i.e., at a constant applied voltage of 
-80 mV) in order to minimize the activity of voltage-gated ion channel proteins that are 
naturally (endogenously) expressed in cells. 
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Figure 2-4. Comparison of Aβ-induced transmembrane ion flux across planar lipid 
bilayers, across plasma membranes of a neuroblastoma cell line, and across plasma 
membranes of primary cortical neurons from mouse embryos.  A) Aβ-induced ion flux 
across a planar lipid bilayer (1:1 w/w POPC:POPE).  Aβ was introduced by 
proteoliposome fusion (final concentration of Aβ = 1-2 μM).  The applied potential was 
+30 mV or –30 mV as indicated.  B) Effect of the addition (arrow) of Zn2+ on the same 
membrane as in (A).  The small vertical arrows indicate the beginning and end of mixing.  
C) Control experiment with a membrane of the same composition as in (A) and (B) that 
did not contain Aβ. D) Whole-cell planar patch clamp recording of Aβ-induced 
transmembrane currents across the plasma membrane of human neuroblastoma cells 
(SH-SY5Y).  Aβ was added to a final concentration of ~10 μM to the extracellular 
solution.  The applied potential was –80 mV.  E) Recording from the same cell and under 
the same conditions as in (D) but after addition of ~2 mM Zn2+ to the extracellular 
solution.  F) Control experiment of a whole-cell recording from a SH-SY5Y cell in the 
absence of Aβ in the extracellular solution.  G)  Whole-cell planar patch clamp recording 
from a primary cortical neuron of a transgenic mouse embryo that expressed human Aβ 
endogenously.  The applied potential was -80 mV.  H) Effect of the addition of Zn2+ on a 
recording from the same cell as in (G).  I) Control experiment with a wild-type cortical 
neuron that did not express Aβ. 
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Figure 2-4 shows stepwise (or spike-like) Aβ-induced transmembrane ion flux in 
both cell types, regardless of whether Aβ was added exogenously (Fig. 2-4D) or 
produced endogenously by transgenic primary neurons (Fig. 2-4G).  It also 
demonstrates that both cell types showed no (or very rare) current fluctuations in the 
absence of Aβ (Fig. 2-4F, I).  We performed sixteen recordings of Aβ ion channel activity 
on SY-SH5Y cells and observed Aβ-induced ion flux in twelve experiments (~75%), 
while addition of Aβ induced no changes in ion flux in the remaining four experiments.  
Typically Aβ-induced current spikes occurred 5-15 min after addition of Aβ, but in at least 
one recording the activity started within less than 30 s suggesting that Aβ can induce a 
measurable current flux quite rapidly. 
In the case of the primary transgenic neurons, we recorded from eight cells that 
were extracted from three different transgenic embryos; seven of these recordings 
(~88%) showed a significant increase in the frequency of current spikes (Fig. 2-4G) 
compared to control recordings from wild-type neurons (Fig. 2-4I).  Only one of eleven 
control recordings from primary, wild-type neurons showed a frequency in current 
fluctuations similar to transgenic neurons; the other ten control cells displayed a 
significantly lower frequency of current spikes than transgenic neurons. 
Since Zn2+ ions have previously been reported to block Aβ-induced stepwise ion 
flux (7, 8, 12, 18, 35, 73, 74), we added Zn2+ to determine its effect on the observed 
current fluctuations.  In both, the SH-SY5Y and the transgenic cells, addition of Zn2+ 
reduced Aβ-induced ion flux significantly (Figs. 2-4E and 2-4H).  The inhibitory effect of 
Zn2+ in these two cell types was similar to the Zn2+-induced inhibition of Aβ ion channels 
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in artificial lipid bilayers (Fig. 2-4B).   
As mentioned above, control experiments, in which Aβ was neither introduced 
exogenously nor produced endogenously, did not result in significant stepwise or spike-
like ion flux under the same experimental conditions (Figs. 2-4F and 2-4I), indicating that 
Aβ was required to induce measurable ion flux across cellular membranes.  These 
results hence pose the question: did this measurable ion flux result from activation of 
endogenous, cellular ion channel proteins or was it a consequence of self-assembly of 
Aβ to pores in cellular membranes? 
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Figure 2-5.  Comparison of short recordings with expanded time axis of Aβ-induced ion 
flux across planar lipid bilayers, across plasma membranes of SH-SY5Y cells, and 
across plasma membranes of transgenic cortical neurons.  A) Aβ-induced ion flux 
through a planar lipid bilayer.  The final concentration of Aβ was 10 μM (applied potential 
-30 mV).  B) Aβ-induced ion flux through membranes of SH-SY5Y cells.  The final 
concentration of Aβ was ~10 μM in the extracellular solution (applied potential -80 mV).  
Current fluctuations significantly above baseline current noise are indicated with an 
asterisk.  C) Aβ-induced ion flux through the plasma membranes of a cortical neuron that 
expressed Aβ (applied potential -80 mV).  Current fluctuations significantly above 
baseline current noise are indicated with an asterisk. 
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A comparison of Aβ-induced ion flux (Fig. 2-5) revealed that the average duration 
of stepwise (spike-like) current fluctuations was significantly longer in bilayer 
experiments than in cellular recordings (although bilayer experiments also revealed 
short-lived events).  In contrast, the duration of Aβ-induced current events was similar in 
SH-SY5Y cells compared to transgenic primary neurons.  The frequency of large-
amplitude current events (i.e., events that were larger than four times the standard 
deviation of the current noise) ranged from ~3 Hz in SH-SY5Y cells to ~10 Hz in bilayer 
experiments and was, thus, similar in magnitude.  The single channel conductance of 
events ranged between 0.2-1.7 nS in planar lipid bilayers and between 0.2-0.6 nS in 
both SH-SY5Y cells and transgenic neurons.  Although these conductance values are 
not directly comparable (since the ion concentrations and lipid compositions in the 
bilayer and cellular experiments could not be matched precisely), this comparison 
suggests that the conductance of Aβ-induced stepwise ion flux in bilayers and live cells 
was on the same order of magnitude. 
In order to minimize the possibility that endogenous, cellular ion channels would 
be activated by Aβ, we performed all recordings close to the resting membrane potential 
(-80 mV) and we added a mixture of ion channel blockers to the extracellular solution; 
this mixture included (final concentration in the extracellular solution): 20 mM 
tetraethylammonium (TEA) ions to block potassium channels (75-78), 1 μM tetrodotoxin 
to block sodium channels (77-79), 2 μM nifedipine to block L-type calcium channels, and 
2 μM ω-conotoxin to block N-type calcium channels (80-85).  Fig. 2-6A shows that Aβ-
induced ion flux persisted in the presence of these blockers.  Only the addition of Zn2+ 
caused a significant reduction in Aβ-induced, large-amplitude current fluctuations in 
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these cells.  Since Aβ ion channels in artificial bilayers are blocked effectively by Zn2+ 
(Fig. 2-4B), the Zn2+-dependent blockage of Aβ-induced ion flux shown in Fig. 2-6A 
suggests that Aβ is also capable of forming ion channels in live cells.  These results do 
not exclude the possibility that Aβ may activate endogenous cellular channels; these 
channels would, however, have to fulfill at least three characteristics: 1) they would have 
to be activated at -80 mV, 2) they would have to be insensitive to the cocktail of 
blockers, and 3) they would have to be sensitive to Zn2+ ions. 
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Figure 2-6. Reduction of Aβ-induced ion flux across the plasma membrane of SH-SY5Y 
cells by Zn2+ ions or NA7 peptides.  A) Effect of Zn2+ (final concentration ~2 mM) on Aβ-
induced ion flux.  Note, these recordings were carried out in the presence of a mixture of 
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ion channel blockers containing 20 mM TEA, 1 μM tetrodotoxin, 2 μM nifedipine, and 2 
μM ω-conotoxin; these ion channel blockers did not affect Aβ-induced ion flux but 
reduced the probability that intrinsic ion channels may be responsible for the observed 
current spikes.  Large-amplitude current spikes, i.e. spikes with amplitudes above the 
threshold (black solid line), are indicated with an asterisk. B) Effect of NA7 peptide (final 
concentration ~100 μM) on Aβ-induced transmembrane ion flux.  Large-amplitude 
current spikes, i.e. spikes with amplitudes above the threshold (black solid line), are 
indicated with an asterisk.  Both recordings were carried out with an applied potential of 
–80 mV. 
 
Since it is, in principle, possible that Zn2+ ions blocked endogenous, cellular ion 
channels, we also tested the effect of a specific blocker of Aβ-induced transmembrane 
ion flux in these cell experiments. Arispe and coworkers reported that a peptide called 
NA7 (corresponding to the amino acid sequence EVHHQKL of residues 11 to 17 of Aβ, 
is an effective and specific blocker of Aβ ion channels (19, 86).  When we tested this 
peptide in SH-SY5Y cells, we found, in three of four recorded cells, up to a 3-fold 
reduction in the frequency of large-amplitude channel events induced by Aβ (Fig. 2-6B).  
This result further supports the hypothesis that Aβ can form independent ion channels in 
cellular membranes by self-assembly.  
 
2.3 Conclusion 
In conclusion, the work presented here demonstrates that Aβ can form stepwise 
transmembrane ion flux in artificial membranes.  The previously postulated membrane 
thinning that was reported to lead to gradual increase in transmembrane ion flux is likely 
not attributable to Aβ, but instead is due to residues of the solvent HFIP used to prepare 
samples of Aβ.  We found that HFIP is membrane-active and cytotoxic in the low 
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millimolar range.  Therefore, it is critical to remove HFIP in any amyloid samples before 
they are used in membrane or cellular studies.  In addition, we present evidence that Aβ 
is capable of inducing stepwise transmembrane ion fluctuations in living cells.  Although 
we cannot rule out the possibility that Aβ activates intrinsic ion channels or ion pumps in 
cells, the results presented here suggest that Aβ is capable of self-assembling into 
independent ion channels.  This conclusion is based on the following four observations: 
1) Since Aβ clearly forms stepwise ion fluctuations in planar lipid bilayers, it is plausible 
that it can form similar transmembrane ion fluctuations in cellular membranes.  2) Aβ-
induced stepwise ion fluctuations in cellular membranes occur at the resting potential of 
cells (where the activity of intrinsic ion channels is minimal) and persist in the presence 
of molecules that block the most common ion channel proteins.  3) In contrast, these Aβ-
induced stepwise ion fluctuations in cellular membranes are blocked by Zn2+ ions and a 
heptapeptide derived from the sequence of Aβ (both Zn2+ ions and this heptapeptide are 
known to block Aβ ion channels in artificial bilayers (86)).  4) Finally, Aβ-induced 
stepwise ion fluctuations in cellular membranes resemble Aβ-induced stepwise ion 
fluctuations in artificial membranes with regards to their frequency and amplitude of 
current events.  Based on these observations, we conclude that the formation of ion 
channels from Aβ could contribute to disruption of Ca2+ homeostasis that is commonly 
associated with Alzheimer’s disease. 
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2.4 Materials and methods 
2.4.1 Chemicals 
 We purchased Aβ1-40 and Aβ1-42 from Biopeptides Inc. and from Bachem Inc., 
hexafluoroisopropanol (HFIP) (GC grade) from Fluka,  and the following seven lipids 
from Avanti Polar Lipids: 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphoethanolamine 
(POPE), 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-[Phospho-L-Serine] (POPS), 1,2-Dioleoyl-
sn-Glycero-3-Phosphocholine (DOPC), 1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine 
(DOPE), 1,2-Dioleoyl-sn-Glycero-3-Phosphoserine (DOPS), 1,2-Diphytanoyl-sn-Glycero-
3-Phosphocholine (DiPhyPC), 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-[Phospho-rac-(1-
glycerol)] (POPG).  All other chemicals were purchased from Sigma Aldrich; SH-SY5Y 
cells were obtained from ATCC. 
 
2.4.2 Preparation of solutions of Aβ by purging HFIP with nitrogen gas 
  We prepared samples of Aβ by following exactly a previously reported protocol 
(23, 36-39). Briefly, we dissolved 1 mg of Aβ peptide in 400 μL of HFIP and incubated 
this solution for 15 min.  We mixed 100 μL of the resulting, clear Aβ solution in HFIP with 
900 μL of deionized water in a siliconized 1.5 mL microtube.  After incubation at room 
temperature for 15 min, we centrifuged the samples for 15 min at 14,000 × g and 
transferred the supernatant fraction (900 - 950 μL) to a new siliconized tube.  To purge 
HFIP from these samples, we bubbled nitrogen gas for 10 min through these samples, 
while adjusting the gas flow to ~30 mL min-1, which was the maximum flow rate that did 
not result in excessive foaming and splashing of the sample.  For purging times longer 
than 10 min, we had to reduce the flow rate of the N2 gas to 2-3 mL min-1 in order to 
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avoid significant loss of material due to slow but steady accumulation and expulsion of 
foam from the sample.  We analyzed aliquots of these samples for residual HFIP 
concentration by gas chromatography-mass spectrometry (GC-MS) and tested their 
ability to induce transmembrane ion flux in planar lipid bilayers and cell membranes. 
 
2.4.3 Quantification of HFIP concentrations by GC-MS analysis 
This analysis was carried out by injecting a sample volume of 2 µL into a: 
Finnigan Trace GC-MS with the following settings: run in electron impact ionization 
mode using a 30 m long, 0.25 mm ID Supelco SLB-5 column, with a film thickness of 
0.25 μm.  Helium was used as carrier gas at a constant flow rate of 1.0 mL min-1; the 
injector temperature was 200° C; the run was performed in split mode with a ratio of 
1:100; the interface temperature was 250° C, and the ion source block temperature was 
220° C.  The temperature of the GC oven was held at 40° C for 2 min and then 
increased to 150° C at a rate of 40 C min-1.  The MS ion source filament was set to an 
emission current of 150 µA at 70 eV.  HFIP standards and calibration curves were 
generated each day.  Samples with unknown HFIP concentrations were measured using 
an external calibration curve; no internal standards were used.  The quantification was 
based on the area under the GC peak in the chromatogram. Data was acquired and 
processed using Excalibur software, version 1.1. 
 
2.4.4 Formation of planar lipid bilayers  
The two reported original procedures that are at the basis of the controversy 
regarding the nature of Aβ-induced ion flux across artificial lipid membranes (1, 36) 
employed different methods to generate planar lipid bilayers.  We, therefore, prepared 
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planar lipid bilayers (also called black lipid membranes or bilayer lipid membranes, 
BLMs) either by the so-called “folding technique” (87-90), which employs apposition of 
lipid monolayers over a pore with a diameter of ~150 μm in a Teflon film or by the so-
called “painting technique” (88, 91), which applies a solution of lipids in decane or 
heptane over a pore with a diameter of ~250 μm in a Delrin septum. 
For the folded bilayers (Fig. 2-1, Fig. 2-2B columns DOPC+DOPE and DiPhyPC), 
we pretreated the Teflon film with 2 µL of 5% (v/v) squalene in pentane and then formed 
the bilayers using 5 µL of either DiPhyPC or a 1:1 (w/w) mixture of a lipid solution in 
pentane that contained DOPC and DOPE.  The total lipid concentration of these 
solutions in pentane was 20 - 25 mg mL-1 (88, 92).  The electrolyte contained 70 mM KCl 
buffered with 10 mM HEPES, pH 7.4. 
For the painted bilayers, we used a bilayer cup (Warner Instruments, Delrin 
perfusion cup, volume 1 mL) and the following four lipid mixtures at a 1:1 (w/w) ratio: 
POPG : POPE, DOPS : POPE, or DOPC : DOPE in heptane, or POPE : POPS in 
decane.  The total lipid concentration of these solutions in heptane or decane was 10 - 
20 mg mL-1.  In order to promote fusion of Aβ proteoliposomes into bilayers, we used an 
ionic gradient formed by filling the cis side (the side of proteoliposome addition) with 370 
mM KCl and the trans side of the bilayer setup with 70 mM KCl.  For these experiments, 
we prepared bilayers using a 1:1 (w/w) mixture of DOPC and DOPE (Fig. 2-1D) or 
POPC and POPE (Fig. 2-4 panels A, B, and C); the proteoliposomes containing Aβ were 
prepared as described previously (1). 
 
2.4.5 Incorporation of Aβ into lipid membranes 
 In order to repeat the procedure for preparing Aβ samples that was previously 
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described to lead to membrane thinning of planar lipid bilayers (23, 36-39), we prepared 
Aβ samples by using the solvent HFIP exactly as described and added the resulting 
solutions to both compartments of the bilayer chamber.  We diluted these samples more 
than 50-fold such that the final concentration of Aβ was 0.5-2.0 μM in each chamber of 
the bilayer setup. 
In order to repeat the alternative Aβ procedure, which was previously described 
to lead to stepwise ion flux across planar lipid bilayers (1), we added 10-20 μL of the Aβ 
proteoliposome solution (this solution contained Aβ at a concentration of 0.4 - 0.8 mg 
mL-1) to the cis compartment (volume 1 mL) and stirred for 5-10 min.  All planar lipid 
bilayers experiments with each lipid composition were performed at least 3 times, more 
typically 5-7 times. 
 
2.4.6 Current recordings 
Before carrying out bilayer recordings, we verified that both, the painted and the 
folded bilayers were stable for several minutes (while applying a voltage of at least ± 100 
mV) and that the membrane capacitances were above 90 pF.  When both criteria were 
fulfilled, we added Aβ (0.5-4.0 µM final concentration of Aβ) or HFIP (0.5-7.0 mM final 
concentration of HFIP without any Aβ present) to both chambers of the bilayer setup. 
We performed all recordings in “voltage clamp mode” using Ag/AgCl electrodes.  
We used a filter-cutoff frequency of 2 kHz, and a sampling frequency of 15 kHz for all 
bilayer recordings. For representation in figures, we filtered the current traces with a 
digital Gaussian low-pass filter with a cutoff frequency of 100 Hz. 
For whole-cell patch clamp recordings, we used the following three solutions: 1) 
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intracellular solution containing 75 mM KCl, 10 mM NaCl, 70 mM KF, 2 mM MgCl2, 10 
mM EGTA, and 10 mM HEPES buffer (pH 7.2), 2) extracellular solution containing 160 
mM NaCl, 4.5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 5 mM D-glucose, and 10 mM HEPES 
buffer (pH 7.4), and 3) a “seal enhancer” solution containing 80 mM NaCl, 3 mM KCl, 10 
mM MgCl2, 35 mM CaCl2 and 10 mM HEPES/NaOH (pH 7.4), which was added to the 
extracellular compartment to promote the formation of seals between the cells and the 
glass chip with electrical resistances higher than 1 GΩ. 
In order to introduce Aβ into membranes of SH-SY5Y cells, we first established 
whole-cell recording conditions followed by adding ~5 μL of extracellular solution 
containing Aβ to a volume of ~20 μL of extracellular solution (this Aβ solution was 
prepared without the use of HFIP by stirring for ~14 h at room temperature prior to use).  
The final concentration of Aβ in the extracellular solution during the recording was ~10 
µM. 
In order to measure the effect of Aβ and HFIP samples on SH-SY5Y cells, we 
used a semi-automated, chip-based electrophysiology instrument (Port-a-patch, Nanion 
Inc.) that allowed for recordings with seal resistances of 1-6 GΩ.  We held the voltage 
at -80 mV in the intracellular compartment versus ground in the extracellular 
compartment to measure Aβ-induced ion channel activity.  At this potential, SH-SY5Y 
cells did not show significant intrinsic ion channel activity.  Samples containing Aβ or 
HFIP were only added after confirming the stability of the recording (i.e., after observing 
a quiescent baseline for 3-5 min).  For all whole-cell recordings, we used a filter cutoff 
frequency of 1 kHz.  
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In order to determine the effect of Zn2+ ions or the peptide NA7 on Aβ-induced 
transmembrane ion flux, we added 1-10 mM (final concentration) of ZnCl2 or Zn(NO3)2 or 
100 – 140 μM (final concentration) of the NA7 peptide to the bilayer chambers or to the 
extracellular solutions. 
 
2.4.7 Preparation of primary neurons 
 Wild type female mice (C57BL/6J) were crossed with double transgenic 
hAPPswe/hPS-1∆E9 male mice, obtained from Jackson Laboratory (Bar Harbor, Maine) 
to generate wild-type, and hAPPswe/hPS-1 transgenic embryos.  Primary cortical 
neuron cultures were prepared from the brains of E16 embryos.  Briefly, the cerebral 
cortices were dissected in calcium-free and magnesium-free Hank's balanced salt 
solution and incubated with a 0.125% trypsin solution for 10 min at 37°C.  The trypsin 
was inactivated with Dulbecco's modified Eagle's medium containing 10% fetal bovine 
serum, and the cortical tissue was further dissociated by serial trituration using a Pasteur 
pipette.  The resulting cell suspensions were diluted in neurobasal medium 
supplemented with B27 supplements (Gibco BRL, Grand Island, New York, USA), and 
plated onto poly-D-lysine-coated Petri dishes.  Neurons were maintained at 37°C in a 
5% CO2 atmosphere for 4-7 days, before the experiments (93).  We carried out the 
planar patch-clamp experiments between day 4 and day 7 of culture.  The neurons were 
detached using a protocol previously described and validated by Lecoeur et al. with 
minor modifications (94).  These modifications entailed: 1) reducing the incubation time 
with trypsin-EDTA from 15 to 14 min at 37° C and 2) dissociating cell aggregates by 
increasing the number of successively aspirating and dispensing the cell suspension to 7 
times with a 1 mL pipette tip and to 15 times with a 200 μL pipette tip. 
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2.4.8 Cytotoxicity assay of HFIP with SH-SY5Y cells 
  We cultured SH-SY5Y human neuroblastoma cells in DMEM/F-12 (1:1) medium 
with 10% fetal bovine serum, 4 mM glutamax, penicillin (100 units mL-1) and 
streptomycin (100 µg mL-1) in 5% CO2 at 37° C.  We plated cells in 96-well plates 
overnight starting with 50,000 cells well-1.  After overnight incubation at 37 °C, we 
exchanged the media with Opti-MEM, and treated cells for 24 h.  We determined the cell 
viability using an MTT toxicology kit (Tox-1, from Sigma) according to the instructions 
from the supplier. 
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Chapter 3 
The Abundance of Aβ Oligomer (tetramer-18mers) Correlates  
with Pore Formation and Cytotoxicity 
 
In this chapter, we examined whether preparations of amyloid-beta (Aβ) that are 
most likely to form detectable ion pores in planar lipid bilayers were also the most 
cytotoxic preparations to a human neuroblastoma cell line (SH-SY5Y cells).  To this end, 
we determined which aggregation protocol of Aβ samples led to maximal pore formation 
and characterized these samples with regard to β-sheet content, thioflavin T 
fluorescence, and relative abundance of oligomers of different size in the mixture.  
Planar lipid bilayer experiments revealed that the probability of pore formation was 
highest with Aβ samples that had aggregated at 22 °C in deionized water for 2-3 days in 
the case of Aβ1-40 or for 2 days in the case of Aβ1-42.  Cytotoxicity studies demonstrated 
that the most cytotoxic Aβ samples were those that had aggregated for 10 d in the case 
of Aβ1-40, and 3 d or Aβ1-42.  Finally, multiple linear regression and Pearson’s correlation 
analyses revealed that pore formation was correlated most strongly with the relative 
abundance of tetramers to hexamers, while cytotoxicity correlated with the relative 
abundance of tetramers to 18 mers.  The partial overlap of Aβ oligomers that induced 
the highest probability of pore formation with those that were most toxic suggests that 
pore formation may be a contributing mechanism to the toxicity of Aβ in vitro.  The 
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observation that this overlap is not complete, however, suggests that the cytotoxic 
effects of Aβ are not solely due to pore formation. 
 
3.1 Introduction 
Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β 
peptide (Aβ) aggregates in the brain.  These aggregates form insoluble amyloid plaques 
that are the hallmarks of the AD (1-3). The major components of these amyloid plaques 
are Aβ peptides with 40 (Aβ1-40) and 42 amino acids (Aβ1-42), which are thought to play 
an important role in AD pathogenesis (4-9).  The pathogenic mechanism leading to AD 
is, however, not fully understood and several hypotheses are being actively investigated 
(10).  
These different hypotheses are based on evidence that Aβ peptides can cause 
neurotoxicity by triggering inflammatory responses, oxidative damage, dysregulation of 
ion homeostasis including Ca2+ ions, and altered kinase and phosphatase activities that 
can lead to neurofibrillary tangles. 
With regard to the question, which size of Aβ oligomers is the most important for 
the pathogenesis of AD, several in vitro neurotoxicity and in vivo studies in mouse 
models of AD (11) implicated the following oligomers as the main triggers of AD: dimers 
(12-16), trimers (17), tetramers to 9 mers (also called Aβ-derived diffusible ligands,  
ADDLs, with an estimated mass of 17-42 kDa) (18-20), 13 mers (also called  Aβ *56) 
(21, 22), and protofibrils containing aggregates larger than 100 kDa, which correspond to 
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22 mers and bigger aggregates (23-25).  In addition to these oligomeric species, some 
studies have revealed that insoluble Aβ fibrils induce neurotoxicity and impair synaptic 
transmission (26-28).   
In the work presented here, we investigated the hypothesis that Aβ peptides 
disrupt the ion homeostasis in neurons, the so-called Aβ ion channel hypothesis.  Pore 
formation by Aβ is one plausible mechanism for neurotoxicity, since such pores could 
mediate the flux of Ca2+ ions and thereby lead to cell death (6, 29-33).   
Various biochemical and biophysical techniques have indicated a range of 
aggregated Aβ species that could potentially form ion channel-like structures in artificial 
lipid bilayers and in neuronal membranes (34-36).  Jang et al. proposed based on 
molecular dynamics (MD) simulations that 16 to 24 mers of Aβ arranged to four to six 
subunits (37), which are compatible with the dimension and shape of putative  Aβ pore 
structures obtained from atomic force microscopy (AFM) (38, 39). In separate MD 
studies, Strodel et al. identified tetramers or hexamers as the most stable structures that 
could form Aβ pores (40), while Shifrir et al. suggested that Aβ channels contain 
assemblies of six hexamers (41).  Recently, Schauerte et al. combined single molecule 
fluorescence spectroscopy with conductivity measurement and reported that hexamers 
were the smallest Aβ oligomeric structure which could permeabilize lipid membranes, 
while 12 to 14 mers resulted in pores with the largest conductivity for ions (42).   
Here we used planar lipid bilayer (PLB) recordings to study the formation of ion 
pores by various Aβ preparations (33, 38, 43-49). One of the challenges that we 
encountered with this functional and sensitive assay is that various Aβ preparations did 
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not always lead to repeatable ion channel formation in PLBs (31).  The reasons for this 
poor reproducibility are that aggregation of Aβ samples is a complex, stochastic process 
(50), that depends on factors, such as ionic strength, pH, concentration of Aβ peptides, 
solvent history, and chemical nature of impurities in the Aβ samples  (33, 48, 50-61).  
Moreover, the initial aggregation state of Aβ samples varies considerably between 
different commercial suppliers (54) (see Appendix, Fig. A3-1), and even between 
batches from the same supplier (62, 63), making it difficult to reproduce functional 
experiments such as ion channel recordings on planar lipid bilayer, and neurotoxicity 
assays that depend on the aggregation state of Aβ (54, 64). 
Previous work typically addressed this challenge by preparing Aβ stock solutions 
either in strongly basic solutions (65) or in organic solvents, such as 
hexafluoroisopropanol (HFIP) (9, 66, 67), trifluroacetic acid (TFA) (68), or 
dimethylsulfoxide (DMSO)(48, 69), in which Aβ aggregates either dissociate or at least 
aggregate more slowly than in water.  The intention of these approaches was that 
starting conditions for the aggregation of Aβ would be somewhat reproducible (54).  
However, these organic solvents can produce artifacts in functional experiments with 
Aβ samples, if they are not removed effectively.  For example, residues of HFIP can 
cause significant ion flux through cellular membranes, and PLBs by thinning lipid 
membranes (33, 70).   
In order to provide defined starting conditions for Aβ aggregation while 
minimizing solvent artifacts, we pre-treated Aβ samples with HFIP, which dissociates 
most of the large aggregates, followed by lyophilization for two days to remove the 
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solvent below its detection limit by fluorine NMR (33).  We used these pre-treated Aβ 
samples as the starting material to compare five different preparation methods for the 
formation of aggregated Aβ species and for the capability of these preparations to form 
ion pores in PLBs.   
We then used the most appropriate Aβ preparation method to address the 
question which size of Aβ aggregates induces maximal pore formation in lipid 
membranes and which one causes maximal cytotoxicity—and, ultimately, is there a 
relationship between these two? To this end, we correlated the relative abundance of Aβ 
oligomers with specific sizes in a mixture of aggregated Aβ species with pore formation 
and cell death.  We used Pearson correlation analysis and multiple linear regression 
(MLR) models to describe a linear relationship between pore formation or cytotoxicity 
and a set of independent variables, which were the relative abundance of Aβ oligomers 
of different size as obtained from SDS-PAGE.  Based on this approach, we selected 
three fitting parameters for the MLR models, which represent three different size ranges 
of Aβ aggregates.  Based on coefficients that resulted from fitting the data to these 
models, we revealed which aggregated Aβ species were most important for pore 
formation or cytotoxicity.  We found that pore formation in PLB was most correlated with 
relative abundance of tetramers to hexamers of Aβ, while cytotoxicity was most 
correlated with relative abundance of tetramers to 18 mers.  A similar approach might be 
useful for other amyloid peptides which share the capability to form ion pores in lipid 
membranes.  
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3.2 Results and Discussion 
3.2.1 Pretreatment of Aβ with HFIP combined with HFIP removal is critical for the 
reproducibility of experiments     
Initial aggregation states of Aβ samples often vary between different suppliers 
and sometimes between batches from the same suppliers, (see Appendix, Fig.A3-1), 
resulting in irreproducibility of experiments that test the function of various Aβ species 
such as ion channel formation.  In order to examine Aβ samples with reproducible initial 
aggregation states, we dissolved Aβ in hexafluoroisopropanol (HFIP) to break up fibrils 
and large aggregates (9, 66, 67).  These samples were then lyophilized for two days to 
remove HFIP below the detection limit by fluorine NMR (see Appendix, Fig.A3-2).  In the 
case of Aβ1-40 samples, this HFIP-treatment dissociated all Aβ oligomers larger than 
tetramers as confirmed by Western blot analysis and improved the solubility of Aβ in 
water (see Appendix, Fig.A3-1).  In the case of Aβ1-42, this procedure was not as 
effective, but it was able to dissolve the largest aggregates (> 225 kDa) (see Appendix, 
Fig.A3-1).  Based on the importance of the initial aggregation state for the kinetics of 
aggregation of Aβ samples (51, 56, 64, 71), we carried out all experiments with HFIP-
treated Aβ samples, unless otherwise indicated.   
 
3.2.2 Pore formation is maximal after incubating Aβ samples for 2-3 days  
Figure 3-1 illustrates that both Aβ1-40 and Aβ1-42 caused channel-like ion flux 
across planar lipid bilayers that could be inhibited by Zn2+ ions, as reported previously by 
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several research groups (29, 31, 33, 38, 39, 45, 48, 72-77).  The conductance values of 
these ion channel events were not well-defined and ranged from 100 pS to 10 nS and 
the open pore lifetimes from milliseconds to several minutes.   
As reported previously, not every experiment with these five different aggregation 
methods that we tested (Table 3-1, A-E) led to pore formation.  This variability was 
possibly due to the stochastic nature of both the aggregation process (31, 50, 54, 74), 
and the interaction of these aggregates with lipid membranes (78, 79).  When comparing 
the ion channel activity from aggregated Aβ samples that were produced with different 
aggregation methods (Table 3-1), we did not observe significant differences in 
conductance or lifetime (or overall “appearance” of the current traces). 
In order to correlate the probability of pore formation by Aβ samples with the 
abundance of various Aβ aggregates and with cytotoxicity, we first determined which of 
the five pre-incubation methods of Aβ samples led to the highest probability of pore 
formation in planar lipid bilayers.  For this comparison, we defined measured current 
fluctuations as pore formation if the following five criteria were met: i) ion flux had to 
have an amplitude significantly different from the baseline current (i.e., at least ten times 
the standard deviation of the current noise) ii) ion flux had to occur toward the expected 
polarity of the applied electric field, iii) ion flux had to occur within 30 min after the 
addition of Aβ to minimize the effect of artifacts by Aβ-independent membrane 
destabilization over time, iv) ion flux had to last for at least 5 min, and v) ion flux had to 
be reduced significantly after the addition of Zn2+ ions. 
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Figure 3-1. Electrophysiological recordings for studying pore formation in planar lipid 
bilayers induced by Aβ1-40 and Aβ1-42.  A) Cartoon illustrating the experimental setup.  
Lipid bilayers were created by the so-called “painting technique” over a 250-μm aperture 
between two electrolyte compartments.  B) Example of a current recording of 
transmembrane ion flux induced by 15 μM Aβ1-40 prepared by incubation in deionized 
water for 1 d using method A in Table 3-1. C) Example of transmembrane current 
induced by 15 μM Aβ1-42 prepared by method A for 3 d.  Addition of Zn2+ to a final 
concentration of 10 mM (indicated by the vertical arrows) inhibited Aβ-induced ion flux.  
The planar lipid bilayer was formed from a 1:1 (w/w) mixture of DOPS: POPE lipids in n-
heptane; the recording electrolyte was composed of 70 mM KCl with 10 mM HEPES at a 
pH of 7.4. The applied voltage was at -50 mV. 
 
Table 3-1 shows the results from this comparison.  We observed the highest 
probability of ion channel formation with method D and E, which were both based on 
fusing Aβ-containing proteoliposomes into preformed PLB.  Unfortunately, these 
methods also destabilized bilayers in the absence of Aβ in the liposomes, leading to 
false positives in one third of control experiments.  Other disadvantages of these two 
methods were that Ca2+-induced fusion of Aβ proteoliposomes with live cells was not 
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practical and therefore this method did not allow comparison of pore formation by Aβ in 
PLBs with toxicity assays on live cells, which was one of the goals of this study. 
Moreover, fusion of positively charged Aβ proteoliposomes led to strong cytotoxicity by 
the control liposomes without Aβ. 
Finally, since the modified Kayed protocol (method C) and experiments with non-
HFIP treated Aβ (method B) led to relatively low probabilities of ion channel formation, 
we chose simple incubation of HFIP-treated Aβ in water for various times (method A) for 
all further experiments.  This method was, within statistical error, one of the most 
efficient ones and had the advantage that we could monitor aggregation over time (from 
1-4 h to 20 d) while making it possible to characterize based on circular dichroism and 
ThT fluorescence as well as the relative abundance of monomers, dimers, trimers, etc., 
to protofibrils (> 49 mers).  
Using pre-incubation of Aβ in water (method A), Fig. 3-2A shows that the 
probability of pore formation was highest when Aβ samples were pre-incubated for 2-3 d 
in the case of Aβ1-40 or for 2 d in the case of Aβ1-42.  In contrast, pore formation was least 
likely when Aβ samples were pre-incubated for 0 d or 20 d.  Control experiments, in 
which we added only diH2O without Aβ, revealed ion flux in 1 of 11 experiments; this 
activity was likely due to a sporadic instability of bilayers within the 30-min recording 
period that is typical for bilayer recordings (80).  To test statistical significance of the 
difference in success rate of pore formation by various preparation methods of Aβ 
samples, compared to the respective control experiments, we used Barnard’s exact test 
to calculate p-values for the success rates based on the binary response (81, 82) that 
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was either pore formation was observed or pore formation was not observed within 30 
minutes after adding the various sample to trans compartment of the bilayer chamber. 
Table 3-1. Comparison of different Aβ aggregation procedures with regard to 
their ability to form detectable ion channels in planar lipid bilayer recordings 
 
Preparation 
Method 
Short 
description of 
preparation 
method 
 
Final 
[Aβ], μM 
Statistics of ion flux observation, % a, b 
Control  
(no Aβ) 
Aβ1-40 Aβ1-42 
A diH2O 0 d 15-25 10 ± 10 
10 ± 10 
10 ± 10 
10 ± 10 
10 ± 10 
10 ± 10 
20 ± 10 15 ± 10 
A diH2O 1 d 15-25 35 ± 15 30 ± 15 
A diH2O 2 d 15-25      55 ± 15 (**) 40 ± 15 (*) 
A diH2O 3 d  15-25      50 ± 15 (**) 25 ± 10 
A 
 
A 
  diH2O 10 d 
  diH2O 20 d 
15-25 
15-25 
30 ± 15 
20 ± 10 
10 ± 10 
0 
B (non-lyophilized 
Aβ),diH2O0 d 
15-25 10 ± 10 20 ± 15 40 ± 15 
C HFIP/ diH2O 2 d 10-25 10 ± 10 30 ± 15 15 ± 10 
D proteoliposomes 
(DOPS) 
1-5 30 ± 15      65 ± 15 (**)  80 ± 10 (**) 
E proteoliposomes 
(positively 
charged) 
1-5 35 ± 10      75 ± 10 (**) 70 ± 15 (*) 
a Aβ ion channel activity was defined as a stepwise or spike-like current fluctuation from 
baseline within 30 min after addition of Aβ. The planer lipid bilayer was composed of    
DOPS:POPE (1:1) lipids dissolved in n-heptane at a concentration of 20 mg mL-1. 
 b The errors are standard errors of proportion of success rate in pore formation calculated by 
S.E. = ඥ݌(100 − ݌)/݊, when p the fraction of observed pore formation (in %) and n is the 
number of PLB experiments. The statistical significance of Aβ ion channel activity compared to 
the respective control sample is determined by Barnard’s exact test (* p < 0.1, and ** p < 0.05) 
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3.2.3 Cytotoxicity is maximal after pre-incubating Aβ1-40 for ten days and Aβ1-42 for 
one to ten days 
 In order to compare the cytotoxicity of the five different Aβ preparation 
procedures (method A-E) used here, we performed cell viability assays with a human 
neuroblastoma cell line.  We observed maximal cytotoxicity with method A after pre-
incubation for ten days, while the toxicity of Aβ1-42 was highest between one and ten 
days of pre-incubation (Fig.3-2B).  In addition to yielding maximal toxicity, method A 
made it possible to compare the results from cytotoxicity assays with those from the 
probability of pore formation, since both assays were done with the same samples.   
As mentioned before, the two proteoliposome-based methods (method D and E) 
were not suitable for toxicity assays, either because of inefficient Ca2+-induced fusion 
with live cells or because of strong toxicity of fusing positively-charged proteoliposomes. 
Table 3-2 also illustrates that a functional assay such as testing an Aβ preparation for 
cytotoxicity depended on the initial aggregation state of Aβ or on the formulation of Aβ.  
For instance, Aβ samples that were not dissociated in HFIP, but were instead used 
directly as received from different suppliers (method B), caused varying degrees of cell 
death.  Similar results have been reported by other groups (55, 62, 63). 
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Table 3-2. Cell death induced by different preparations of Aβ 
Preparation 
Method 
Short description  
of preparation method
Final 
[Aβ], μM 
Cell death, % a 
Aβ1-40 Aβ1-42 
A diH2O 0 d 20 15 ± 2 (***) 13 ± 2 (***) 
A diH2O 1 d 20 26 ± 2 (***) 39 ± 2 (***) 
A diH2O 2 d 20 35 ± 2 (***) 43 ± 2 (***) 
A diH2O 3 d  20 38 ± 2 (***) 44 ± 2 (***) 
A 
 
A 
   diH2O 10 d 
  diH2O 20 d 
20 
 
20 
45 ± 3 (***) 
28 ± 3 (***) 
43 ± 3 (***) 
36 ± 4 (***) 
BbGL Bioscience (non-lyophilized 
Aβ),diH2O0 d 
20 22 ± 4 (***) 40 ± 7 (***) 
BbBiopeptide (non-lyophilized 
Aβ),diH2O0 d 
20 5 ± 2 (*) 46 ± 6 (***) 
C HFIP/ diH2O 2 d 20 31 ± 4 (***) 40 ± 4 (***) 
D proteoliposomes 
(DOPS) 
1-10 not possible not possible 
E proteoliposomes 
(positively charged) 
1-10 not possible not possible 
a Cell death was defined as 100%- viability in %,  The errors are standard errors of the 
mean. 
 b Biopeptide and GL Bioscience indicate two different suppliers of Aβ 
The statistical significance of Aβ ion channel activity compared to the respective control 
sample is determined by Students’ t test (* p < 0.1, and *** p < 0.01) 
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Figure 3-2. Comparison of pore formation, and cytotoxicity as a function of aggregation 
time of Aβ samples prepared by method A.  A) Percentage of experiments that showed 
pore formation in planar lipid bilayers.  Each point represents 10-15 experiments; error 
bars represent the error of proportion. The solid blue curve is a plot of probability of pore 
formation (P) obtained from multiple linear regression model as a function of relative 
abundance of oligomers (X) from different size ranges, P = 8.67 – 1.03*X1-3mer + 4.96*X4-
6mer - 0.80*X≥ 7mer for Aβ1-40, and P = 9.05– 0.43*X1-3mer + 3.86*X4-6 mer – 1.00*X≥ 7mer for 
Aβ1-42.  The sign of coefficients for all parameters is summarized in the table adjacent to 
the graph, suggesting correlation (+) or anti-correlation (-) of the parameter for prediction 
of pore formation.   B) Cell death of human neuroblastoma SH-SY5Y cells 24 h after 
exposure to serum-free media containing 20 μM Aβ prepared by method A.  Percentage 
cell death was defined as 100% - cell viability (in %) as determined by MTT assay from 
5-15 independent experiments. The solid red curve is a plot obtained from multiple linear 
regression function which describes the percentage of cell death or cytotoxicity (T) as a 
function of relative abundance of oligomers (X) from different size ranges, T = - 0.34 – 
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0.26*X1-3mer + 1.87*X4-18 mer - 0.42*X≥ 19mer for Aβ1-40, and T = 0.05 – 0.58*X1-3mer + 
2.95*X4-18 mer + 0.04*X≥ 19mer for Aβ1-42.  
 
3.2.4. During aggregation, the relative abundance of small Aβ oligomers 
decreases, of intermediate sizes undergoes a maximum, and of large sizes 
increases. 
In order to correlate both pore formation and cytotoxicity with the aggregation 
state of Aβ samples, we used SDS-PAGE combined with Western blot analysis to 
estimate the relative abundance of monomeric and oligomeric species of Aβ as a 
function of pre-incubation time in diH2O.  In order to prevent dissociation of Aβ oligomers 
during SDS-PAGE, we crosslinked the samples for 20 minutes with 12 mM 
glutaraldehyde before heating and running the gels (83). 
We used image analysis of grey levels in scanned images from Western blots 
after SDS-PAGE (e.g. Fig. 3-3) to determine relative abundance of different-sized Aβ 
species with the following resolution: monomer, dimer, trimer, tetramer, pentamer, and 
hexamer.  For larger oligomers, individual species were difficult to distinguish on the gel; 
therefore we determined the relative abundance of oligomers larger than hexamers 
based on the molecular weight markers.  This approach resulted in the following 
resolution of ranges in molecular weight:  34-55 kDa, 55-78 kDa, and 78-210 kDa, which 
correspond approximately to 8-13 mers, 14-18 mers, and 19-49 mers, respectively. Fig. 
3-3 shows bands from aggregated forms of Aβ that did not leave the sample wells of the 
electrophoresis gels.  We labeled these (proto)fibrillar species as > 49 mers.   
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Figure 3-3. Separation of Aβ samples prepared by method A by SDS-PAGE followed by 
Western blot analysis.  Aβ1-40 (left) and Aβ1-42 (right) were incubated in diH2O for 0, 1, 2, 
3, 10, and 20 days.  All samples were crosslinked with 12 mM glutaraldehyde before 
electrophoresis was carried out using a 16.5% Tris-Tricine gel.  The position of 
molecular-weight markers are indicated on the left. 
 
Figure 3-4 shows that the relative abundance of low molecular weight aggregates 
(i.e., monomers to trimers) decreased as a function of aggregation time, while the 
relative abundance of intermediate-sized oligomers (tetramer to 13 mers in the case of 
Aβ1-40 and tetramer to hexamers in the case of Aβ1-42) underwent a maximum and the 
relative abundance of high molecular weight species (> 18 mers) increased.   
In order to fit the kinetic data in Fig. 3-4, we used one of the simplest models to 
describe the formation of Aβ oligomers (O) and (proto-) fibrils (F) from monomers (M) by 
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a system of two consecutive, first-order, reversible reactions, without considering 
stoichiometric coefficients or mechanistic details: 
M  ⇌  O ⇌ F 
As discussed by G.N. Vriens, this approach can be used to model data empirically and 
makes it possible to describe the time-dependent mole fraction of the reactant and 
product by an equation of the form (84). 
   ݕ = ݕ଴ + ܣଵ ∙ ݁஻భ∙௧ + ܣଶ ∙ ݁஻మ∙௧    (3-1) 
Here we used equation (3-1) to carry out empirical fits to the relative abundance of each 
species as a function of time in Fig. 3-4.  The red curves in Fig. 3-4 illustrate that this 
simple model was indeed able to fit the time-dependent changes of the mole fraction of 
each oligomer species well.  Therefore, on a very basic level, the kinetics of 
oligomerization and fibrillization of Aβ that we found in Fig. 3-4 could be described by a 
series of consecutive reversible reactions, as might have been predicted by G.N. Vriens. 
Regardless of their possible mechanistic relevance, these empirical fits were useful for 
the work presented here, because they describe, quantitatively, the trends of the relative 
abundance of each Aβ species during the course of the aggregation.  These trends are 
also useful for correlating the relative abundance of various species with the probability 
of pore formation and with cytotoxicity, because they result from curve fits to all six 
points in each graph and therefore represent the trend of an entire data set in each 
graph rather than a single point within each graph. 
 
k4 k2 
k1 k3 
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Figure 3-4. Relative abundance of aggregated Aβ species of different size as a function 
of pre-incubation time as determined by quantitative image analysis from Western blot 
analysis after SDS-PAGE.  Each point represents the mean value of the relative 
abundance of each species from 4-6 gels; error bars represent the standard error of the 
mean. The red curves are best curve fits of equation (1) to the data. 
 
We also quantified the relative abundance of each Aβ species from the other 
Aβ preparations (Method B-E).  SDS-PAGE/Western blotting experiments showed that 
the presence of lipid membranes in the proteoliposome formulations accelerated the 
aggregation of both Aβ1-40 and Aβ1-42 compared to Method A (see Appendix, Fig. A3-3).  
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For comparison with Western blot analysis, we used silver staining for protein 
detection since the immunoreactivity of oligomers can be conformation dependent (85).  
Results with Aβ1-40 showed that the silver stain detection; however, had low sensitivity for 
the aggregated species larger than hexamers (see Appendix, Fig. A3-4, and Fig. A3-5).  
The bands from aggregated Aβ species with intermediate and high molecular weight 
were not as clearly visible on silver stained gels than on gels developed by Western 
blotting (as reported previously by other research groups) (85, 86).  Both detection 
techniques revealed similar trends for the change of relative abundance of small 
oligomer sizes, but accurate quantification for the aggregated species greater than 
hexamers, was difficult with silver staining.  Therefore, we performed Western blot 
analysis for most of the gels used in this work. 
 
3.2.5 Pore formation and cytotoxicity correlate with the relative abundance of 
oligomers of intermediate size. 
In order to determine the correlation between the aggregated Aβ species of 
different size and pore formation or cytotoxicity, we used Pearson’s correlation analysis.  
We used the experimental data for pore formation or cytotoxicity at various aggregation 
time points, while we used calculated relative abundance values of Aβ aggregates as 
obtained from the fit to equation (1) at each respective time point for each species (as 
shown in Fig. 3-4). 
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Figure 3-5 demonstrates Pearson’s correlation coefficients, r, between the 
relative abundance of different-sized Aβ aggregates and pore formation or cytotoxicity 
(see Eq.A3-1, Appendix).  Among all of the aggregated Aβ species, we found the 
strongest correlation with pore formation or cytotoxicity for the intermediate aggregated 
Aβ species.   The probability of pore formation correlated the most with pentamers (r = 
0.808, p = 0.028) of Aβ1-40 and tetramers (r = 0.688, p = 0.087) of Aβ1-42.  In contrast, we 
found a strong correlation between cell death and hexamers (r = 0.971, p < 0.001) of 
Aβ1-40, and for 14-18 mers (r = 0.952, p = 0.001) of Aβ1-42.   
 
Figure 3-5. Summary of Pearson’s correlation coefficients between the relative 
abundance of different-sized aggregate species of Aβ1-40 and Aβ1-42 with A) pore 
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formation or B) cytotoxicity. Aβ aggregates with similar correlation with pore formation or 
cytotoxicity for both Aβ1-40 and Aβ1-42 were arranged in the same group as indicated by 
the boxed areas.  
 
Overall, Pearson’s correlation analyses suggested that Aβ oligomers ranging 
from tetramers through hexamers were the dominant aggregated species which most 
correlated with pore formation, and tetramers through 18-mers for cytotoxicity as 
indicated in Fig. 3-5.  These findings represent a similar range of Aβ oligomer sizes as 
reported previously to correlate with pore formation based on various techniques: this 
range includes tetramer through 14-mer for Aβ1-40, and tetramer through 24-mer for  
Aβ1-42 (30, 36-38, 40-42).  In previously reported cytotoxicity studies, the most toxic 
aggregated species were found within the range of dimers to the insoluble fibrils (12, 13, 
15, 16, 20, 23, 24, 26, 28, 87-91). 
 
3.2.6 Multiple linear regression models describe the relationship between multiple 
Aβ oligomer species and pore formation or cell death 
One of the main goals of this work was to test, which size range of Aβ 
aggregates led to maximal probability of pore formation in PLBs and which one caused 
maximal cytotoxicity.  In order to answer this question, we employed a multiple linear 
regression (MLR), which is a method widely used to describe a linear relationship 
between a dependent variable and a set of independent variables (92).  For the 
approach taken here, the independent variables (Xi) were relative abundance of all 
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aggregated species (in %) as obtained from quantification analyses of SDS-PAGE 
combined with Western blot.  While the dependent or response variable (y) of interest 
was either the probability of pore formation (in %) or cell death (in %) as described in 
equation (A3-2) (see Appendix). MLR can be used to describe pore formation or 
cytotoxicity as a function of the relative abundance of Aβ aggregates of all sizes starting 
from monomers to large aggregates (> 49 mers).  The abundance of Aβ species in each 
combination was expressed with its own Xi value, which changed during the course of 
the aggregation.   
We determined the relative importance of each aggregated Aβ species by 
comparing coefficients of all variables by assuming that relatively high values of 
coefficients suggested relatively important variables for the response.  We selected three 
parameters for “simplicity of description” for a model in order to use as few meaningful 
variables as possible to make it easier to understand the process (92).  Based on the 
Pearson’s correlation coefficients given in Fig. 3-5, we selected the appropriate 
predicting variables for MLR models to describe pore formation and cytotoxicity, where 
these variables represent three different size ranges of aggregates, including 1) small Aβ 
aggregates (< tetramers), 2) intermediate Aβ oligomers (tetramers through hexamers or 
tetramers through 18-mers), and 3) (proto) fibrils (> hexamers or > 18-mers).  We used 
the data of relative abundance of Aβ aggregated species, pore formation and cytotoxicity 
to fit with MLR models and obtained coefficients for the models as summarized in Table 
3-3.  Based on adjusted R2 values, p-values and residual mean squares (RMS) values 
obtained for each model, we found that the MLR model of the same sets of predicting 
parameters (either model I or model II) could not fit equally well for both pore formation 
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and cytotoxicity, in the case of Aβ1-40; however the dominant Aβ aggregates for both 
cases appear to be the intermediate oligomers as determined by the values of 
coefficients.  In the case of Aβ1-42, both models could describe pore formation and 
cytotoxicity reasonably well.   
Table 3-3. Summary of multiple linear regression models, which best described the 
probability of pore formation (P) and percentage of cell death (T) by various aggregate 
species of Aβ† 
Model                                          Aβ1-40 Adjusted R2 p-values† RMSǂ 
 
      I        P = –1.03*X1-3 mer  + 4.96*X4-6 mer –  0.80*X ≥ 7 mer – 8.67 
 
      II       P = – 0.81*X1-3 mer + 3.75*X4-18 mer –  2.28*X ≥ 19 mer + 10.09 
 
      I        T = – 0.08*X1-3 mer  + 1.33*X4-6 mer + 0.40*X ≥ 7 mer – 0.55 
 
      II       T = – 0.26*X1-3 mer + 1.87*X4-18 mer –  0.42*X ≥ 19 mer – 0.336 
 
0.683 
 
0.616 
 
           
0.859 
 
0.971 
 
p1=0.108, p2=0.049,  
p3 =0.154, p4=0.403 
 
p1=0.164, p2=0.065, 
p3=0.113, p4=0.380,  
 
p1=0.809, p2=0.272, 
p3=0.231, p4=0.930 
p1=0.115, p2=0.012, 
p3=0.218, p4=0.905     
 
80.07
 
97.17 
 
 
32.50 
 
 6.76 
Model                                          Aβ1-42 Adjusted R2 p-values† RMSǂ 
 
      I         P = –0.43*X1-3 mer  + 3.86* X4-6 mer –  1.00* X≥ 7 mer + 9.05 
      
      II       P = – 0.51*X1-3 mer + 2.35* X4-18 mer –  1.73* X≥ 19 mer + 9.02 
 
      I        T = – 0.52*X1-3 mer  + 3.98* X4-6 mer + 0.57* X≥ 7 mer + 0.09 
 
      II       T = – 0.58*X1-3 mer + 2.95* X4-18 mer +  0.04* X≥ 19 mer + 0.05 
 
 0.831 
 
0.809 
 
 0.966 
 
0.961 
 
p1=0.140, p2=0.021, 
p3=0.049, p4 =0.210 
 
p1=0.131, p2=0.030, 
p3=0.020, p4=0.236  
 
p1=0.021, p2=0.003, 
p3=0.849, p4=0.988 
p1=0.029, p2=0.005, 
p3=0.031, p4=0.982     
 
32.34 
 
36.60
 
 
 
31.00
 
35.54 
†  p-values correspond to statistical significance for coefficients of fitting parameters and a constant for 
each MLR model starting from the left of the equation 
ǂ RMS: residual mean squares is a measure of closeness of the observed (yi) and predicted values from 
the model (ŷi), which are calculated from ∑ (௬೔ି௬ො೔)
మ
௡ି௣ିଵ , when n is a number of observation, and p is a number 
of fitting parameters in the model 
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The results from these MLR models suggest that aggregated Aβ species of 
intermediate size were the most important for pore formation (tetramers through 
hexamers), while smaller or larger aggregates than this size range were less important.  
For cytotoxicity, the dominant Aβ aggregates were tetramers through 18-mers for both 
Aβ1-40 and Aβ1-42.  In the case of Aβ1-42, the oligomers larger than 18-mers partially 
contributed to the cytotoxicity, suggesting that cytotoxic forms of Aβ1-42 were found in a 
broader size range than Aβ1-40. 
In addition, we extrapolated the predicted probability of pore formation and 
cytotoxicity using these selected MLR models on the plots of experimental data in Fig. 3-
2A and 3-2B, where the solid curve represented the appropriate model for each case 
(model I for pore formation, and model II for cytotoxicity), while the dotted curve 
corresponded to the model, which yielded a less satisfactory fit.  Although both model I 
and II for each case of pore formation or cytotoxicity presented in Table 3-3 and Fig. 3-
2A and 3-2B varied slightly in their prediction of the dominant Aβ species between the 
models, the coefficients with the largest values in these models converged to the similar 
range of most important Aβ oligomer sizes.  Figure 3-6 illustrates the final results 
obtained from the models suggesting that the important Aβ oligomers for pore formation 
ranged from tetramers through hexamers, while tetramers through 18-mers were most 
cytotoxic.   
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Figure 3-6. Comparison of the size of Aβ aggregates that led to maximal pore formation 
with those that cause maximal cytotoxicity determined from multiple linear regression 
models.  The dark shade of color indicated relatively strong correlation with the 
parameter of interest (pore formation or cytotoxicity) compared to all size range of Aβ 
aggregates based on the values of coefficients.  The presence of tetramers through 
hexamers suggested the strongest contribution to probability of pore formation, while 
tetramers through 18-mers most correlated with cytotoxicity. 
 
3.2.7 Characterization of aggregation of Aβ by Thioflavin T binding assay, circular 
dichroism, and transmission electron microscopy 
We used thioflavin T (ThT) fluorescence to monitor the formation of Aβ fibrils and 
measured the circular dichroism (CD) spectra from 190 to 260 nm to examine the extent 
of secondary structure in the samples of Aβ1-40 and Aβ1-42 in diH2O after pre-incubation 
times of 0, 1, 2, 3, 10, and 20 d.  Figure 3-7 shows that the ThT signal in the Aβ1-40 
samples reached approximately 80% of the maximum intensity within 2 days.  After this 
time point, further increases in ThT fluorescence were much slower.  Samples of Aβ1-42 
aggregated faster than Aβ1-40; we observed approximately 60% of the maximum intensity 
after 1 day of incubation and approximately 80% after 2 days. 
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With regard to secondary structure, CD data revealed that the relative amount of 
β-sheet followed a similar trend as the ThT signal, i.e., a rapid increasing during the first 
1-2 days, followed by a slower increase as aggregation continued (see Fig. 3-8 and 
Table 3A-1).  Interestingly, the time point where the rate of ThT and CD signal slowed 
corresponded to the maximal probability of pore formation and cytotoxicity. 
 
 
Figure 3-7 Fibril formation of Aβ over time determined by relative intensity of ThT 
fluorescence (black), and the relative β-sheet content (in %) as determined from CD 
spectra (red). The solid curves are fits of ThT fluorescence intensity or β-sheet content 
(y) as a function of time (t) to a sigmoidal function,  y = ܣଵ −
஺మ
ଵାୣ୶୮ (೟ష೟బ೟భ )
 , where A1, A2, t0, 
t1 are constants.  Each point represents an average value from 5-20 experiments for ThT 
binding assays, and from 3-5 experiments for CD experiments.   
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Figure 3-8. Circular dichroism spectra of Aβ1-40 (left panel) and Aβ1-42 (right panel) 
samples prepared by method A. using increasing incubation times.  Aβ samples were 
diluted in 10 mM sodium phosphate buffer to a final concentration of 20 μM.  With 
increasing incubation time, the β-sheet content in Aβ samples increased, while the 
random coil content decreased. 
 
We also confirmed by Transmission electron microscope imaging that 
aggregates of Aβ1-40 and fibrils evolved over the aggregation time.  Figure 3-9 revealed 
that Aβ samples at 0-d incubation contain mostly the small amorphous aggregates, 
developed into protofibrils, and eventually long fibrillar structures as the incubation time 
progressed.  We began to observe Aβ fibrils after 2 days of incubation and these 
structures were predominant after 3 d of incubation. 
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Figure 3-9. Transmission electron micrographs of Aβ1-40 at various aggregation states. 
Aβ1-40 sample was prepared in diH2O at a final concentration of 1 mg mL-1, and was 
incubated under a controlled temperature at 22 °C while shaking at 750 RPM.   
 
3.3 Conclusion 
One of the proposed mechanisms of Aβ-induced neurotoxicity is pore formation.  
At least six studies based on various techniques (22, 49-53) have identified that 
aggregated forms of Aβ with a broad range of sizes can form pore-like structures in lipid 
membranes.  We used MLR models and Pearson’s correlation analyses to determine 
the relationship between the relative abundance of various aggregated species of Aβ 
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and probability of pore formation in PLB as well as cytotoxicity in human neuroblastoma 
cells.  These MLR models suggested that the probability of pore formation by Aβ1-40 or 
Aβ1-42 correlated with the relative abundance of tetramers through hexamers, while 
cytotoxicity was correlated with the relative abundance of tetramers through 18-mers.  
We concluded that the overlap between the most important Aβ oligomer species for pore 
formation and cytotoxicity for Aβ1-40, and Aβ1-42 suggests that pore formation may indeed 
be an important contributor to Aβ-induced cytotoxicity.  Altogether, the results presented 
here identify Aβ oligomers with four to 18 monomers as the most relevant for both pore 
formation and cytotoxicity. 
 
3.4 Materials and Methods 
3.4.1. Chemicals 
We purchased all of the lipids from Avanti Polar Lipids Inc. (Birmingham, AL), 
while we obtained Aβ peptides, both Aβ1-40 and Aβ1-42, from Biopeptide Inc. (San Diego, 
CA), GL Biochem Ltd. (Shanghai), and Bachem Inc. (Torrance, CA).  We obtained 
1,1,1,3,3,3 hexafluoro-2-propanol (HFIP) (GC grade, > 95% purity) from Fluka; 
potassium chloride (KCl), HEPES, and hexane from Fisher Scientific.  All other 
chemicals and reagents were obtained from Sigma-Aldrich (St. Louis, MO).  
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3.4.2. Lipid preparation 
The lipid compositions used for forming planar lipid bilayers were DOPS:POPE 
(1:1, w/w) at a concentration of 20 mg mL-1 in n-heptane.   After drying 200-300 μL of the 
lipid solution in chloroform in a glass vial with a rotary evaporator under vacuum for 1 h, 
we resuspended the resulting lipid film in n-heptane or n-hexane. 
 
3.4.3. Formation of planar lipid bilayers 
We used a lipid mixture of DOPS:POPE(1:1) in n-heptane for the formation of all 
bilayers in bilayer recording experiments.  We prepared planar lipid bilayers using the 
“painting method” (93, 94) by applying a solution of 20 mg mL-1 DOPS:POPE in n-
heptane over an aperture with a diameter of ~250 μm in a Delrin cup (Warner 
Instruments).  Before bilayer formation, we pretreated these apertures with a droplet of a 
solution of 20 mg mL-1 DOPS:POPE in n-hexane.  Both compartments of the bilayer 
chamber (cis and trans) were filled symmetrically with electrolytes containing 70 mM KCl 
with 10 mM HEPES buffer adjusted to pH 7.4 with HCl unless indicated otherwise.  For 
each experiment, we confirmed the stability of the lipid membrane by applying a voltage 
of ± 100 mV for 10 min before addition of Aβ or control samples to both compartments 
followed by stirring for 5 min using a magnetic stir bar and stir plate for planar bilayer 
recordings (SPIN-2, Warner Instruments).  We monitored the capacitance of the bilayers 
throughout the recordings using the built-in capacitance compensation of the amplifiers 
(see below) and continued the current recording up to 1 hour after addition of Aβ 
samples to monitor the ion channel activity with an applied voltage of – 50 mV.  In most 
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experiments, we also tested the inhibition of Aβ ion channel activity by addition of 
Zn(NO3)2 to a final concentration of 10 mM. 
 
3.4.4. Current recordings across planar lipid bilayers 
For current recordings, we used amplifiers in voltage clamp mode (Geneclamp-
500 amplifier from Axon Instruments, or a BC-535 amplifier from Warner Instruments). 
The compartment of the bilayer chamber that was connected to the amplifier head stage 
by a Ag/AgCl electrode is referred to as cis compartment, the other one as trans 
compartment.  We monitored the ionic current across the planar bilayers with a filter 
cutoff frequency of 2 kHz of the built-in 4-Pole Bessel filter of the amplifiers and recorded 
currents using an A/D converter card from National Instruments (PCI-6221) with a 
sampling frequency of 15 kHz and LabVIEW 7.1 software.  For analysis, data were 
filtered with a Gaussian filter at 100 Hz and analyzed by using the software Clampfit 9.2 
software (Axon Instruments).  
 
3.4.5. Preparation of Aβ samples 
To break up large aggregates of Aβ, we dissolved all Aβ powders that we 
obtained from different suppliers in HFIP at a concentration of 1 mM and incubated 
these solutions for 24 hours at room temperature in a glass vial.  We then diluted these 
samples in cold (4 °C) deionized water at a 2:1 (v/v) ratio (H2O:HFIP).  After aliquoting 
the resulting Aβ solution into glass vials, we immediately froze these aliquots in liquid 
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nitrogen followed by lyophilization for two days to remove HFIP below the detection limit 
by fluorine NMR (see Fig. A3-2, Appendix).  Unless noted otherwise, we used the Aβ 
powder from these HFIP-treated lyophilisates for all experiments. 
Method A: Aggregation of Aβ in deionized H2O  
Before starting the aggregation process, we dissolved the Aβ powder in diH2O at 
a concentration of 1 mg mL-1 in siliconized microvials (Fisher Scientific, Pittsburg, PA), 
shock-froze 50-300 μL of these solutions in liquid nitrogen and stored them at -80 °C.  
To start the aggregation of Aβ samples, we thawed these Aβ samples and incubated 
them while shaking at 750 RPM at a temperature of 22 °C in a thermomixer (Eppendorf, 
Hauppauge, NY) for 1, 2, 3, 10 and 20 d (with an error of ± 4 h for each day).  The 0-d 
sample was typically used within 0-2 h after thawing the samples.   
Method B: Aggregation of non-HFIP treated Aβ in deionized H2O  
This method was exactly the same as method A, with the exception that we used 
Aβ powder as obtained from the suppliers without HFIP treatment. 
Method C : Aggregation of Aβ in HFIP/ diH2O for 2 d  
 This method is a modified version of a preparation method of amyloid oligomers 
reported by Kayed et al. (43, 44, 95).  We made modifications to minimize the artifacts 
by remaining HFIP solvent in the Aβ samples (33).  Briefly, we resuspended 1.0 mg of 
lyophilized Aβ powder in 400 μL HFIP for 15 min at room temperature. We then diluted 
100 μL of this Aβ solution with 900 μL deionized H2O in a siliconized microvial, and 
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incubated this solution for 15 min at room temperature, followed by centrifugation at 
14,000 x g for 15 min at 22 °C.  We transferred 950 μL of the supernatant to a new 
siliconized microvial and exposed it to shaking at 750 RPM for 2 d (48 ± 4 h) at a 
temperature of 22 °C.  During this incubation, we kept the lid of the microvial open, in 
order to remove HFIP by evaporation.  We have shown previously that this method 
removed HFIP sufficiently to carry out planar bilayer recording without detectable 
artifacts (33).  We calculated the final concentration of Aβ from the remaining volume of 
Aβ solution after this two-day incubation.  
Method D and E: Aggregation of Aβ in proteoliposomes  
To prepare proteoliposomes with Aβ, we followed the original method described 
by Arispe et al (29) (method D).  We evaporated 20 μL DOPS lipids in chloroform (20 mg 
mL-1) in a glass vial with a rotary evaporator under vacuum for 1 h and formed liposomes 
using the gentle rehydration method in 30 μL of a 1 M potassium aspartate solution with 
a pH of 7.2, followed by bath sonication for 10-15 min.  We mixed the liposome 
suspension with 1 mg mL-1 Aβ solution in water to reach a final concentration of 0.4-0.5 
mg mL-1 of Aβ.  This mixture was then sonicated for 10-15 min to produce Aβ 
proteoliposomes. 
In order to initiate fusion of Aβ proteoliposomes into a preformed PLB, we added 
10-30 μL of the Aβ proteoliposome solution to the cis compartment to reach a final 
concentration of ~ 1-5 μM of Aβ.  In order to promote fusion, we established an ionic 
gradient of 370 mM KCl with 1 mM CaCl2 on the cis side and 70 mM KCl on the trans 
side of the bilayer setup.   
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In an alternative approach, (method E) with the intent to remove the requirement 
of Ca2+-mediated fusion, we adapted this method by forming liposomes containing 
positively charged lipids, 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) before 
incorporating Aβ.  Instead of using 100% DOPS lipids, we used a mixture of 
DOTAP:DOPS:POPE:POPC (3:1:4:2, by weight). Fusion of these positively charged 
proteoliposomes did not require an ionic gradient for planar lipid bilayer recordings as 
they fused spontaneously to the PLB. 
 
3.4.6 Cytotoxicity assay 
SH-SY5Y human neuroblastoma cells obtained from ATCC were maintained in 
5% CO2 at 37 °C in Dulbecco’s Modified Eagle’s medium (DMEM)/F-12 (1:1) containing 
10% (v/v) fetal bovine serum, 4 mM glutamax, 100 U mL-1 penicillin and 100 μg mL-1 
streptomycin.  All cell culture reagents were purchased from Invitrogen (Carlsbad, CA).  
We seeded cells in 96-well plate (50,000 cells well-1) 24 h before performing cell viability 
assays.  We diluted Aβ samples as described previously with serum-free Opti-MEM 
medium (33).  We exchanged the culture medium with the fresh Aβ-containing Opti-
MEM medium such that the final concentration of Aβ was 20 μM.  After 24 h of 
incubation, we determined cell viability using an MTT cell proliferation assay (ATCC), 
according to the instructions from the supplier.  
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3.4.7 SDS-PAGE/Western blotting 
In order to maintain the aggregation state of Aβ samples during SDS-PAGE, we 
crosslinked the Aβ peptides with 12 mM glutaraldehyde for 20 min, followed by addition 
of 1 M Tris buffer to stop the reactions (38, 83)}. We then diluted these Aβ samples in 
Tricine sample buffer (Bio-rad), containing 200 mM Tris-HCl at pH 6.8, 40% glycerol, 2% 
w/v SDS, 0.04% w/v Coomassie Blue G-250, and 2% β-mercaptoethanol, and heated 
them at 95˚C for 5 min.  We separated these samples by SDS-PAGE using 50 ng of Aβ 
for each sample using a 1-mm-thick, 16.5% Tris-Tricine SDS gel (Bio-rad) in 100 mM 
Tris-HCl, 100 mM tricine, and 0.1 % SDS (unless indicated otherwise), operating at 100 
V.  We then transferred the samples from the gel to a polyvinylidene fluoride (PVDF) 
membrane (PerkinElmer Life Science).  After incubation in a blocking solution containing 
5% w/v nonfat dry milk in Tris-buffered saline (TBS) with 0.0625% w/v Tween 20 for 1 h 
at room temperature with a gentle agitation, we washed the membrane three times for 5 
minutes with 50 mM Tris, 150 mM NaCl, and 0.05% Tween20 (TBS-T), and then 
incubated the membrane with a primary antibody 6E10 (monoclonal antibody against 
Aβ) diluted in 5% nonfat dry milk in TBS-T (1:4000 dilution, v/v) for 1.5 hour, followed by 
washing three times with TBS-T for 5 minutes each time.  We then incubated the gels 
with an anti-mouse IgG-horseradish peroxidase conjugated secondary antibody 
(Southern Biotech, Birmingham, AL) diluted in 5% nonfat dry milk in TBS-T (1:8000 
dilution, v/v) for 1 hour under a gentle agitation. 
We detected the Aβ aggregated species on the PVDF membrane by using an 
enhanced chemiluminescence detection kit (ECL, PerkinElmer Life Sciences) according 
to a protocol from supplier.  We developed images of gels using Hope Micro-MAX film 
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processor Model 319 (Hope X-ray Products Inc., Warminster, PA).  We estimated the 
molecular mass of the Aβ aggregates based on rainbow molecular weight markers 
(Amersham Biosciences, Pittsburg, PA) and SeeBlue Plus2 pre-stained standard 
markers (Invitrogen, Carlsbad, CA) 
 
3.4.8 SDS-PAGE/silver staining 
For silver staining detection, we used the same type of gel as used in Western 
blotting.  We loaded each well in the gels with 2 μg of the different Aβ samples.  After gel 
electrophoresis, we fixed the polyacrylamide gels by incubating them for 90 minutes in 
an aqueous solution containing 10% (v/v) acetic acid, and 45% (v/v) ethanol under a 
gentle agitation, followed by washing the gels with diH2O for 30 minutes.  After 
incubating the gel in 32.5 μM dithiothreitol (DTT) for 30 minutes, we stained the proteins 
with 0.1% (w/v) silver nitrate for 30 minutes, followed by rinsing the gels in diH2O.  In the 
developing step, we soaked the gels in the developing solution (an aqueous solution 
containing 0.0365% (v/v) formaldehyde and 3%(w/v) Na2CO3) until the bands on the gel 
were visible.  We then rinsed the gel with diH2O, incubated the gels with 5% acetic acid 
for 1 minute to stop the destaining process, and imaged the gels with a dual light 
transluminator (Fotodyne Inc. Hartland, WI). 
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3.4.9 Quantification of the relative abundance of Aβ species  
After obtaining the scanned images of gels from Western blotting or silver 
staining in TIFF format, we converted the images into 256 grayscale mode, and adjusted 
the levels of brightness and contrast of the scanned image by using Adobe Photoshop 
CS3 software to maximize the dynamic range of the resulting image histograms which 
represent a distribution of intensity of all image pixels.  We then imported each image 
into Matlab 7.9 software and determined the intensity values of all image pixels by using 
the Image Processing Toolbox of the program.  For each lane of the gel, we obtained a 
matrix which contained intensity values ranging from 0 to 255, corresponding to the 
image pixels, where 0 corresponds to the darkest pixel, and 255 correspond to the 
lightest pixel on the image.  We scaled the intensity of the darkest pixel on the band to 1 
and the lightest pixel located in the area outside the band to 0, and combined these 
values in each row of the matrix to obtain an intensity profile for each Aβ sample.  To 
determine the relative abundance of each aggregated Aβ species (i.e., monomer, dimer, 
trimer, etc.), we integrated the area under the respective peak on the intensity profile 
and divided it by the sum of the intensity values from all pixels in the same lane.  For the 
aggregated species which were larger than hexamers, individual species were not 
distinguishable on the gel; therefore we estimated the relative abundance of oligomers 
based on the positions of molecular weight markers on the same gel and combined the 
intensity of the pixels with the following ranges: 34-55 kDa, 55-78 kDa, and 78-210 kDa, 
which correspond to approximately 8-13 mers, 14-18 mers, and 19-49 mers, 
respectively.   
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3.4.10 ThT binding to aggregates of Aβ peptides 
To monitor the fibril formation of Aβ as a function of the incubation time, we 
measured the fluorescence intensity of ThT after different incubation times.  For each 
incubation time point, we diluted 30 μL of each Aβ sample to a final concentration of 10 
μM Aβ with an aqueous buffer containing 10 mM of NaH2PO4/Na2HPO4 pH 7.0, 150 mM 
NaCl, and 15 μM of ThT (96).  After mixing, we transferred 30 μL of the resulting Aβ 
sample into a disposable cuvette (Precision Cells, Inc., Farmingdale, NY), and incubated 
the sample for 5 minutes at room temperature.  We measured the intensity of ThT 
fluorescence at an emission wavelength of 485 nm using an excitation wavelength of 
440 nm, with a Fluorolog-3 spectrofluorometer (Horiba Jobin Yvon, Edison, NJ).  We 
calculated the relative ThT fluorescence intensity with respect to the maximum 
fluorescence when Aβ was incubated for 20 d. 
 
3.4.11 Circular Dichroism Spectrometry 
 We measured the CD spectra of 20 μM Aβ samples in 10 mM 
NaH2PO4/Na2HPO4 pH 7.4 at a temperature of 25 °C using a wavelength range of 190-
260 nm in a quartz cuvette with a path length of 0.1 cm (Starna), and an Aviv model 202 
circular dichroism spectrometer (Aviv Biomedical Inc., Lakewood, NJ).  Each CD 
spectrum was averaged from 5 consecutive scans and followed by a subtraction of its 
buffer control spectrum which was averaged from 3 consecutive scans.  The secondary 
structures of Aβ were analyzed using the CONTINLL algorithm, which is available 
through the CDPro software with reference basis set of SDP42 (97).  
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3.4.12 Transmission Electron Microscopy 
We prepared the samples for TEM analysis by using negative staining method. 
We applied 5 μL of each Aβ sample which was pre-incubated at various aggregation 
times to glow-discharged Formvar/carbon coated on 200 mesh copper grids (Fisher 
scientific).   After adsorption for 2 min, we washed the grids with 5 μL deionized water, 
and applied a 5-μL drop of 2% uranyl acetate for 1 min.  We blotted off the excess fluid 
on the grids with filter paper and allowed the grids to dry.  We examined the images of 
negatively stained Aβ structures, using JEOL 3011 High resolution electron microscope 
(Jeol Ltd., Tokyo, Japan). 
 
3.4.13 Statistical analysis 
To determine statistical significance of differences between Aβ samples from 
different pre-incubation times, we determined all p-values using a two-sample Student’s 
t-test from the Origin 8.0 software package (Northampton, MA).  Since the results from 
the pore formation experiments were binary responses, we used Barnard’s exact test, 
which is a statistical test to determine the exact p-values between binary responses (see 
Appendix). We obtained a Matlab algorithm for calculating Barnard’s exact test from the 
Matlab Central site (98). 
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Chapter 3 Appendix  
A3-1. Comparison of aggregation states of Aβ samples from different suppliers 
with and without HFIP-treatment and lyophilization for 2 d 
 
 
 
 
 
 
Figure A3-1. SDS-PAGE/Western Blot of Aβ samples from different suppliers with or 
without treatment with HFIP followed by lyophilization.  All Aβ samples were prepared 
freshly in deionized H2O at a concentration of 1 mg mL-1. Each well in the 18%Tris-HCl 
gel (Bio-rad) was loaded with 0.2 μg of Aβ. Lane 1 = Bachem (non-lyophilized); 2 = GL 
Biochem, Ltd (Shanghai) (non-lyophilized); 3 = Biopeptide Inc. (non- lyophilized); 4 = GL 
Biochem, Ltd (Shanghai) (lyophilized); and 5 = Biopeptide Inc. (lyophilized).  
Aggregation of Aβ varies in commercial sources.  HFIP treatment followed by 
lyophilyzation removed all aggregates of Aβ larger than ~ 12 kDa in the case of Aβ1-40 
and it removed large Aβ aggregates (>225 kDa) in the case of Aβ1-42.   
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A3-2. Detection of HFIP by 19F-NMR in Aβ samples after lyophilization for 2 d 
 
 
Figure A3-2. 19F-NMR spectroscopy of HFIP in CD3OD (left) and Aβ1-40 sample that was 
incubated with HFIP and then lyophilized for two days as described in the Materials and 
Methods section (right). 19F resonance of HFIP gave a doublet at -77.8 ppm, while the 
peak was absent after Aβ was lyophilized in HFIP for 48 h. 
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A3-3. Comparison of aggregation states of Aβ from various preparation methods 
 
 
Figure A3-3. SDS-PAGE/Western blotting of Aβ1-40 and Aβ1-42 samples from various 
preparation methods. 1) Method B: non-HFIP treated Aβ in di-H2O with 0-d incubation; 2) 
Method C: Modified Kayed preparation (HFIP/di-H2O that entailed evaporation of HFIP 
during 2-d incubation); 3) Method D: Aβ proteoliposomes containing DOPS; and 4) 
Method E: Aβ proteoliposomes containing 30% of positively charged lipids, DOTAP. The 
high molecular weight oligomers from these four samples indicate that these 
preparations accelerated the aggregation of Aβ compared to preparations in diH2O (e.g. 
lanes 4 and 5 in Figure 3-1) (78, 79). 
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A3-4. Determination of aggregation states of Aβ by SDS-PAGE/silver staining 
 
 
Figure A3-4. Silver staining after SDS-PAGE of Aβ1-40 samples prepared by method A 
for 0 - 20 d.  Two micrograms of sample was loaded into each well.  The relative amount 
of intermediate (dimers to hexamers) or large aggregates of Aβ (the species in lane 10 
and 20 in the stacking gel) increased with incubation time.  The stacking portion of the 
silver stained gel appeared with a dark background even in the absence of protein 
(blank) as shown in the first lane on the left of the gel, making quantitative analysis of 
large aggregates difficult. 
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A3-5. Quantification of relative abundance of aggregate species with silver 
staining detection technique 
 
Figure A3-5. Relative abundance of various Aβ1-40 aggregates of different size obtained 
after SDS-PAGE and silver staining.  The intensity on the gel was corrected by 
subtraction with the blank (in the absence of protein).  Each point represents the 
average of relative abundance of aggregates from six independent gels and samples; 
error bars represent the standard error of the mean. 
 
A3-6. Pearson’s correlation 
 Pearson’s correlation, r, is a statistical measure of the correlation between two 
variables, giving a value between +1 and -1; a positive value implies a positive 
association and negative value implies the inverse relationship.  The Pearson’s 
correlation coefficient, r, is calculated by equation (A3-1). 
  ݎ = ∑ (௑೔ି௑ത)(௒೔ି௒ത)
೙
೔సభ
ට∑ (௑೔ି௑ത)మ(௒೔ି௒ത)మ೙೔సభ
     (A3-1) 
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where xi represents aggregated Aβ species) and yi represents probability of pore 
formation or cytotoxicity.  We examined the Pearson’s correlations between the relative 
abundance of each aggregated species obtained from the fit to the equation (1) and the 
probability of pore formation or cytotoxicity.   
 
A3-7. Multiple Linear Regression  
A multiple linear regression (MLR) model can be used to describe a given 
process for a complex interacting system.  The purpose of Eq. (A3-2) is to clarify the 
nature of this complex interaction, in this case, a mixture of monomeric and aggregated 
Aβ species.  The MLR model expresses a dependent variable as a linear function of a 
set of predicting variables with a constant as shown in Eq.(A3-2) under the following 
assumptions: 1) the relationship between the dependent variable and independent 
variables is linear, 2) the errors are independently and normally distributed, and 3) 
observations are independent of one another (92). 
y = β0 + β1x1 +β2x2 + … +βnxn    (A3-2) 
where   y = response or dependent variable, 
  xi = predicting or independent variable 
β0 = regression constant, 
βi = coefficient on the ith predicting variables, 
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n = number of predicting variables 
The model is estimated by a least squares method, which minimizes the sum of 
squares of errors (εi2) between predicted (ŷ) and observed data (y), as given by the 
following equation (92).  
   ∑ ߝ௜ଶ௡௜ୀଵ = ∑ (ݕ௜ − ݕො௜)ଶ௡௜ୀଵ     (A3-3) 
For each model, we selected Xi values from different combinations of the relative 
abundance of aggregated Aβ species, while including the entire range of aggregated 
species in the model.  Based on the control for both pore formation experiments and 
cytotoxicity assays, we determined the probability of pore formation (as well as the 
percentage of cell death) in the absence of Aβ (i.e., when the relative abundance of all 
Aβ species was zero).  We found that without Aβ, the probability of pore formation was 
9.1 %, while the percentage of cell death was by definition 0.  Given these two additional 
points, each data set for MLR analysis contained seven points, corresponding to the 
control experiment, and the experiments from Aβ samples with 0, 1, 2, 3, 10, and 20 d-
incubation.   
Determining the most appropriate MLR model  
After performing the MLR analyses, we determined the quality of the fit by 
comparing the following parameters: 1) residual mean squares (RMS), which indicates 
the discrepancy between predicted and observed data; the small values are preferable, 
2) p-values of all parameters, which indicate significance of the coefficient and the 
strength of the linear relationship between independent and dependent variables, and 3) 
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adjusted R-squared (Ra2) values which measure a goodness of fit with a compensation 
of the degrees of freedom in the model as shown in equation (A3-4),    
R2a  =  1 − ௡ିଵ௡ି௣ିଵ (1 − ܴ
ଶ),     (A3-4) 
where n is the sample size, and p is the number of parameters (92). 
 
Table A3-1. Deconvolution of CD spectra of Aβ in different preparation methods. 
 
Preparation 
% Content of secondary structure 
Helix β-sheet β-turn Unordered
Aβ1-40-diH2O 0 d 3 25 14 59 
Aβ1-40-diH2O 1 d 3 32 17 48 
Aβ1-40-diH2O 2 d 4 34 19 43 
Aβ1-40-diH2O 3 d 6 35 19 41 
Aβ1-40-diH2O 10 d 4 34 20 42 
Aβ1-40-diH2O 20 d 9 43 23 24 
Aβ1-40-HFIP/diH2O 2 d 5 39 21 35 
Aβ1-42-diH2O 0 d 4 27 37 33 
Aβ1-42-diH2O 1 d 4 30 41 36 
Aβ1-42-diH2O 2 d 5 32 42 37 
Aβ1-42-diH2O 3 d 5 45 21 29 
Aβ1-42-diH2O 10 d 5 44 22 30 
Aβ1-42-diH2O 20 d 9 43 23 29 
Aβ1-42-HFIP/diH2O 2 d 5 41 21 33 
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Chapter 4 
Membrane Disruption in Unilamellar Liposomes Induced by Amyloid-beta (Aβ) 
Peptides at Different Aggregation States 
 
Increasing evidence indicates that Aβ peptides, especially in their oligomeric 
states, play an important role in pathogenesis of AD.  A possible pathogenic mechanism 
of Aβ oligomers is formation of pores through neuronal membranes, resulting in cell 
death.  In this chapter, we examine the effect of Aβ on permeabilization of liposomes by 
using proton leakage and dye quenching assays.  The studies confirm that Aβ is able to 
disrupt the membranes and cause the leakage of liposomal contents that range in size 
as small as protons to as large as dye molecules.  With regards to aggregation states of 
Aβ, we demonstrate that the ability of Aβ to induce leakage in unilamellar liposomes 
decreased as the aggregation of Aβ progressed.  A decrease in activity of membrane 
disruption in the liposomes could be because of a decrease in abundance of Aβ 
monomers, and small oligomers (dimers and trimers), which were decreasing over the 
incubation time, or a decrease in effective concentration of Aβ in the suspension (since 
small oligomers become larger assemblies).  This observed trend does not correlate with 
results of pore formation in the planar lipid bilayers.  We postulate that membrane 
permeabilization in these lipid models could be driven by different mechanisms due to 
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the fundamental differences in the experimental systems such as the membrane 
curvature, stability and sensitivity of lipid membranes. 
4.1  Introduction 
A disruption of membrane integrity or membrane permeabilization induced by 
peptide is considered as a primary indicator of toxicity (1).  Biophysical and biochemical 
studies have demonstrated that the toxicity of Aβ along with other amyloid proteins is 
associated with their ability to disrupt membrane integrity (1, 2).  However, the details 
regarding the membrane permeabilization induced by amyloid proteins still remain 
unclear at the molecular level (3). 
The mechanism of membrane permeabilization depends on lipid composition, 
membrane integrity, and structure of peptides.  Aggregation of Aβ peptides associates 
with stochastic process as the peptide samples exist in a heterogeneous mixture of 
assemblies and also depend on factors, such as ionic strength, pH, concentration of Aβ 
peptides, and chemical nature of impurities and residues in the Aβ samples (ions, 
solvents, etc.)  (4-6).  To date, several research groups considered that the oligomeric 
forms of Aβ are the most toxic species which can disrupt membrane structural integrity 
by inducing an unregulated passage of ions and small molecules through the membrane  
(7). 
In chapter 2, we discuss two mechanisms of ion flux induced by Aβ, namely pore 
formation through membranes, and thinning of membranes. (4)  We demonstrate by 
electrophysiological techniques that Aβ induce ion flux across membranes by inserting 
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through the membranes as opposed to the thinning of membranes, thus clarifying the 
controversy with regard to mechanism of Aβ-induced ion flux. 
Biological membranes are complex mixtures of phospholipids, glycoproteins, and 
cholesterols, having several functions including transport, and maintaining the structural 
integrity of cells (1, 8).  Given their spherical shape with water-filled interior, and ease of 
producing, lipid vesicles are commonly used lipid models in lipid-protein interaction 
studies.   
Dye leakage assay is a common technique used for studying peptide-induced 
membrane permeabilization.  The liposomes are loaded with self-quenching fluorescent 
dyes, such as carboxy-fluorescein, calcein, or sulforhodamine B, at high concentrations 
(1, 9-11).  The peptide-induced permeabilization of membranes causes the dye 
molecules to leak from the inside of the liposomes to the outside, resulting in an increase 
in the fluorescence intensity upon the dilution of dyes in the external media.  The other 
method to determine peptide-induced membrane permeabilization is by cation leakage 
assays using ion-sensitive dyes, such as Fura-2, a Ca2+ sensitive fluorescent dye (12). 
In chapter 3, we examine the influence of Aβ at various aggregation conditions 
on pore formation in planar lipid bilayers.  Our studies revealed that Aβ1-40 and Aβ1-42 
yielded the highest probability of pore formation when the samples were pre-incubated in 
pure water for 2-3 days.  These samples contained the highest relative abundance of Aβ 
oligomers (tetramer to 13-mer), as revealed by SDS-PAGE. 
In this chapter, we investigate the effect of aggregation state of Aβ on 
permeabilization of unilamellar liposomes in order to compare the results with the planar 
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lipid bilayer (PLB) recordings in chapter 3.  We employed liposome leakage assays to 
determine the leakage of protons or dye molecules upon the addition of Aβ using the 
same preparation methods used in PLB recordings.  We assessed the membrane 
permeabilization in the unilamellar liposomes by detecting the change in fluorescent 
signal in response to leakage of protons or dye molecules whereas in the 
electrophysiological studies, we measured an electrical response (i.e., current) due to 
conductivity of ions across the PLB.   
The main advantage of the liposome-based leakage assay over the 
electrophysiological technique is that we could examine the overall membrane 
permeability from a large number of membranes in one experiment, while the PLB 
recording allows us to examine the permeability of one bilayer for each experiment.  The 
properties and environment of lipid membranes in both lipid systems were; however, not 
strictly the same; thus various factors may influence membrane permeability differently 
in these membrane models. 
 
4.2 Results and discussion 
4.2.1 Characterization of Aβ 
We examined the aggregation states of Aβ in water at each time point of 
aggregation using several techniques as described in chapter 3, including thioflavin T 
(ThT) binding assay, circular dichroism (CD), SDS-PAGE/Western blotting, and 
transmission electron microscopy (TEM).  ThT binding assay revealed that a significant 
amount of Aβ fibrils were present in the samples after 2 d of incubation for Aβ1-40 
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samples and within 1 d for Aβ1-42 samples.  The increase in fibril formation correlated 
with results from circular dichroism which also showed an increasing percentage of β-
sheet structure over the incubation time.   
Based on the Western blotting analysis, the relative abundance of monomers, 
dimers, and trimers decreased over the incubation time (see Fig. 3-4, Chapter 3).  The 
intermediate aggregated species (i.e., tetramers through 13-mers in the case of Aβ1-40, 
and tetramers through hexamers for Aβ1-42) increased and underwent the maximum after 
2-d of incubation, while the larger aggregates (Aβ fibrils) increased over the incubation 
time.  These findings were consistent with TEM images which confirmed that the large 
oligomers and fibrils increased with a longer period of incubation. 
 
4.2.2 Calibration curves of relative fluorescence ratio (FS/SR) as a function of pH 
The shape and conformational change in Aβ peptides during its aggregation may 
alter the properties of fluorophores.  For instance, the ThT dye exhibits a distinct 
characteristic upon binding of Aβ fibrils, but not for small oligomers (13). Also, the 
fluorescence of dyes in indole family is quenched by prefibrillar Aβ, but not by the fibrillar 
states (14).  In our studies, we found that the fluorescence intensity of the sodium-
sensitive dye; sodium-binding benzofuran isophthalate (SBFI) was altered by the 
aggregation states of Aβ.  We observed a significant increase in fluorescence intensity of 
SBFI in the presence of Aβ1-40, when pre-incubated in diH2O for longer than 1 d, with a 
loss of sensitivity of SBFI to sodium.  This finding suggested that the aggregated species 
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of Aβ may bind to the SBFI dye molecules and alter its fluorescence properties.  This 
observed effect varied for different samples, and was more pronounced in the case of 
Aβ1-40 than Aβ1-42 (see Appendix, Fig. A4-1).  Therefore, we could not carry out the Na+ 
leakage assay, using SBFI dye to study the membrane permeabilization by Aβ at various 
aggregation states.  
Hence, it is critically important to examine the influence of aggregation states of 
Aβ peptides on the properties of fluorescent dyes being used in liposome leakage 
assays, and to ensure that the measurement of fluorescence intensity is due to the 
leakage, as opposed to an alteration of dye properties in the presence of peptides.  We 
used the membrane-impermeable dyes in order to preclude the leakage of dyes through 
the membranes while monitoring the translocation of protons between two 
compartments.  We chose a mixture of two fluorescent dyes, fluorescein-5-(and-6)-
sulfonic acid (FS) and sulforhodamine B (SR) at 20:1 molar ratio as adapted from a 
previous study on the measurement of pH of trans-golgi in living cells (15).  The 
fluorescence intensity of FS increased as a function of pH in the range of 5 to 9, while 
the fluorescence intensity of SR remained relatively constant throughout the same pH 
range.   
We carried out the experiments to obtain a calibration curve of the ratio of 
fluorescence (FS/SR) in 20 mM HEPES buffer as a function of pH.  We found that the 
Aβ samples which were pre-incubated for 0, 1, 2, or 3 d, quenched the fluorescence 
signal of both FS and SR dyes in buffer solutions in the range of pH 5 to 9 by ~ 10 %, 
and 25%, respectively; therefore the fluorescence ratio FS:SR increased by ~ 20% in the 
presence of Aβ.  However, this quenching effect was independent from the aggregation 
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states of Aβ.  Figure 4-1 shows a calibration curve of the fluorescence ratio of FS and 
SR in the solution as a function of pH, in the presence and absence of Aβ1-40.  
 
 
Figure 4-1. Calibration curves of fluorescence ratio of fluorescein sulfonate (FS) and 
sulforhodamine B (SR) in 20 mM HEPES as a function of pH.  In the presence of Aβ1-40 
which were pre-incubated for 0, 1, 2, and 3 d, the fluorescence ratio increases by 20% 
due to quenching effect by Aβ.  The influence of Aβ on fluorescence properties of dyes 
was not significantly different for all aggregation states.  
 
We used a second approach for studying leakage of dye molecules through the 
membranes.  Instead of using a pH-sensitive dye to monitor the Aβ-induced leakage of 
protons, we used the self-quenching dye, SR, and monitored the leakage of dye 
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molecules upon the addition of Aβ.  We created a calibration curve of fluorescence 
intensity of SR as a function of dye concentration in the absence of Aβ (see Fig.4-2).  
The fluorescence intensity increased in a concentration-dependent manner at a low 
range of concentration, and reached its maximum at ~ 100 μM.  The fluorescence 
intensity began to decline at the concentration of SR greater than 100 μM and was not 
detectable at 50 mM due to self-quenching of SR.  For the dye leakage assay, we 
loaded 80 mM SR inside the liposomes, which led to self-quenching. 
 
Figure 4-2. Calibration curve of fluorescence intensity of sulforhodamine B in 20 mM 
HEPES, pH 7.4 as a function of dye concentration 
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4.2.3 Leakage of protons induced by Aβ at various aggregation states 
The purpose of this study is to investigate the influence of aggregation states of 
Aβ on the permeabilization of liposomes and to compare these results with the PLB 
systems in chapter 3.  We prepared unilamellar liposomes of 100-nm diameter size, 
using a lipid composition, DOPS:POPE (1:1), as used previously for PLB formation in 
the electrophysiological studies. 
To create a proton gradient across the liposome membranes, we prepared 
liposomes with a pH value of 5.5 inside and a pH value of 7.4 outside the liposomes by 
buffer exchange with a size exclusion column.  We monitored the change in 
fluorescence ratio (FS:SR) due to the leakage of protons through the liposomes upon 
the addition of Aβ samples pre-incubated in diH2O for 0, 1, 2, or 3 d at a monomeric 
concentration of 20 μM.  Upon the leakage of protons induced by Aβ, deprotonation of 
the pH sensitive dye FS occurred, resulting in a change in fluorescence (F) ratio.  We 
determined the percentage change in F ratio with respect to the maximum F ratio on 
addition of 0.2% triton x-100 that resulted in a complete membrane disruption.  Figure 4-
3 demonstrates that Aβ1-40 and Aβ1-42 samples with 0-d incubation yielded the highest 
percentage of proton leakage compared to Aβ samples with longer incubation time.  In 
other words, the percentage of proton leakage decreased with an increasing incubation 
time for both Aβ1-40 and Aβ1-42 in the following order: 0 d > 1 d > 2 d > 3d.  The effect of 
Aβ on the leakage of protons was greater than that of 20 nM gramicidin A, which is 
known as a well-defined cation-selective pore-forming peptide. 
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Figure 4-3. Percentage of change in fluorescence ratio inside the liposomes upon the 
addition of A) Aβ1-40 and B) Aβ1-42, which were prepared in diH2O and incubated for 
different days, (●) 0 d, (▲ ) 1 d, (▼ ) 2 d and () 3 d, compared to control (■ ) diH2O, 
and (●)  20 nM gramicidin A.  The liposomes were prepared from DOPS:POPE (1:1, 
w/w) in 20 mM HEPES at pH 5.5, and loaded with FS and SR dyes at 200 μM and 10 
μM, respectively. The final concentration of monomeric Aβ in liposome suspension was 
20 μM.  The percentage of change in F ratio was an average of 5 independent 
experiments 
 
In order to verify that the change in fluorescence was due to the leakage of 
protons from one side of liposomes to the other, we performed the leakage assay 
switching the orientation of proton gradient (i.e., the pH inside the liposomes was at 7.4 
instead of 5.5).  We further examined the leakage in the absence of a proton gradient 
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(i.e., both internal and external compartments of liposomes were at the same pH) to 
prove that a proton gradient was required for the leakage of protons through liposomes.   
When the pH was higher in the internal than the external compartments of 
liposomes, the protons moved from the external compartment (pH 5.5) toward the inside 
of liposomes (pH 7.4) upon the addition of Aβ, which led to a protonation of the pH 
sensitive dye FS, and a decrease of F ratio decreased over time.    
Similar to the liposomes with an internal pH of 5.5, the influence of aggregation 
time of Aβ on liposomes with an internal pH of 7.4 was followed the sequence: 0 d > 1 d 
> 2 d > 3 d, although the effect was not as pronounced as observed in the former case 
(see Fig. 4-4).  In this experiment, we also examined the Aβ samples which had 
aggregated in diH2O for 20 d (which contained relatively high amount of fibrils), and 
observed a minor leakage, suggesting that the Aβ fibrils (with the lowered effective 
concentration of Aβ in the suspension) did not effectively permeabilize the membranes.  
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Figure 4-4. Percentage change in fluorescence ratio within liposomes prepared with an 
internal pH of 7.4 and an external pH of 5.5.  The leakage of protons due to Aβ at 
various aggregation times was in the sequence of 0 d > 1 d > 2 d > 3 d >> 20 d.  Inset 
shows the fluorescence ratio FS:SR decreased over time after the addition of Aβ or 
gramicidin A to the liposomes, due to the passage of protons from the outside to the 
inside of liposomes. 
 
In the absence of a proton gradient (i.e., the pH of both internal and external 
compartments were the same at 7.4), we observed no significant change in F ratio after 
addition of gA or Aβ.  Figure 4-5A shows that the F ratio increased by approximately 1-2 
units after addition of Aβ samples.  The change in F ratio was due to the quenching of 
fluorescence dyes (both FS and SR) by Aβ peptides as described previously in section 
4.2.1.  This change was not significant compared to the change due to membrane 
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permeabilization in the presence of proton gradient, where the F ratio was typically 15 to 
20 units greater than the control as shown in Fig. 4-5B.  The proton leakage assays 
confirm that Aβ can induce the leakage of protons only when there is a difference in 
proton concentration between the interior and exterior of liposomes.
 
 
Figure 4-5. Comparison of F ratio (FS:SR) after addition of Aβ1-40 at 0, 1, 2, and 3-d of 
incubation in water, A) in the absence and B) the presence of a proton gradient between 
the interior and exterior of liposomes.  Aβ peptide itself quenched the fluorescence of 
both dyes, resulting in a small increase in F ratio, while the leakage of protons due to Aβ 
led to a significant change in F ratio.  In the absence of a proton gradient, the change in 
F ratio with an addition of gramicidin A was not detectable, suggesting that no proton 
leakage occurs with the lack of proton gradient. 
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4.2.4 Influence of membrane curvature on membrane permeabilization 
We found that the effect of Aβ at various aggregation states on the 
permeabilization of liposomes was not in agreement with the results from 
electrophysiological studies presented in chapter 3.   
Since the curvatures of liposomal membranes are typically greater than the 
PLBs, we hypothesized that the curvatures may play a role in the membrane 
permeabilization by various aggregation states of Aβ.  We attempted to investigate the 
proton leakage induced by the different aggregation states of Aβ, using the liposomes 
with lower curvature.  We prepared liposomes with the same lipid composition, 
DOPS:POPE (1:1, w/w) having a size of larger than 100 nm in diameter by extruding the 
liposomes through an extrusion membrane filter with a size of 5 μm.  The resulting 
liposomes; however, were obtained in the size range of 270 ± 130 nm diameter, as 
quantified by dynamic light scattering (see Appendix A4-2).  The proton leakage assay 
using liposomes with lower membrane curvature revealed that the effectiveness of Aβ at 
different aggregation times was in same order (0 d > 1 d > 2 d > 3 d) as observed 
previously; thus the effect of membrane curvature on membrane permeabilization might 
not be significant.  Further characterization may be required to understand the roles of 
membrane curvature on membrane permeabilization induced by various aggregation 
states of Aβ.  The effect of Aβ at different aggregation states needs to be examined 
using various sizes of liposomes, ranging from small (< 50 nm diameter) to giant 
liposomes (> 1 μm diameter) (1).  The membrane curvature could be another critical 
parameter that influences the membrane permeabilization of Aβ peptides in neuronal 
membranes, since the neurons typically possess high membrane curvature, which may 
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be prone to membrane defects and disruption induced by Aβ; however, the subject is 
beyond the scope of this study.      
 
4.2.5 Influence of lipid composition on membrane permeabilization 
The interaction of Aβ and lipid membrane is dependent on composition of the 
lipid headgroups.  Previous studies have shown that Aβ prefers to interact with 
negatively charged lipid such as PG or PS lipids, rather than zwitterionic PC lipids (16), 
although the reports in literature are contradictory (1).  We examined the influence of 
lipid composition on the membrane permeabilization induced by various aggregation 
states of Aβ. 
The liposomes composed of DOPS:POPE(1:1) were not optimized for membrane 
stability in the liposome flux assays, as we observed the leakage of protons due to the 
membrane diffusion even without addition of Aβ.  We performed the leakage assays 
using lipid compositions with an increased stability, DiphyPC : Cholesterol : DiphyPG : 
DPPE-PEG2000 (9:9:1:1, molar ratio) at a final concentration of 20 mg mL-1.  The 
presence of poly(ethylene glycol) (PEG) in the formulation of liposomes prevents 
nonspecific interactions with the membrane surface, while cholesterol reduces the 
fluidity of lipid membranes, thus enhancing its stability (17, 18).  With the preparation of 
liposomes with improved stability, we found that the leakage of proton in the control 
liposomes became smaller than that observed in the DOPS:POPE lipid composition.  
Figure 4-6A shows that the leakage of protons induced by Aβ was generally weaker than 
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that observed previously, but the effect of incubation time followed the same trend in 
both lipid compositions (i.e., 0 d > 1 d > 2 d > 3 d).  
To explore the leakage in more pathologically relevant system, we prepared 
liposomes prepared from brain extract lipid, containing a mixture of phospholipids, PC: 
PE: PI: PS: PA in 9.6, 16.7, 1.6, 10.6, and 2.8%, respectively.  The liposomes composed 
of this lipid composition were; however, not as stable as those from the other two lipid 
compositions.  Despite the leakiness of the membranes, we observed the same pattern 
of effect of Aβ at various incubation times; yet not as pronounced as in the cases of the 
other two lipid compositions (see Fig. 4-6B). 
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Figure 4-6. Leakage of protons induced by Aβ1-40 and Aβ1-42 which were pre-incubated in 
diH2O for different times.  Membrane permeabilization varied with the stability of 
liposomes, A) high stability lipid composition, DiphyPC : Cholesterol : DiphyPG : DPPE-
PEG2000 (9:9:1:1), and  B) low stability lipid composition, brain extract.  In both lipid 
compositions, the leakage of protons decreased over the aggregation time of Aβ. 
 
Based on the leakage of protons from liposomes prepared with three different 
lipid compositions, leakage was the strongest in the case of the liposomes composed of 
DOPS:POPE, possibly because of the preference of Aβ to interact with negatively 
charged lipids (PS) (16). 
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4.2.6 Dye quenching assay 
We extended our studies from proton leakage assay to a dye-quenching assay in 
order to determine whether Aβ could disrupt the membranes and cause the leakage of 
dye molecules, which are significantly larger than protons.  In this study, we loaded 80 
mM of sulforhodamine B inside the liposomes composed of DOPS:POPE used 
previously in the proton leakage assay.  In Figure 4-7, the addition of Aβ caused the 
liposomal membranes to disrupt, causing the dye molecules to leak.  
We determined the percentage of dye leakage over time with respect to the 
maximum leakage obtained with the addition of 0.2% of Triton-x 100 to the liposomes.  
The leakage of dye molecules was not detectable in 30 minutes after addition of control 
sample (without Aβ).  Consistent with results from proton leakage assays, we found that 
the leakage was the highest for Aβ with 0-d incubation, and decreased with increasing 
incubation time (see Fig. 4-7).  
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Figure 4-7. Percentage leakage of sulforhodamine B upon the addition of Aβ at different 
aggregation time with respect to the maximum leakage when 0.2 % Triton x-100 was 
added to the liposomes.   
 
Taken together, our studies confirm that Aβ peptides induce leakage of the 
encapsulated molecules that range in size as small as protons to as large as dye 
molecules, and the activity of membrane permeabilization decreased as the Aβ samples 
were incubated for longer time.  The leakage of dye was less than that of proton 
leakage, due to the faster rate of passage of protons.  Nevertheless, the results from 
leakage assays do not provide the exact mechanism of membrane permeabilization.  In 
the liposome-based assays, the observed leakage may not necessarily result from an 
insertion of peptides through the membranes, but could be due to the breakage of 
liposomes. 
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4.2.7 Membrane permeabilization of Aβ in planar lipid bilayers and liposomes are 
driven by different mechanisms 
In chapter 3, electrophysiological studies revealed that the highest probability of 
pore formation in the PLBs was induced by Aβ samples which were pre-incubated 2 or 3 
d when the relative abundance of Aβ oligomers was at the maximum as shown in Fig. 3-
2.  In liposome-based assays, we found that the effect of pre-incubation time of Aβ on 
the leakage was in the following sequence:  0 d > 1 d > 2 d > 3 d (>> 20 d), regardless of 
the size of contents that were released out of liposomes, and the stability of liposomes, 
suggesting that the effect of Aβ on membrane disruption decreased with the incubation 
time of Aβ.  This finding was in agreement with previously published works that 
employed a calcein leakage assay in the study (19). The authors explained that the 
decreasing percentage of dye leakage over the pre-incubation time of Aβ was due to a 
decrease in amount of early state of Aβ oligomers.  In our studies, SDS-PAGE/Western 
blotting analysis revealed that the relative abundance of Aβ monomers and small 
oligomers (i.e., dimers and trimers) decreased over the incubation time, as they became 
larger assemblies (i.e., large oligomers and fibrils) (see Fig. 3-3 and Fig.3-4, Chapter 3).  
The trend of relative abundance of these small aggregated species correlated with the 
reduction of activity of permeabilization of the liposomal membranes.  The small 
aggregated Aβ species, which were mostly abundant in the samples, could be 
responsible for the membrane permeabilization as they may interact with the lipids via 
the hydrophobic interaction.  The abundance of these aggregated species, on the other 
hand, showed a weak correlation with pore formation in the PLB experiments, 
suggesting that the mechanism of membrane permeabilization induced by various 
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aggregation states of Aβ could be different in PLBs and liposomes due to the differences 
in experimental conditions, based on the following observations.   
First, the observed time for the Aβ-induced membrane permeabilization was 
much faster in liposomal membranes than the PLB recordings.  In liposome-based 
leakage assays, we were able to detect the change in fluorescence signal due to the 
membrane disruption within seconds, while it took several minutes to observe the 
conductance due to membrane permeabilization in the PLBs after addition of Aβ, and 
the mixing upon the addition was necessary. 
Second, the total surface area of lipid membranes in the liposome suspension 
was greater than the PLB.  Given the same concentration of monomeric Aβ which were 
used in both systems, the likelihood of peptide-lipid interaction was much higher in the 
case of liposomes than in the PLB system.   
Another aspect is that the structural properties of liposomes and PLBs are 
physically different.  Besides the high membrane curvature which may induce the stress 
in membranes, the liposomes can move freely in the aqueous solution and are prone to 
fuse with one another, resulting in breakage.  In contrast, the PLBs are immobilized on 
the aperture of the bilayer set-up, while the organic solvent used in the formation of 
PLBs by the “painted” method provides an additional support.   
We hypothesized that the sharp increase in fluorescence intensity upon the 
addition of Aβ is caused by the breakage of membrane or bursting of liposomes rather 
than pore formation observed in the PLB recordings.  Nonetheless, the breakage of lipid 
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membranes upon the addition of Aβ was unlikely to occur in the PLBs, since we could 
observe stepwise ion flux through the PLBs while the membrane was still intact.   
In addition, one factor that could play an important role in the breakage of 
liposomes is the effective concentration of Aβ, which decreased over the aggregation 
time as the small oligomers became larger assemblies.  In the liposome-based leakage 
assays in which the total surface area of lipid membranes was substantial, the effective 
concentration of Aβ, especially for Aβ with 0-d incubation time, was relatively high, 
leading to the high likelihood for peptides to interact with lipid membranes and induce 
rapid membrane disruption.  On the other hand, the aged Aβ samples which contained 
lower effective concentrations of Aβ in suspension had less probability to interact with 
liposomes; thereby inducing the low amount of leakage.  The observed leakage could 
simply reflect the number of bursting liposomes, which depended on the likelihood of 
peptide-lipid interactions.  Figure 4-8 shows schematic models for membrane 
permeabilization by Aβ at different aggregation states in liposomes and PLB.   
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Figure 4-8. Schematic illustration of membrane permeabilization induced by Aβ at 
different aggregation states in two systems, the liposome-based leakage assay and the 
electrophysiological recordings (not drawn to scale).  The total surface area of lipid 
membranes of liposomes is substantially higher than that of PLB.  In liposomes (left), at 
early aggregation state of Aβ, the effective concentration of Aβ interacting with the 
membranes is high (i.e., monomers and small aggregated species are the majority of the 
population); therefore the membrane disruption (i.e., bursting) could happen instantly.  
Over the aggregation time, the effective concentrations of Aβ in the solution decreased 
as the Aβ monomers and small oligomers become larger assemblies (i.e., Aβ fibrils), 
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thereby reducing the chance of membrane disruption.  In the electrophysiological 
recordings (right), the influence of effective concentration of Aβ on the membranes is 
less relevant than in the case of the liposome leakage assay.  The surface area of PLB 
is small compared to the abundance of peptides in the solution.  Aβ oligomers, rather 
than Aβ monomers and fibrils, could induce the ion flux across the membranes by pore 
formation. 
 
A more detailed study is required for better understanding of the mechanism of 
Aβ-induced membrane disruption and the influence of aggregation states of Aβ.  The 
advantage of this liposome flux assay is that it provides an opportunity to conduct 
experiments in high-throughput,  making it possible to screen several potential drug 
candidates for their ability to inhibit or reduce the leakage of liposomes as presented in 
the Appendix A4-3.  
 
4.3 Conclusions 
We examined the influence of Aβ at various aggregation states on membrane 
permeabilization in liposomal membranes.  The liposome-based leakage assays 
confirmed that Aβ was able to cause the leakage of liposomal contents (i.e., both 
protons and dye molecules).  The activity of leakage decreased as Aβ samples were 
incubated for longer period of time.  This finding contradicted to the results from the 
electrophysiological studies.  Due to fundamental differences between the two 
approaches, and the differences in physical properties of membranes, the mechanism of 
membrane permeabilization in both systems could be different (i.e., bursting of 
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liposomes versus pore formation in PLB).  SDS-PAGE/Western blotting quantification 
revealed a decreasing trend of relative abundance of monomers, dimers and trimers, as 
they become larger oligomers, resulting in a lower effective concentration of peptides.  
The reduction in leakage with an increase in pre-incubation time of Aβ was likely 
because of the lowered effective concentration of peptides in the solution as the 
likelihood of peptide-membrane interaction decreased.  Another possibility is that the 
aggregated species smaller than tetramers could be sufficiently effective in bursting the 
liposomes upon their addition, whereas the intermediate oligomers (from tetramers to 
hexamers) could form pore through the PLB.   
 
4.4 Materials and methods 
4.4.1 Preparation of Aβ 
We purchased the Aβ from GL Biochem (Shanghai) Ltd., and treated with HFIP, 
followed by 2-d lyophilization, according to the protocol described in material and 
method section in chapter 3.   
 
4.4.2 Preparation of liposomes 
We prepared liposomes from a total lipid concentration of 10 mM of 
desired composition.  We obtained a lipid film by placing the lipid mixture 
dissolved in chloroform in a 10 mL round bottom flask, followed by rotary 
evaporation.  We rehydrated the lipid film with 750 μL of 20 mM HEPES, pH 5.5, 
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containing a mixture of the pH-sensitive dye, fluorescein sulfonate (Molecular 
Probes, Eugene, OR) and a pH-insensitive dye, sulforhodamine B  (Molecular 
Probes, Eugene, OR) at a concentration of 200 μM and 10 μM, respectively, and 
incubated the liposomes for 4 h at 37 °C.  The resulting lipid vesicles were 
subjected to 15 freeze-thaw cycles and extruded through 100-nm membrane for 
21 times.  We used Sephadex-G25 M gel filtration columns (GE Healthcare, 
Buckinghamshire, UK) to separate liposomes with encapsulated fluorescent dyes 
from the fluorescent dyes in solution, and to change the solution outside the 
liposomes to 20 mM HEPES, pH 7.4.   
Before each experiment, we determined the size distribution of liposomes 
by dynamic light scattering using 90 Plus particle analyzer (Brookhaven 
Instruments Corporation, Holtsville, NY) to confirm that the size of vesicles were 
in the range of 100 ± 30 nm unless indicated otherwise.  We then transferred the 
resulting liposomes to 96-well plates (100 μL in each well) followed by addition of 
compounds of interest.   
 
4.4.3 Fluorescence measurement 
We transferred the liposomes with encapsulated dyes to 96-well plates (100 μL in 
each well), followed by addition of Aβ samples or gramicidin A.  We monitored changes 
of fluorescence signal due to ion or dye leakage using Fluroskan Ascent FL (Thermo 
Fisher Scientific, Waltham, MA). The leakage of protons corresponded to a ratio of 
fluorescent signal at EX485/EM518 for Fluorescein sulfonate and EX560/EM590 for 
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sulforhodamine (non-pH sensitive dye). We determined the percentage of change in 
fluorescence ratio as calculated from  
% Change in F ratio = (R-R0)*100/(Rmax-R0), 
when R is the fluorescence ratio at individual time point, R0 is the initial fluorescence 
ratio before the addition of Aβ samples, and Rmax is the maximum fluorescence ratio 
obtained by the addition of 0.2% Triton x-100 to freshly prepared liposomes. 
For the self-quenching assay, we detected changes of fluorescence intensity 
upon the release of SR molecules into the medium.  We observed an increasing 
fluorescent signal upon leakage of dye out of membranes over time and determined the 
percentage of leakage with respect to the maximum leakage. 
% Leakage = (F-F0)*100/(Fmax-F0),  
when F is the fluorescence intensity of SR at individual time point, F0 is the initial 
fluorescence intensity before the addition of Aβ samples, and Fmax is the maximum 
fluorescence intensity obtained from the addition of 0.2% Triton x-100 to the liposomes. 
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Chapter 4 Appendix 
A4-1. Influence of Aβ on fluorescence properties of sodium-sensitive dye; sodium-
binding benzofuran isophthalate (SBFI) 
We initially attempted to develop Na+ leakage assay using sodium-sensitive dye, 
SBFI (Molecular Probes, Eugene, OR) to study Aβ-induced leakage.  Figure A4-1.1 
demonstrates a sensitivity of SBFI to concentration of sodium in the buffer solution.  We, 
however, observed an interference of Aβ peptides with the fluorescence properties of 
SBFI as shown in Fig. A4-1.2. Therefore, we could not use this dye to study leakage of 
Na+ in liposome leakage assays.  
 
Figure A4-1.1. Calibration curve of SBFI dyes as a function of concentration of sodium 
chloride.  The fluorescence intensity was measured at the emission wavelengths of 460 
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nm and 590, while the excitation wavelength was at 355 nm.  The final concentration of 
SBFI was at 15 μM in 20 mM HEPES buffer at pH 7.4.   
 
 
Figure A4-1.2. Effect of aggregated forms of Aβ on the sodium sensitivity of SBFI dyes.  
A) The intermediate Aβ1-40 aggregated species in diH2O (between in 1-3 d) induced a 
significant increase in fluorescence intensity and disturbed the sodium sensitivity of 
SBFI, whereas B) aggregated Aβ1-42 did not have as strong influence on fluorescence 
properties of SBFI as in Aβ1-40.   
 
A4-2. Determination of size of liposomes by dynamic light scattering (DLS) 
Dynamic light scattering (DLS) is a simple and rapid method for determining the size of 
liposomes, but this technique only provides an estimate of size distribution of the 
liposomes in bulk solution (18). 
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Figure A4-2. Distribution of the number of liposomes with various sizes as obtained by 
dynamic light scattering.  The size of liposomes could be adjusted by using membrane 
filters of different sizes in the extrusion step, as shown for A) 100-nm sized and, B) 5-μm 
sized membrane filters. The liposomes were composed of DOPS:POPE (1:1, w/w) and 
contained 200 μM FS and 10 μM SR dyes.  
 
A4-3. Using liposome-based assay for screening small molecules that can reduce 
the leakage on lipid membranes 
We also employed the proton leakage assays for screening small molecules 
which could prevent the Aβ-induced membrane permeabilization.  We selected the 
molecules that bind with high affinity to Aβ fibrils as examined by our collaborators and 
other research groups.  We found that none of these molecules could significantly 
reduce the Aβ-induced proton leakage.   
Among the testing molecules, we are particularly interested in two molecules, 
BTA-EG4 and BTA-EG6, as they showed promising results as potential therapeutic 
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molecules based on the molecular and behavioral studies (23).  In our studies, we 
examined whether these molecules could reduce or inhibit the membrane 
permeabilization induced by Aβ in both PLB recording and leakage assays.  We 
observed minor decrease in percentage of Aβ-induced proton leakage in the presence of 
these two molecules at low concentrations in a concentration-dependent manner for all 
of lipid compositions.  The reduction in proton leakage was the most explicit in the case 
of liposomes composed of DiphyPC : Cholesterol : DiphyPG : DPPE-PEG2000 (9:9:1:1, 
molar ratio) as shown in Fig. A4-3.1.  In electrophysiological studies, we tested the ion 
flux activity of Aβ1-40 incubated for 2 d in diH2O in the presence of BTA-EG4 or BTA-EG6 
molecules at 10 :1 molar ratio in 10 experiments for each condition.  In addition, we 
performed bilayer recording experiments to examine the inhibitory effect of Aβ-induced 
pore formation.  Figure A4-3.2 demonstrates that the probability of pore formation 
induced by Aβ1-40 at 2-d incubation had reduced from ~ 50% to 20% when either BTA-
EG4 or BTA-EG6 was present. 
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Figure A4-3.1. Reduction of change in F ratio, FS:SR, as a function of time upon the 
addition of Aβ1-40  with A) BTA-EG4 or B) BTA-EG6.  The leakage of protons induced by 
Aβ1-40 was reduced in the presence of these two molecules at low concentrations.  
Liposomes was prepared from DiphyPC : Cholesterol : DiphyPG : DPPE-PEG2000 
(9:9:1:1, molar ratio) at 20 mg mL-1, and the final concentration of Aβ1-40 was 10 μM. 
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Figure A4-3.2. Probability (%) of Aβ-induced flux through planar lipid bilayers in 
electrophysiological studies.  The probability of ion flux due to Aβ reduced when Aβ1-40 
was pre-incubated in di-H2O with BTA-EG4 or BTA-EG6 at 10:1 molar ratio. Significance 
(p-value < 0.1) was indicated by an asterisk (*).  The PLBs were composed of 
DOPS:POPE (1:1, w/w) and the final concentrations in the bilayer chamber were 10-15 
μM for Aβ1-40 , and 2 μM for BTA-EG4 and BTA-EG6. 
 
Despite the potential use of BTA-EG4 and BTA-EG6 as drug candidates for 
Alzheimer’s disease, these molecules exhibited an undesired biological activity on the 
lipid membranes.  The electrophysiological experiments revealed that BTA-EG4 and 
BTA-EG6 at the concentration above 10 μM could form channels through the 
membranes and induced toxicity in human cells.  The details of BTA-EG4 and BTA-EG6 
molecules with regards to their characteristics in pore formation and toxicity are 
discussed in chapter 5.  
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Chapter 5 
Self-assembled, cation-selective ion channels from an oligo(ethylene 
glycol) derivative of benzothiazole aniline6 
 
This chapter describes the spontaneous formation of well-defined pores 
in planar lipid bilayers from the self-assembly of a small synthetic molecule that 
contains a benzothiazole aniline (BTA) group attached to a tetra-ethylene glycol) 
(EG4) moiety.  Macroscopic and single-channel current recordings suggest that 
these pores are formed by the assembly of four BTA-EG4 monomers with an 
open pore diameter that appears similar to the one of gramicidin pores (~0.4 nm).  
The single-channel conductance of these pores is modulated by the pH of the 
electrolyte and has a minimum at pH ~3.  Self-assembled pores from BTA-EG4 
are selective for monovalent cations and have long open channel lifetimes on the 
order of seconds.  BTA-EG4 monomers in these pores appear to be arranged 
symmetrically across both leaflets of the bilayer, and spectroscopy studies 
suggest that the fluorescent BTA group is localized inside the lipid bilayers.  In 
terms of biological activity, BTA-EG4 molecules inhibited growth of gram-positive 
Bacillus subtilis bacteria (IC50 ~50 μM) and human neuroblastoma SH-SY5Y cells 
                                                
 
6 Content of this chapter includes in submitted publication, Prangkio P., Rao D.K., Lance K.D., 
Rubinshtein M., Yang J.,Mayer M. (2011) “Self-assembled, cation-selective ion channels from an 
oligo(ethylene glycol) derivative of benzothiazole aniline” 
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(IC50 ~60 μM), while they were not toxic to gram-negative Escherichia coli 
bacteria at a concentration up to 500 μM.  Based on these properties, this drug-
like, synthetic, pore-forming molecule with a molecular weight below 500 g mol-1 
might be appealing as a starting material for development of antibiotics or 
membrane-permeating moieties for drug delivery.  From a biophysical point of 
view, long-lived, well-defined ion-selective pores from BTA-EG4 molecules offer 
an example of a self-assembled synthetic supramolecule with biological function. 
 
5.1 Introduction 
Ion channel proteins mediate transport of ions across cell membranes 
and play a critical role in physiological processes such as signal transduction, 
regulation of membrane potentials, and cell proliferation (1, 2).  Due to the 
importance of ion channels in applied fields, such as biosensing, and for the 
pathogenesis of certain diseases (3-15), semi-synthetic as well as synthetic 
versions of pore-forming molecules or artificial ion channels are attracting 
increasing attention (16-24).  Additional applications of synthetic ion channels or 
engineered biological pores include their use as antimicrobial agents, drug 
delivery agents, fluidic diodes, and components of bio-inspired batteries (13, 14, 
25, 26).  
With regard to the synthesis of ion channel-forming molecules, two 
approaches have been applied: 1) covalent attachment of pore-forming residues 
to a molecular scaffold or template, which can have additional functionality as a 
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selectivity filter (24, 27-31), or 2) self-assembly of small molecules to pores, 
which can conduct ions across lipid membranes (27, 30, 32-34).   
With regard to the templated approach, several research groups 
developed synthetic ion channels and pores by attaching amphiphilic moieties to 
cyclodextrin (29, 35-37), crown ethers (38), calixarenes (39), or cucurbituril 
templates (40).  Some of these templated channels contained oligo(ethylene 
glycol) (OEG) groups or moieties with alternating oxygen and carbon molecules, 
which were typically attached to a cyclodextrin scaffold.  Lehn et al. proposed in 
1993 that OEG groups grafted on a cyclodextrin scaffold could form ion channels 
(41).  Gin’s group created ion channels composed of a β-cyclodextrin template 
with oligoether chains attached to the “primary face of cyclodextrin” through 
amine linkages (29).  Liposome flux experiments revealed that this molecule was 
able to induce transport of Na+ ions across lipid membranes.  Recently, Badi et 
al. demonstrated by single-channel recordings through planar lipid bilayers that 
per-2,3-heptyl-β-cyclodextrin scaffolds modified with poly(ethylene oxide) (PEO) 
chains, could form ion channels in lipid membranes (42).  These authors also 
showed that PEO moieties by themselves did not form pores at the equivalent 
concentrations, demonstrating the importance of the cyclodextrin scaffold. 
With regard to self-assembly of synthetic ion channel-forming molecules, 
Neumann and colleagues have shown by fluorescence spectroscopy and ion 
channel recordings through planar lipid bilayers that molecules with an ester 
bond between a fatty acid and an OEG moiety can form ion channels (43).  They 
also demonstrated by agar well diffusion assays that these molecules had 
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antibacterial activity against gram-positive bacteria (44).  In addition, Yang et al., 
Hirata et al., and Kim et al. have demonstrated by X-ray diffraction, TEM, 
molecular dynamics (MD) simulations, and liposome-based fluorescence assays 
that molecules with alternating oxygen and carbon atoms, including OEG, could 
interact with lipid membranes and form ion channels (45-47). 
Here, we introduce a small synthetic molecule that self-assembles and forms 
ion-selective channels with surprisingly well-defined single-channel conductance 
in phospholipid membranes.  This molecule has a molecular weight below 500 g 
mol-1 and is based on a tetra-ethylene glycol moiety that is attached to a 
relatively hydrophobic benzothiazole aniline (BTA) group (Fig. 5-1A).  We chose 
this OEG derivative of BTA, which we call BTA-EG4, based on our ongoing 
research in the context of Alzheimer’s disease and HIV transmission, which 
revealed that BTA-EG4 can readily cross cellular membranes and affect disease-
related biological processes after uptake into mammalian cells (48-50).  Based 
on the observed membrane permeability, we focused here on the effect of BTA-
EG4 on planar lipid bilayer membranes under well-defined experimental 
conditions.  We show by single-channel recordings that BTA-EG4 forms well-
defined ion pores that are selective for monovalent cations.  We characterize the 
open lifetime, the approximate number of monomers in each pore, the 
conformational stability of the pores, and the pH-dependence of the single-
channel conductance.  Finally, we show that this self-assembling, pore-forming 
molecule is toxic to the gram-positive bacterium Bacillus subtilis and to a human 
neuroblastoma cell line (SH-SY5Y), while it had no detectable toxic effect on the 
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gram-negative bacterium Escherichia coli.  The cytotoxic concentration of BTA-
EG4 was similar to the concentrations necessary to observe ion channel activity, 
suggesting pore formation as the mechanism of toxicity. 
 
5.2  Results and discussion 
5.2.1 BTA-EG4 molecules self-assemble to well-defined pores with 
quantized conductance levels 
Figure 5-1 shows that BTA-EG4 molecules were capable of forming ion 
channels with well-defined single-channel conductance steps at concentrations 
of 10 μM or above (Fig. 5-1B).  In contrast, the reactants for the synthesis of 
BTA-EG4, BTA or tetra-ethylene glycol (EG4), did not form detectable ion 
channels at concentrations up to 100 μM in planar lipid bilayers.  Remarkably, 
self-assembly of BTA-EG4 appeared to form one predominant pore structure; 
only a few single channel events resulted in a single-channel conductance that 
was different from the predominant one (Fig. 5-1B and for an extended current 
versus time trace, see Appendix, Fig. A5-2).  These sub-conductances typically 
had exactly half the current amplitude of the main conductance (see Fig.5-1B 
second channel opening event from the left).  The probability for observing these 
sub-conductances was approximately one fifth of that for the main conductance 
and their lifetime was significantly shorter than that of the main conductance (Fig. 
A5-2).  These sub-conductances may indicate a pair-wise organization of BTA-
EG4 pores, in which the activity of each pore is usually synchronized but not 
 
 
153 
 
 
always.  Alternatively, BTA-EG4 pores may have two conformations, of which the 
one with the larger pore is more stable than the sub-conductance state.  
Occasionally, we observed conductance values that were multiples of the 
amplitude of the main conductance value; we attribute these events to the 
simultaneous opening of two or more pores in the bilayer.  From recordings at 
various applied potentials, we determined an average single-channel 
conductance of BTA-EG4 of 37.8 ± 1.3 pS in an electrolyte solution containing 1.0 
M CsCl with 10 mM HEPES, pH 7.4.  Recordings of the single-channel 
conductance through BTA-EG4 pores as a function of the concentration of CsCl 
revealed that the CsCl concentration required to reach half-maximal single-
channel conductance (51) was 0.06 M (see Appendix, Fig. A5-3), and the 
maximum conductance was γmax,Cs+ = 40.0 ± 1.7 pS.  
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Figure 5-1. Benzothiazole aniline derivatives with four ethylene glycol units 
(BTA-EG4) self-assemble to well-defined and long-lived ion channels in lipid 
bilayer membranes. A) Chemical structure of 2-(4-aminophenyl)benzothiazole 
tetra-ethylene glycol, BTA-EG4.  Molecular dimensions refer to the fully extended 
conformation as obtained by Macromodel software.  B) Original current versus 
time trace from single ion channel recordings through self-assembled pores from 
BTA-EG4 in a planar lipid bilayer composed of DiPhyPC lipids. The histogram of 
current amplitudes reflects their number of occurrence in the corresponding 
current trace.  C) Normalized survival plot of the open channel lifetime 
determined from 174 single channel opening events under the same 
experimental conditions as in B).  The lifetime,τ , of BTA-EG4 pores was 
determined from a fit of the histogram to the equation, N(t)/N(0) = exp{-t/τ }, 
where N(t) represents the number of channels with lifetimes longer than the time 
t, and N(0) represents the total number of channels with observable single-
channel conductance. BTA-EG4 was added at a final concentration of 20 μM to 
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both bilayer compartments, the applied voltage was + 50 mV, and the electrolyte 
contained 1.0 M CsCl with 10 mM HEPES buffer, pH 7.4. 
 
 
 
Table 5-1 Single-channel conductance of pores from BTA-EG4 
and gramicidin A in electrolytes of different ions at 
concentrations of 0.5 M and 1.0 M with 10 mM HEPES, pH 7.4 
 
Electrolyte 
Single-channel conductance, pS a 
BTA-EG4 Gramicidin A 
 (0.5 M) (1.0 M) (1.0 M) 
LiCl 1.6 ± 0.2 1.9 ± 0.1 2.2 ± 0.1 
NaCl 7.9 ± 0.3 8.5 ± 0.5 12.8 ± 0.3 
KCl 13.4 ± 1.0 16.8 ± 0.8 20.0 ± 0.1 
CsCl 27.9 ± 0.4 37.8 ± 1.3 38.8 ± 0.9 
HCl n.d. 470 ± 90 b 860.2 ± 15.2 
KFc n.d. 14.8 ± 0.8 17.1 ± 0.7 
KBrc n.d. 19.6 ± 0.6 21.6 ± 0.5 
KNO3c n.d. 18.2 ± 1.3 21.2 ± 0.6 
CaCl2 n.d. <1.7 d n.d 
a Determined from the average slope of current-voltage (IV)-curves from 
multiple experiments  (n ≥ 3) for each experimental condition, expressed in 
mean ± standard error of the mean.   
b Since the conductances of BTA-EG4 fluctuated strongly when recording  in 
1.0 M, we also provide the single-channel conductance in 0.01 M HCl (28.6 
± 2.0 pS). 
c Contained 10 mM KCl to stabilize the potential of the Ag/AgCl electrodes. 
d Unable to resolve a precise single-channel conductance. 
  n.d, not determined. 
 
 
156 
 
 
Table 5-1 compares single-channel conductance values of BTA-EG4 pores to 
those of gramicidin A (gA) pores under the same experimental conditions.  The 
single-channel conductance of BTA-EG4 was only slightly smaller than that of gA, 
indicating that the inner diameter of pores from BTA-EG4 was probably on a 
similar size scale as the diameter of gA pores (i.e., ~ 0.4 nm) (52).  This 
comparison assumes that the spatial arrangement of polar groups in the lumen of 
BTA-EG4 pores was comparable to gA pores (see below) and that pores from 
BTA-EG4 had approximately the same length as gA pores.  Given the molecular 
dimensions of BTA-EG4 (Fig. 5-1A), it is unlikely that pores from this molecule 
would be longer than the thickness of a lipid bilayer (i.e., ~ 3.5 nm) and it is also 
unlikely that these transmembrane pores would be significantly shorter than gA 
pores (i.e., ~ 2.6 nm) (53) since gA pores are already sufficiently short to induce 
a hydrophobic mismatch that leads to energetically unfavorable thinning of the 
lipid bilayer next to the opening of a gA pore (54, 55). 
 
5.2.2 Self-assembled pores from BTA-EG4 are selective for monovalent 
cations 
Based on the small single-channel conductance of pores from BTA-EG4, we 
investigated the ion selectivity of these pores.  Table 5-1 shows that BTA-EG4 
pores were selective for monovalent cations, while divalent Ca2+ cations did not 
result in detectable single channel events.  We were, however, able to observe 
macroscopic currents in an electrolyte containing 1.0 M CaCl2, if the 
concentration of BTA-EG4 exceeded 35 μM.  When comparing various cations, 
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the slopes from current versus voltage curves revealed the following order of 
conductance through BTA-EG4 pores:  H+ >> Cs+ > K+ > Na+ > Li+ >> Ca2+.  This 
order is exactly the same as in gA pores and it is close to the mobility sequence 
for these ions in water (56).  Based on these findings and on the observation that 
the absolute values of the single conductances in electrolytes from these 
different cations are also similar to those of gA pores, we propose that BTA-EG4 
channels, like gA channels, behave essentially like water-filled pores (56). 
In an electrolyte containing 1.0 M HCl (pH ~ 0), we observed large single-
channel conductances through BTA-EG4 pores that ranged from 200-800 pS, but 
the formation of open pores was less frequent than in less acidic electrolytes.  
For instance, in an electrolyte with 0.01 M HCl (pH ~2), pore formation by BTA-
EG4 was more frequent than at pH 0 and its single-channel conductance did not 
fluctuate more than in electrolytes with a pH value of 7.4.  These experiments 
revealed that the single-channel conductance of BTA-EG4 in 0.01 M HCl was 
comparable to its single-channel conductance in 1.0 M CsCl, indicating very high 
permeability of protons through these pores; a result that is consistent with a 
water-filled pore. 
With regard to anions, monovalent potassium salts with large anions 
generated a slightly larger single-channel conductance through pores of BTA-
EG4 in this sequence: KBr > KNO3 > KCl > KF; although the maximum difference 
of the single-channel conductance between electrolytes containing KBr and KF 
was only 24% and this difference was not statistically significant at a significance 
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level of 0.05. (For the bulk conductance of aqueous solutions with various 
potassium salts, see Appendix, Table A5-1).  
Based on the observation that the single-channel conductance, and in 
particular, the ion selectivity of BTA-EG4 pores, are very similar to that of gA 
pores, we propose that the mechanism of ion selectivity may also be similar.  In 
gA pores, the selectivity filter is lined by the carbonyl oxygen atoms of the 
peptide backbone and cation selectivity results from interactions of this polar 
backbone with cations (51, 57).  In BTA-EG4 pores, the polar ethylene glycol 
oxygen atoms could serve as the selectivity filter by lining parts of the lumen of 
the pore.  Another mechanism that may contribute to the cation selectivity of 
BTA-EG4 pores is cation-π interaction of cations with the electron-rich π system 
of the BTA moiety.  In this case, the interaction of the BTA group with small 
cations (e.g. Li+) would be stronger than with large cations (e.g. Cs+), leading to 
the observed reduction of single-channel conductance with decreasing size of 
monovalent cations (26, 58, 59).  It is also possible that both mechanisms 
contribute to the strong cation selectivity of BTA-EG4 pores. 
 
5.2.3 Self-assembly of BTA-EG4 forms long-lived, open pores in lipid 
bilayers 
Figure 5-1C shows the lifetime of open channels from BTA-EG4, which was 
approximately twice as long (τ = 1.97 ± 0.08 s) as that of gramicidin A pores (τ = 
0.95 ± 0.02 s) under the same experimental conditions (see Appendix, Fig. A5-
4A).  The long lifetime of pores from BTA-EG4 suggests either that the driving 
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forces for the assembly of BTA-EG4 pores are stronger than the hydrogen 
bonding between the two hemi-channels in gA (51, 60, 61), or that the driving 
forces for the disassembly of BTA-EG4 pores are smaller than the hydrophobic 
mismatch that drives disassembly of gA pores (54, 55, 62).  
 
5.2.4 Each BTA-EG4   pore contains approximately four monomers  
In order to provide an estimate for the number of BTA-EG4 molecules in each self-
assembled pore, we performed time-averaged recordings of transmembrane current 
over discrete time intervals as a function of the concentration of BTA-EG4 molecules 
(63).  Figure 5-2 shows that increasing concentrations of BTA-EG4 resulted in a strong 
increase in transmembrane current.  For instance, at concentrations above 35 μM BTA-
EG4, multiple pores were opening at the same time, resulting in “macroscopic currents” 
across the membrane.  By keeping the experimental conditions constant (e.g. constant 
applied voltage, ionic strength, type of electrolyte, bilayer thickness, etc.), we found that 
the time averaged currents and hence the macroscopic conductance, G, followed the 
relationship:  
     G ∝ [BTA-EG4]n    (5-1) 
where n provides a rough estimate for the average number of monomers in the 
channels (63-65).  To account for possible variations in membrane area during an 
experiment or between different experiments, we normalized all time averaged currents 
by the membrane capacitance, which is proportional to membrane area and directly 
measurable (66).  This analysis suggests that pores from BTA-EG4 consisted of 4.2 ± 
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0.9 BTA-EG4 monomers (Fig. 5-2).  For comparison, we performed a similar experiment 
with gA and obtained an estimate of 2.08 ± 0.08 monomers of gA in a single channel 
(see Appendix, Fig. A5-4B), which is in agreement with pore formation by dimerization 
of two gA monomers (60). 
 
 
Figure 5-2. Macroscopic ion flux through planar lipid bilayers as a function of 
increasing concentrations of BTA-EG4.  The graph shows time averaged currents 
from 3 min recordings normalized to the membrane capacitance as a function of 
the concentrations of BTA-EG4.  Different symbols indicate three experiments 
performed independently under the same experimental conditions.  The red 
curve is a global fit to the data from all experiments to equation 1 (considering 
that the time averaged current is directly proportional to the macroscopic 
conductance, G).  The applied voltage was ± 50 mV, and the electrolyte 
contained 1.0 M CsCl with 10 mM HEPES buffer, pH 7.4. 
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 Figure 5-2 shows that the self-assembly of BTA-EG4 to pores in planar lipid 
bilayers required relatively large concentrations (≥ 10 μM), while gA is capable of 
forming pores at approximately one million-fold lower concentrations (see Figure 
A5-4B, Appendix).  We attribute this difference mainly to the extremely low 
solubility of gA in aqueous solutions; at equilibrium gA partitions almost 
completely into the bilayer phase.  BTA-EG4, in contrast, is significantly more 
water soluble than gA and therefore it does not concentrate in the bilayer as 
much as gA.  Moreover, self-assembly of tetrameric BTA-EG4 pores may require 
a larger local concentration of BTA-EG4 molecules in the bilayer than self-
assembly of dimeric gA pores.  In the context of a possible use of BTA-EG4 as a 
starting molecule for the synthesis of pore-forming antibiotics, this requirement 
for micromolar concentrations is a disadvantage compared molecules such as 
gA.  On the other hand, BTA-EG4 meets the criteria of Lipinski’s empirical rule of 
five (67) and small chemical modifications may increase its lipophilicity and 
potency while preserving its pore-forming activity. 
 
5.2.5 The noise level of open BTA-EG4 pores is larger than that of open gA 
pores 
In order to assess the conformational stability of BTA-EG4 pores, we 
compared the current noise through the main open state of BTA-EG4 pores with 
the noise through single gA pores.  For this analysis, we used original current 
traces that were hardware-filtered with a four-pole Bessel filter with a cutoff 
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frequency of 10 kHz and sampled at 50 kHz.  Based on eight different open 
events of the main open state of BTA-EG4 pores, we found an average rms 
current noise (i.e., average standard deviation of the current from the mean 
current) of 0.650 ± 0.033 pA.  For comparison, the average rms current noise 
from nine different opening events of individual gA pores was 0.277 ± 0.052 pA, 
when determined in the same way and under identical experimental conditions 
as for BTA-EG4 channels.  Note, these noise values represent the average rms 
current noise through the open channels after subtracting, in an rms fashion and 
with error propagation, the average rms current noise of the respective baseline 
current.  These estimates of the channel noise assume that the current noise 
from the recording setup (i.e., the baseline noise when no channel was open) 
and the current noise from fluctuations of ion flux through an open ion channel 
were both random and independent of each other.  Since current histograms 
from the open events of BTA-EG4 and gA channels could be fitted well with 
Gaussian distributions (Fig. 5-1B), the assumption of randomness appears 
justified.  Finally this simplified approach also assumes that differences in 
frequency-dependence of these two noise sources can be neglected. 
Based on these assumptions, two-sample T-tests revealed that the average 
rms current noise through open BTA-EG4 pores was significantly larger than 
through open gA pores (p < 0.01).  Given that a part of this rms current noise 
likely resulted from small conformational fluctuations of the channels (68), this 
difference suggests that these fluctuations were more prominent in open pores of 
BTA-EG4 than of gA.  This result may on the one hand be surprising since the 
lifetime of BTA-EG4 pores is longer than that of gA pores, on the other hand, 
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BTA-EG4 pores contain approximately four monomers that can each undergo 
small fluctuations in an open pore, while gA pores contain only two monomers. 
 
5.2.6 The single-channel conductance through BTA-EG4 pores has a 
minimum at pH ~ 3 
In order to gain insight in the arrangement of BTA-EG4 molecules to a pore, 
we characterized the pH dependence of the single-channel conductance through 
these pores.  Since BTA-EG4 contains an anilinium group with a pKa of 
approximately 4.6 in pure water (69, 70), we hypothesized that protonation of this 
group in acidic electrolytes may reduce the permeation of cations through these 
pores by electrostatic repulsion.  Figure 5-3 shows that the single-channel 
conductance of BTA-EG4 pores had a minimum at a pH ~ 3.  Since the high 
concentration of CsCl (3.0 M) in the electrolyte used for these recordings might 
have shifted the pKa of the anilinium group towards a more acidic pKa (71), we 
determined the pKa of BTA-EG4 in the presence of 3.0 M CsCl (and 12% DMSO 
to increase the solubility of BTA-EG4 and to mimic the hydrophobic environment 
in the proximity of planar lipid membranes).  Under these conditions, an acid-
base titration experiment indicated a pKa of ~ 3.5 for BTA-EG4.  This pKa value is 
consistent with protonation of BTA-EG4 molecules and with concomitant 
reduction of the single-channel conductance of cations through pores from BTA-
EG4 molecules at pH values below 4.  Since the Debye screening length in this 
3.0 M CsCl electrolyte was approximately 0.2 nm (71), the minimum conductance 
of BTA-EG4 pores at a pH value of ~3 suggests that the aromatic ring with the 
protonated anilinium group was located either at the mouth of the pores or faced 
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the lumen of the pores.  In contrast to the reduction of the single-channel 
conductance as the pH in the electrolyte was lowered from 7.4 to 2.8, the 
increase in conductance at pH values below 2.8 was likely due to the increased 
concentration of highly permeable protons in these increasingly acidic 
electrolytes (see Table 5-1, and Appendix, Fig. A5-5). 
For comparison, Figure 5-3 shows data from gA pores, whose conductance 
increased steadily with increasing acidity in the same 3.0 M CsCl electrolyte, 
indicating that the observed minimum conductance of BTA-EG4 pores at pH ~ 3 
is characteristic for these pores and likely a consequence of protonation of the 
anilinium group of BTA-EG4.   
 
Figure 5-3. Single-channel conductance of BTA-EG4 and gramicidin A as a 
function of the pH in the recording electrolyte.  Ion channel recordings were 
performed with DiPhyPC bilayers in unbuffered electrolytes that contained 3.0 M 
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CsCl at various pH values that were adjusted by adding HCl.  Statistical 
significance (p<0.05) of differences in single-channel conductance of BTA-EG4 
pores at different pH values was determined with respect to the minimum 
conductance at pH 2.8 and indicated by an asterisk (*).  Error bars represent the 
standard error of the mean.   
 
5.2.7 Fluorescence spectroscopy suggests localization of the BTA moiety 
inside lipid bilayers 
To gain complementary insight in the assembly of BTA-EG4 molecules to 
pores, we took advantage of the dependence of the fluorescence emission 
spectra of BTA derivatives on their chemical environment.  Excitation at 350 nm 
revealed a shift to shorter emission wavelengths when BTA-EG4 molecules were 
dissolved in octanol compared to water.  The wavelengths of maximum emission 
of BTA-EG4 in an aqueous suspension of liposomes was between the 
wavelength of maximum emission in water and octanol, suggesting that at least a 
part of the fluorescent BTA moiety was located inside the bilayer membrane (Fig. 
5-4). 
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Figure 5-4. Comparison of fluorescence emission spectra of 50 μM BTA-EG4 in 
pure H2O (■), pure octanol (●), and in an aqueous liposome suspension (▲) 
using an excitation wavelength of 350 nm.  Liposomes were made of DiPhyPC 
with a total lipid concentration of 10 mM in water. 
 
5.2.8 Asymmetric addition of BTA-EG4 to one side of the bilayer leads to 
symmetric current-voltage relationships 
In order to test whether membrane incorporation of BTA-EG4 molecules from 
only one side of the bilayer would lead to pores with transverse asymmetry 
across the bilayer (72), we obtained a current versus voltage curve after addition 
of BTA-EG4 only to the cis-compartment.  Since the resulting current versus 
voltage curve was linear with the same slope at both polarities, we did not 
 
 
167 
 
 
observe a measurable indication of transverse asymmetry of BTA-EG4 pores in 
DiPhyPC bilayers (see Appendix, Fig. A5-1).   
 
5.2.9 High concentrations of BTA-EG4 molecules destabilize lipid bilayers 
At concentrations above 35 μM, BTA-EG4 occasionally destabilized planar 
bilayers sufficiently to break the membranes irreversibly.  We observed this effect 
in approximately 20% of experiments.  In addition, liposomal leakage assays 
revealed that BTA-EG4 induced leakage of protons through liposome membranes 
(see Appendix, Fig. A5-6).  The same liposome-based assay revealed that EG4 
by itself did not cause detectable leakage, while BTA by itself was capable of 
inducing approximately half the rate of proton leakage than BTA-EG4.  We could 
not, however, detect any ion channel activity from BTA by itself (or from EG4 by 
itself) in planar lipid bilayer recordings. 
 
5.2.10 BTA-EG4 has antibacterial activity 
Gramicidin A and its analogs have antibiotic activity by forming cation-
selective pores in biological membranes (57, 61, 73).  This activity is directed 
against gram-positive bacteria, not gram-negative bacteria, due to differences in 
structure of the bacterial cell walls (74, 75).  Since we observed similarities in the 
characteristics of pores from BTA-EG4 and gA, we tested the antibacterial activity 
of BTA-EG4 molecules on a gram-positive and a gram-negative bacterium.  
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Figure 5-5 shows that BTA-EG4 inhibited the growth of the gram-positive 
bacterium Bacillus subtilis: a concentration of 100 μM BTA-EG4 completely 
suppressed the growth of these bacteria after overnight exposure. The extent of 
this inhibitory effect was similar to that of 10 μM kanamycin or 5 μM gA, as 
shown in Figure A5-7 of the Appendix.  Consequently, we estimate a MIC value 
(i.e., the minimal concentration that inhibited visible growth over night) of ~100 
μM BTA-EG4, while its IC50 value was ~50 μM.  For comparison, we found the 
following values for five other pore-forming, antimicrobial peptides against gram-
positive bacteria: i) alamethicin, IC50 = 1-3 μM (76); ii) gramicidin D, MIC = 0.5 
μM; iii) melittin, MIC = 8.5 μM; iv) magainin II, MIC = 18 μM; and v) human 
defensing HNP-1, MIC >60 μM (77). In contrast, BTA-EG4 concentrations up to 
500 μM did not show significant toxicity on gram-negative E. coli bacteria (see 
Appendix, Fig. A5-8). 
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Figure 5-5. Inhibitory effect of BTA-EG4 on the growth of Bacillus subtilis bacteria 
22 h after incubation in LB media containing various concentrations of BTA-EG4.  
Growth was quantified by the optical density at a wavelength of 600 nm relative 
to untreated control cells. The concentration of BTA-EG4 molecules that inhibited 
growth by 50% (IC50 value) was ~ 50 μM.  Each point represents the mean of two 
experiments with three replicates in each experiment; error bars represent the 
standard error of the mean.  
 
5.2.11  BTA-EG4 is toxic to human neuroblastoma cells  
Since BTA-EG4 was capable of forming ion channels in artificial lipid bilayers 
and exhibited antibacterial activity against gram-positive bacteria, we 
investigated the effect of BTA-EG4 on the viability of a human neuroblastoma cell 
line.  After treating SH-SY5Y cells for 24 h in serum-free media containing 
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various doses of BTA-EG4, we determined their viability by an MTT assay (78).  
Figure 5-6 shows that BTA-EG4 was toxic to these mammalian cells in a dose-
dependent manner with an IC50 value of ~ 60 μM.  For comparison, the IC50 value 
of gA in human embryonic kidney (HEK) cells was ~0.12 μM. 
 
Figure 5-6. Cytotoxicity of BTA-EG4 on human neuroblastoma cells (SH-SY5Y) 
24 h after exposure.  Each point represents the mean of two or three 
experiments with six replicates in each experiment.  Error bars reflect the 
standard error of the mean.  The red curve is a fit of the equation, y = ܣଶ +
(஺భି஺మ)
ଵାଵ଴(಺಴ఱబషೣ)∗ಹ೔೗೗ೞ೗೚೛೐ to the data on a linear x-scale, where A1, A2, and Hillslope are 
constants. The IC50 value was ~ 60 μM. 
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Since BTA-EG4 concentrations above 35 μM occasionally broke planar 
lipid bilayers irreversibly and since the IC50 values for killing gram-positive 
bacteria and neuroblastoma cells were above this concentration, we tested 
whether BTA-EG4 exerted its cytotoxic activity by cell lysis or by pore formation.  
To this end, we performed a hemolysis assay by exposing red blood cells to 
increasing concentrations of BTA-EG4.  This assay revealed that BTA-EG4 does 
indeed have hemolytic activity, which, at BTA-EG4 concentrations above 200 μM, 
can reach 80% of the maximum hemolytic activity (Fig. A5-9).  The concentration 
to reach half-maximal hemolytic activity (~140 μM), however, was significantly 
higher than the IC50 values of ~ 50 and ~ 60 μM for killing bacteria or 
neuroblastoma cells.  In fact, below a concentration of 80 μM, BTA-EG4 had no 
detectable hemolytic activity.   Together, these findings suggest pore formation 
with concomitant disruption of ionic gradients as a possible mechanism of toxicity 
of BTA-EG4 molecules.  Similar to gA molecules, the large conductance to 
protons may cause BTA-EG4 molecules to act as an uncoupler of oxidative 
phosphorylation (79, 80).  
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5.3 Conclusion 
Self-assembly of a tetra-ethylene glycol derivative of benzothiazole aniline in planar 
lipid bilayers led to well-defined and long-lived transmembrane ion pores that are 
strongly selective for monovalent cations.  In contrast to pores formed by gramicidin A, 
pores from BTA-EG4 have a minimum single-channel conductance at pH ~ 3, which 
suggests that the protonatable anilinium group is located less than 2 Å away from the 
lumen of the pores.  Likely due to its pore-forming ability, this molecule exhibits antibiotic 
activity against gram-positive bacteria with an IC50 value of ~ 50 μM, but not against 
gram-negative bacteria.  As expected for a pore former, BTA-EG4 was also toxic to 
human neuroblastoma cells with an IC50 value of approximately ~ 60 μM.  Given the 
recent development of molecules with similar general structure (i.e., a short 
hydrophobic/aromatic component attached to a short OEG group) as in vivo diagnostic 
agents for Alzheimer’s disease (48, 50), our findings highlight the risk of pore formation 
as a mechanism for possible cytotoxic side effects.  On the other hand, this small 
synthetic pore-forming molecule might be appealing as a starting material for 
development of synthetic ion channels, antibiotics, membrane-permeating agents for 
drug delivery, or as uncouplers of oxidative phosphorylation since it is able to cross 
cellular membranes (50) and since oligo(ethylene glycol) moieties are biocompatible and 
suitable for polymeric drug delivery (81). 
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5.4 Materials and methods 
5.4.1 Materials 
We purchased cesium chloride (CsCl) from International Biotechnologies Inc.; 
sodium chloride (NaCl), and potassium bromide (KBr) from Fluka; and potassium 
chloride (KCl), HEPES, and hexane from Fisher Scientific. All other chemicals 
and reagents were obtained from Sigma-Aldrich (St. Louis, MO).  
 
5.4.2 Formation of planar lipid bilayers 
We used 1,2-diphytanoyl-sn-glycero-3-phosphatidylcholine (DiPhyPC) from 
Avanti Polar Lipids (Alabaster, Alabama) for the formation of all bilayers in this 
work.  We prepared planar lipid bilayers by the “painting method” by applying a 
solution of 20 mg mL-1 DiPhyPC in n-heptane or n-decane over an aperture with 
a diameter of ~ 250 μm in a Delrin cup (Warner Instruments) (11, 82).  Before 
bilayer formation, we pretreated these apertures with a droplet of a solution of 20 
mg mL-1 DiPhyPC in n-hexane.  Both compartments of the chamber (cis and 
trans) were filled symmetrically with electrolytes containing 1.0 M concentrations 
of various salts with 10 mM HEPES buffer adjusted to pH 7.4 with HCl unless 
indicated otherwise.  For each experiment, we confirmed the stability of the lipid 
membrane by applying a voltage of ± 100 mV for 10 min before addition of 
reagents to both compartments with stirring for 5 min using a stir plate for planar 
bilayer recordings (SPIN-2, Warner Instruments). 
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5.4.3 Current recordings across planar lipid bilayers 
For current recordings, we used amplifiers in voltage clamp mode (either 
Geneclamp-500 amplifier from Axon Instruments, or a BC-535 amplifier from 
Warner Instruments).  The compartment of the bilayer chamber that was 
connected to the amplifier head stage by a Ag/AgCl electrode is referred to as cis 
compartment, the other one as trans compartment.  We monitored the ionic 
current across the planar bilayers with a filter cutoff frequency of 10 kHz of the 4-
Pole Bessel filters of the amplifiers and recorded currents using LabVIEW 7.1 
and an A/D converter card from National Instruments (PCI-6221) with a sampling 
frequency of 50 kHz.  For analysis, data were filtered with a Gaussian filter at 100 
Hz and analyzed by using the software Clampfit 9.2 (Axon Instruments).  We 
determined all single-channel conductance values from the slope of current 
versus voltage (IV) curves, which were linear up to voltages of ±100 mV (see 
Appendix, Fig. A5-1).  Ion channel recording was repeated at least 3 times for 
each experimental condition.  We monitored the capacitance of the bilayers 
throughout the recordings using the built-in capacitance compensation of the 
amplifiers.  For the determination of the estimate of the number of BTA-EG4 
molecules in each self-assembled pore, we used time-averaged currents over 
discrete time intervals (3 min) as a function of increasing concentrations of BTA-
EG4.  We averaged transmembrane currents at positive and negative voltages at 
± 50 mV by integrating areas under current versus time traces and dividing the 
resulting area by the total recording time followed by normalizing the averaged 
currents by the membrane capacitance.  All experiments were performed in 1.0 
M or 3.0 M CsCl with 10 mM HEPES, pH 7.4 unless otherwise noted. 
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5.4.4 Statistical analysis of differences in single-channel conductance 
To determine statistical significance of differences in single-channel 
conductance of BTA-EG4 or gA at different pH values, we compared all single-
channel conductances obtained from different applied voltages.  We determined 
P-values using a two-sample Student’s t-test included in the Origin 8.0 software 
package (Northampton, MA).  
 
5.4.5 Liposome leakage assay 
We prepared liposomes from a total lipid concentration of 10 mM of the 
following lipids, DiPhyPC:cholesterol:DiPhyPG:DPPE-PEG2000 in a 9:9:1:1 molar 
ratio.  See section 4.4.3 in Chapter 4 for experimental method. 
 
5.4.6 Cell viability assay 
 See section 3.3.5 in Chapter 3 for cell culture maintenance.  We determined 
the cell viability using an MTT cell proliferation assay, according to the 
instructions from the supplier (78). 
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5.4.7 Microbial toxicity 
 E. coli and B. subtilis were grown in LB media overnight at 37 oC and 31 oC, 
respectively.  The cells were harvested, washed, and subsequently resuspended 
in fresh LB medium containing compounds of interest at various concentrations.  
We added 200 μL of cells to each well of 96-well plates with three replicates for 
each condition and allowed the cells to grow for 30 h while shaking. We 
monitored the growth of bacteria by measuring optical density at 600 nm relative 
to control cells every 15 min, using a VersaMax microplate reader (Molecular 
Devices Inc., East Falmouth, MA). 
 
5.4.8 Hemolysis assay 
We purchased bovine red blood cells (bRBC) from Lampire Biological Laboratories 
(Pipersville, PA).  After washing bRBC in phosphate buffered saline (PBS) buffer 
(Dulbecco’s PBS, Gibco) at pH 7.4, we prepared the stock bRBC suspension by diluting 
the originally purchased suspension 10-fold in PBS buffer (after several wash steps in 
PBS).  We pipetted 200 μL of the resulting bRBC stock solution into reaction vials and 
added various final concentrations of BTA-EG4 in PBS such that the final volume of all 
vials was 1 mL.  These suspensions were mixed and incubated at 37 ˚C for 1 h followed 
by centrifugation at 10,000 x g for 5 min at a temperature of 21 ˚C.  To assess 
hemolysis, we collected the supernatant from each tube and determined the absorbance 
at 541 nm.  We added 800 μL PBS as the negative control, which yielded 0% hemolysis 
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and 800 μL diH2O as the positive control, which yielded 100% hemolysis.  We performed 
the experiment in triplicates for each condition.   
 
5.4.9 Measurement of fluorescence emission spectra 
We diluted BTA-EG4 molecules to a final concentration of 50 μM in deionized 
H2O, pure octanol, and a liposome suspension. The liposomes were prepared 
from a total lipid concentration of 10 mM of DiPhyPC in water by the gentle 
dehydration rehydration method, followed by tip sonication. We transferred 800 
μL of each BTA-EG4 sample to a disposable cuvette (Precision Cells, Inc., 
Farmingdale, NY), and measured fluorescence emission spectra at an excitation 
wavelength of 350 nm, using a Fluorolog-3 spectrofluorometer (Horiba-Jobin 
Yvon, Edison, NJ).  
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Chapter 5 Appendix 
 
A5-1 Current-voltage (IV) curves of BTA-EG4 ion channels 
 
Figure A5-1. Single-channel current-voltage relationship of pores formed by 
BTA-EG4.  The solid lines represent linear fits to the data. The results indicate a 
single-channel conductance of 36.8 ± 1.4 pS (R2 = 0.99) for symmetrical addition 
of BTA-EG4 (red) and 36.0 ± 1.1 pS (R2 = 0.99) when adding BTA-EG4 to the cis 
compartment only (blue).  Both conductance values were the same within error.  
The planar lipid bilayer consisted of DiPhyPC lipids and the electrolyte contained 
1.0 M CsCl with 10 mM HEPES, pH 7.4 in both compartments.  The offset in the 
y-intercept between the two lines was due to a small voltage offset. 
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A5-2. Single-channel recordings at different applied voltages 
 
 
 
Figure A5-2. Single-channel recordings of pores from BTA-EG4 (20 μM) through 
lipid bilayers composed of DiPhyPC in 1.0 M CsCl with 10 mM HEPES buffer, pH 
7.4 at various applied voltages.  Each current-time trace was recorded for 5 min.  
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A5-3. Single-channel conductance as a function of the concentration of 
CsCl in the recording electrolyte 
 
Figure A5-3. Single-channel conductance as a function of the concentration 
of CsCl in the recording electrolyte.  As the concentration of CsCl increases, 
the single-channel conductances of both BTA-EG4 and gA pores increase 
and reach saturation.  The curves are best fits of the data to the following 
equation: γCs = γ max, Cs/(1+ KCs/[Cs]) , where γ max, Cs represents the maximal 
single-channel conductance that can be reached with Cs+ ions and the 
concentration for half-maximal single-channel conductance,γ
 0.5 max, Cs, is KCs.  
The curves yield γ max, Cs values of 36.9 ± 3.2 pS and KCs values of ~ 0.06 M 
for BTA-EG4 as well as γ max, Cs values of 40.0 ± 1.7 pS and KCs values of 
~ 0.07 M for gA pores.  The planar bilayer consisted of DiPhyPC lipids. 
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Table A5-1: Bulk conductivity of aqueous electrolyte solutions containing 
different anions at 22 °C 
 
Electrolyte 
 
MW,  
g mol-1 
Conductivity, mS/cm 
 
0.01 M  
 
0.1 M 
 
1.0 M 
KF 58.09 1.27 12.23 95.8 
KCl 74.55 1.49 15.19 130.6 
KNO3 101.10 1.48 13.93 104.5 
KBr 119.00 1.56 15.21 133.4 
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A5-4. Characterization of ion channel formation by gramicidin A 
 
Figure A5-4. Characterization of ion channel formation by gramicidin A.  A) 
Lifetime, τ , of gramicidin A pores as determined from a best-curve fit of a 
normalized survival plot of the open channel lifetime to an exponential decay 
function. B) Time-averaged current across the lipid bilayer normalized to the 
membrane capacitance as a function of the concentration of gA in the 
electrolyte solution.  The data was fit well with a power law (equation 1; main 
text) with an exponent of 2.08 ± 0.08, suggesting that two molecules of gA 
assemble to form a single pore through lipid membranes.  Two independent 
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experiments are indicated in different symbols.  The applied potential was ± 
50 mV and the electrolyte contained 1.0 M CsCl with 10 mM HEPES, pH 7.4.  
 
A5-5. Dependence of the single-channel conductance of BTA-EG4 pores on 
the proton concentration in an electrolyte 
 
Figure A5-5. Dependence of the single-channel conductance of BTA-EG4 pores 
in DiPhyPC bilayers on the proton concentration in an electrolyte that did not 
contain other ions than HCl.  The single-channel conductance of protons was not 
detectable at HCl concentrations below 1.0 mM (pH 3).  In the absence of other 
ions, the effect of increasing proton concentration was stronger than the 
electrostatic repulsion of protons as a result of protonation of the BTA moiety.  
Therefore, in the absence of 3.0 M CsCl, the single-channel conductance of 
BTA-EG4 did not have a detectable minimum between pH 2 and 3. 
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 A5-6. Leakage of protons through liposomes as detected by change of 
fluorescence ratio 
 
Figure A5-6. Leakage of protons through liposomes after addition of BTA-EG4 
expressed as fluorescence ratio of the pH-sensitive fluorophore, fluorescein 
sulfonate (FS) and the pH-insensitive fluorophore, sulforhodamine B (SR).  
Control: liposomes only, without addition of compounds.  Inset:  0.2% of Triton X-
100, and 20 nM gramicidin A were used as positive controls for leakage of 
protons.  The lipid composition of the liposomes was DiPhyPC:cholesterol: 
DiPhyPG:DPPE-PEG2000 (9:9:1:1).  The excitation/emission wavelengths were 
485 nm/518 nm for FS and 560 nm/590 nm for SR. 
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A5-7. Inhibitory effect of BTA-EG4 on the growth of Bacillus subtilis  
 
Figure A5-7. Inhibitory effect of BTA-EG4 on the growth of Bacillus subtilis at 
various concentrations determined by the optical density at a wavelength of 600 
nm.  Growth of bacteria was compared to control cells that were not treated with 
compounds.  Kanamycin (10 μM) and gA (5 μM) were used as positive controls 
for antibiotic compounds. 
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A5-8. BTA-EG4 shows no inhibitory effect of on the growth of E.coli  
 
Figure A5-8. Effect of BTA-EG4 on the growth of E. coli bacteria. A) Comparison 
of the bacterial growth 22 h after exposure to LB media containing BTA-EG4 at 
various concentrations relative to control cells (no treatment).  BTA-EG4 did not 
show significant toxicity at concentrations up to 500 μM.  Each point resulted 
from an average of one or two experiments with three replicates for each 
experiment; error bars represent standard error of the mean. B) Growth of E. coli 
with or without treatment of BTA-EG4 at 500 μM as determined by optical density 
at a wavelength of 600 nm.  
 
  
 
 
187 
 
 
A5-9. Hemolytic activity of BTA-EG4 as a function of its concentration 
 
Figure A5-9. Hemolytic activity of BTA-EG4 as a function of its concentration.  Each 
point presents the mean and the standard error of the mean of three independent 
experiments done in triplicate.  The red curve is a fit to an equation, y = ܣଶ +
(஺భି஺మ)
ଵାଵ଴(಺಴ఱబషೣ)∗ಹ೔೗೗ೞ೗೚೛೐ , where A1, A2, and Hillslope are constants. The obtained IC50 of BTA-
EG4 dose response curve was ~ 140 μM.  
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A5-10. Additional results on BTA-EG6 molecule 
In our studies, we also conducted the same experiments on another 
molecule in the same family as BTA-EG4.  This molecule is a derivative of BTA, 
attached to hexa(ethylene glycol), which we refer to BTA-EG6.  BTA-EG6 
molecule is also capable of forming well-defined ion channels through PLB, with 
similar conductances as BTA-EG4.  In addition, this molecule exhibits the same 
sequence of cation selectivity, and minimum conductance at pH ~ 3 as observed 
in BTA-EG4.  Some distinct characteristics are summarized below. 
lifetime, τ :        3.58 ± 0.06 s  
estimated number of molecules assembled in a channel :      5.9 ± 0.9  
antibacterial activity against Bacillus subtillis:   IC50 ~ 100 μM 
cytotoxicity in neuroblastoma cells :     IC50 ~ 60 μM 
 
A5-11. Synthesis of BTA-EG4 and BTA-EG6 molecule 
2-(2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)ethyl toluenesulfonate 
In a clean, dry 1 L round bottom flask equipped with a stir bar, we dissolved tetra-
ethylene glycol (10.0 g, 51.5 mmol) in 500 mL dry dichloromethane (DCM) and stirred at 
room temperature.  After 5 min, potassium iodide (1.71 g, 10.3 mmol), Ag2O (17.9 g, 
77.2 mmol), and p-toluenesulfonyl chloride (10.8 g, 56.6 mmol) were successively added 
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to the reaction flask.  The reaction mixture was stirred vigorously for 2 h, filtered through 
celite to remove the solids and concentrated in vacuo. The residue was purified via silica 
column chromatography (100% DCM to 95:5 DCM:CH3OH) giving 2-(2-(2-(2-
hydroxyethoxy)ethoxy)ethoxy)ethyl toluenesulfonate as a colorless oil (13.2 g, 74%). 1H-
NMR (400 MHz, CDCl3): δ = 7.74 (d, 8.0 Hz, 2H), 7.30 (d, 8.0 Hz, 2H), 4.11 (t, 4.8 Hz, 
2H), 3.66-3.53 (m, 12H), 2.79 (s, 1H), 2.39 (s, 3H). 13C-NMR (100 MHz, CDCl3); δ = 
145.04, 133.17, 130.10 (2C), 128.19 (2C), 70.95, 70.79, 70.70, 69.49, 68.88, 21.87. ESI-
MS (m/z) calculated for C15H24O7S [M]+ 348.1243; found [M+H]+ 348.96,  [M+NH4]+ 
365.94 and [M+Na]+ 371.08. 
2-(2-(2-(2-iodoethoxy)ethoxy)ethoxy)ethanol 
 We combined 2-(2-(2-(2-hydroxyethoxy)ethoxy)ethyoxy)ethyl toluenesulfonate  (12.01 
g, 34.5 mmol), sodium iodide (20.7 g, 137.9 mmol) and 200 mL dry acetone in a clean, 
dry round bottom flask and heated to reflux with vigorous stirring.  After 12 h the reaction 
was cooled to room temperature and diluted with 100 mL ethyl acetate.  The organic 
phase was washed with 10% Na2S2O3, (2 x 10 mL), deionized H2O (1 x 20 mL), 
saturated NaCl (1 x 20 mL), dried over anhydrous Na2SO4, filtered, and concentrated in 
vacuo giving 2-(2-(2-(2-iodoethoxy)ethoxy)ethoxy)ethanol as a pale yellow oil (5.61 g, 
54%). 1H-NMR (400 MHz, CDCl3): δ = 3.73-3.58 (m, 14H), 3.24 (t, 2H), 2.59 (s, 1H). 13C-
NMR (100 MHz, CDCl3); δ = 72.70, 72.19, 70.90, 70.76, 70.58, 70.39, 61.94, 3.07.  
BTA-EG4 
 A microwave reaction tube was charged with 2-(2-(2-(2-
iodoethoxy)ethoxy)ethoxy)ethanol(1.47 g, 4.83 mmol), benzothiazole aniline (3.49 g, 
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14.5 mmol), potassium carbonate (3.34  g, 24.2 mmol) and 20 mL dry THF.  The tube 
was then equipped with a small stir bar, sealed and placed in a microwave reactor.  The 
reaction was heated at 125 oC for 2 h.  The reaction was cooled to room temperature 
and filtered to remove the solids. The solids washed several times with DCM until the 
filtrate was colorless. The combined organic layers were concentrated in vacuo and 
purified by column chromatography to give the desired BTA-EG4 compound as a yellow 
solid (1.13g, 56%).  1H-NMR (400 MHz, CDCl3): δ = 7.87 (d, 8.8 Hz, 2H), 7.83 (d, 8.4 Hz, 
1H) 7.63 (s, 1H) 7.23 (d, 8.4 Hz, 1H), 6.68 (d, 8.8 Hz, 2H), 3.76-3.64 (m, 14H), 3.37 (t, 
5.2 Hz, 2H), 2.47 (s, 3H). 13C-NMR (100 MHz, CDCl3); δ = 168.03, 152.64, 150.92, 
134.87, 134.47, 129.13 (2C), 127.70, 122.88, 122.03, 121.41, 112.82 (2C), 72.86, 70.88, 
70.69, 70.43 (2C), 69.64, 61.91, 43.32, 21.70.  HR-ESI-MS (m/z) calculated for 
C22H28N2O4SNa [M+Na] 439.1662; found [M+Na]+ 439.1660. 
BTA-EG6 
17-Iodo-3,6,9,12,15-pentaoxaheptadecan-1-ol was prepared according to literature.  17-
Iodo-3,6,9,12,15-pentaoxaheptadecan-1-ol (0.18 g, 0.45 mmol) was coupled to 2-(p-
aminophenyl)-6-methyl-benzothiazole (0.09 g, 0.38 mmol) with potassium carbonate 
(0.39 g, 2.8 mmol) in dry acetone (4 mL) under reflux conditions. The acetone was 
removed and the residue was taken up into dichloromethane, and separated from an 
insoluble precipitate (presumably excess potassium carbonate and potassium iodide). 
After the precipitate was removed by filtration, the solution was washed with brine, dried 
over sodium sulfate, and the solvent was removed under reduced pressure. The residue 
was purified via flash chromatography using 4% methanol in ethyl acetate as the eluent 
to yield a yellow oil (isolated yield was 28%).  1H-NMR (400 MHz, CDCl3): δ = 7.83-7.79 
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(m, 3H), 7.54 (s, 1H), 7.17 (dd, 8.8 Hz, 1.0 Hz, 1H), 6.61 (d, 8.8 Hz, 2H), 3.67-3.51 (m, 
24H), 3.28 (t, 5.2 Hz, 2H), 2.39 (s, 3H). 13C-NMR (100 MHz, CDCl3); δ = 168.04, 151.82, 
151.03, 134.50, 134.29, 129.14 (2C), 127.80, 121.93, 121.65, 121.39, 112.68 (2C), 
72.73, 70.64 (6C), 70.40 (2C), 69.35, 61.61, 43.16, 21.63.  ESI-MS (m/z) calculated for 
C26H36N2O6S [M]+ 504.2294; found [M+H]+ 505.25 and [M+Na]+ 507.20. 
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Chapter 6 
Conclusions and Future Works 
 
Inconsistent evidence with regards to pore formation and cytotoxicity has been 
observed across the literature in this research field as well as the same research groups 
over time (1).  This variability is mostly due to various aggregation states of Aβ from 
different preparation methods (2).  A number of studies have provided evidence that the 
intermediate aggregated Aβ species can permeabilize cellular membranes and induce 
the unregulated passage of ions, in particular Ca2+, resulting in cell death (3). The 
controversies regarding membrane permeabilization mechanisms by Aβ (i.e., pore 
formation versus membrane thinning mechanisms) had been going on for a decade, 
thereby slowing the progress of understanding the underlying mechanism of Aβ 
neurotoxicity (4, 5).  
In this thesis, we combined electrophysiological techniques with the cytotoxicity 
assays, along with various biochemical and biophysical techniques to investigate the 
effect of aggregation conditions of Aβ on pore formation in lipid bilayers and cytotoxicity.   
We summarize the conclusions of this work and suggestions for future works in the 
following sections.   
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6.1 Concluding remarks 
6.1.1 Resolving the controversy of mechanism of Aβ-induced ion flux across 
membranes 
In Capone et al., 2009 (6), we provided evidence that Aβ can induce ion channel-
like ion flux through the membranes of artificial lipid and neuronal cell.  This effect could 
contribute to the disruption of Ca2+ homeostasis.  We also showed that the previously 
reported “thinning membrane” mechanism, on the other hand, was due to an artifact 
from the residual amount of the solvent HFIP, which was used in the preparation 
procedure to break up fibrils and large aggregates of Aβ.  These findings resolved the 
controversy with regard to membrane permeabilization of Aβ, and also provided a 
caution for using HFIP in lipid bilayer experiments or cellular studies, since this solvent, 
which is commonly used for dissolving various types of proteins or polymers effectively 
(7), could disrupt the lipid membranes or cause cytotoxic effect, if not removed properly. 
 
6.1.2 Development of HFIP-treatment procedure for Aβ preparation  
In order to obtain reliable results in all experiments, it is important to prepare the 
Aβ samples with well-defined starting aggregation states for each experiment.  We 
developed a protocol for Aβ preparation.  The protocol uses the solvent HFIP to 
disaggregate the peptides, followed by lyophilization for 2 d to remove the HFIP solvent.  
This preparation protocol improved the solubility of Aβ in water and reduced the amount 
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of large aggregates, which are considered the major cause of irreproducibility in 
functional experiments such as ion channel recordings on planar lipid bilayers, and 
neurotoxicity assays (2, 3).  Throughout these studies, we carried out experiments using 
this developed HFIP-treatment procedure.   
 
6.1.3 Determination of the aggregated Aβ species which correlate with pore 
formation and cytotoxicity by using multiple linear regression models  
We investigated the aggregation conditions of Aβ that yield the maximal 
probability of pore formation in lipid bilayers and cytotoxicity in neuroblastoma cells.  We 
found that the probability of pore formation was highest when Aβ samples were 
incubated in water for 2-3 days in the case of Aβ1-40 or for 2 days in the case of Aβ1-42.  
The cytotoxicity studies revealed that the Aβ was the most toxic to neuroblastoma cells 
were when Aβ samples had aggregated for 10 d in the case of Aβ1-40, and 3 d in the 
case of Aβ1-42.   
With regard to the question of which aggregation state of Aβ is important for pore 
formation and neurotoxicity mechanisms, multiple linear regression models revealed that 
the most strongly correlated aggregated species of Aβ1-40 were tetramers to hexamers 
for pore formation and tetramers to 18 mers for cytotoxicity.  Whereas in the case of Aβ1-
42, tetramers to hexamers were most strongly correlated with pore formation, while 
hexamer was the important aggregated species found for cytotoxicity.  These findings 
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were in a good agreement with literatures where different techniques have been 
employed.  
 
6.1.4 Membrane permeabilization of Aβ in different lipid systems are driven by 
different mechanisms 
We further investigated the effect of Aβ at various aggregation states on 
membrane permeabilization in another lipid system, liposomes, by monitoring the 
leakage of fluorescent dyes or protons induced by Aβ.   We found that Aβ peptides 
disrupted the membrane of liposomes, resulting in leakage of liposomal contents.  Unlike 
the observation in PLB recordings, the activity of membrane disruption was highest for 
Aβ with 0-d incubation and decreased as Aβ samples were incubated for longer period 
of time.  The decreasing trend of leakage over the incubation time of Aβ suggested that 
membrane disruption on liposomes was likely due to Aβ monomers and small oligomers 
(dimers and trimers), which were mostly abundant in the early aggregation time, 
whereas the aggregated species which were highly correlated with pore formation in 
PLB were oligomeric species (tetramers through 13 mers).  We concluded that the 
leakage observed in these liposome-based assays resulted from bursting of liposomes 
as opposed to the pore formation in the planar lipid bilayers.  One of the possibilities 
accounting for the different mechanisms included the physical properties of both lipid 
models such as the membrane curvature, stability, and mobility of lipid membranes. 
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6.1.5 Discovery of novel drug-like pore-forming synthetic molecules 
In a search for a specific blocker of Aβ-induced pores in membranes, we 
examined several compounds that were designed by our collaborators’ research lab 
based on the interaction of aggregated Aβ peptides and cellular proteins.  We examined 
two promising molecules, which are derivatives of benzothiazole (BTA) attached to 
oligo(ethylene glycol), so-called BTA-EG4 and BTA-EG6.  We demonstrated that each of 
these molecules could reduce the probability of pore formation from 50% to 20% when it 
was incubated with Aβ1-40 in diH2O for 2 d at 1:5 molar ratio (BTA-EGx : monomeric Aβ). 
In addition, the works from our collaborators have shown that these molecules were able 
to reduce Aβ-induced oxidative stress (8) and improve the memory of transgenic mice in 
the behavioral studies.  These molecules could be potential drug candidates for AD 
treatment, as they could mediate the aggregation process of Aβ and reduce the ability of 
Aβ to form pores through cellular membranes; however a large number of PLB 
recordings need to be carried out to confirm this statistical significance. 
Aside from the effect on Aβ-induced ion flux, we found that both BTA-EG4 and 
BTA-EG6 molecules self-assemble and form well-defined channels in PLB.  The 
characteristics of these channels from BTA-EGx mostly resemble those of gramicidin A 
(gA), such as cation selectivity, and conductance values.  We also found that these 
molecules exhibited anti bacterial activity against gram-positive bacterium, Bacillus 
subtilis, but not gram-negative bacterium, Escherichia coli.  Unlike gA, the single-
channel conductance of these pores could be modulated by the pH of the electrolyte 
with a minimum conductance observed at pH ~3.   
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6.2 Future Works 
6.2.1  Investigation of Aβ-induced ion flux in high-throughput PLB recordings  
 A traditional electrophysiological technique typically allows one PLB recording at 
a time.  The Aβ-induced ion flux in PLB experiments occurred with only a certain 
probability.  In our studies, we compared the pore formation by Aβ with various 
aggregation conditions.  It was necessary to perform the several experiments to obtain 
the meaningful statistical significance.  An individual PLB recording experiment for 
measuring activity of Aβ generally requires at least one hour (sometimes several 
hours)starting from the formation of a stable lipid bilayer, waiting for the peptide to 
incorporate into the PLB, monitoring the current activity, and finally the cleaning steps.  
Therefore, this low-throughput and laborious technique may result in a slow progress of 
studies and lack of reports with regards to pore formation by Aβ.   
Recently, an electrophysiological technique for measuring ion channels in a high- 
throughput lipid membrane platform has become available in another research group (9).  
This high throughput system allows measurements of ion channel activity in over 2200 
lipid membranes simultaneously in 3 h with automated liquid-handling equipment, 
enabling the measurement of a large number of different samples with multiple 
repetitions.  We could potentially apply this approach to study ion flux induced by Aβ 
from various conditions in multiple experiments in order to obtain powerful statistical 
analyses for all different aggregation conditions.  For extensive studies, the investigation 
of pore formation could also be carried out with more aggregation time points of Aβ, 
especially within the time window that the intermediate Aβ species are mostly present.  
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After we establish optimal conditions for Aβ to form pores in the PLB along with 
the careful characterization of Aβ, we could employ the similar high-throughput approach 
for screening small molecules which provide an inhibitory effect of Aβ-induced ion flux, 
including the potential drug candidates, BTA-EG4 and BTA-EG6.  Ultimately, this 
approach may direct us to discover new lead compounds for AD treatment.  
 
6.2.2  Investigation of Aβ-induced ion flux in cellular membranes using high- 
throughput technology 
In chapter 2 of the thesis, we demonstrated by a semi-automated patch-clamp 
technique that Aβ is capable of forming pores and inducing ion flux across cellular 
membranes.  To gain more powerful statistical analysis, we could also adopt the high-
throughput approach for electrophysiological recordings in live cells.  The available high-
throughput technology, IonWorks HT device (Essen Instruments, Ann Arbor) enables 
measurements of ion channel activity in a large number of cells in parallel within one 
hour (10).  One disadvantage of this technology is that it is not optimized for ion channel 
recording over 30 min, whereas these experiments typically take several minutes for the 
ion flux to occur after the addition of Aβ, and the addition of Aβ onto the cells could 
cause a reduction of seal resistance, thereby reducing the efficiency of the assay. 
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6.2.3  Investigation of the influence of membrane curvature on the membrane 
disruption induced by Aβ at various aggregation states 
Based on the findings in chapters 3 and 4, one of the possibilities that we 
obtained different results regarding the effects of Aβ at various aggregation states on 
membrane permeabilization in the two lipid systems (planar lipid bilayer and liposomes) 
could be the membrane curvatures.  To test this hypothesis, we could perform leakage 
assays on various sizes of liposomes, ranging from small (< 50 nm diameter) to giant 
liposomes (> 1 μm diameter), and compare the effects of aggregation states of Aβ on 
the leakage.  The size of liposomes could be determined by dynamic light scattering 
technique.  In the case of giant liposomes, one could monitor the leakage of fluorescent 
dyes through liposomal membrane upon addition of Aβ, by using confocal fluorescence 
microscopy.  This approach will allow us to visualize the membrane disruption due to Aβ 
on each liposome and compare the effect among Aβ with various aggregation states. 
 
6.2.4 Modification of BTA-EG4 and BTA-EG6 structures to improve biocompatibility 
Both BTA-EG4 and BTA-EG6 molecules have shown promise as potential drugs 
for AD in molecular and behavioral studies.  Moreover, these molecules exhibit 
antibacterial activity against gram-positive bacterium Bacillus subtilis.  These small 
synthetic molecules might also be appealing as starting materials for development of 
antibiotics.  Nevertheless, these molecules form ion channels in lipid membranes and 
induce cytotoxicity in human neuroblastoma cells at micromolar concentrations, resulting 
in a biocompatibility issue in drug development. 
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To minimize the cytotoxicity of these BTA-EGx molecules, we could potentially 
modify the molecular structures of these molecules in an attempt to improve 
biocompatibility.  It is worthwhile to increase understanding of how these molecules 
assemble into channels.  Based on our current findings, we proposed that the annilinium 
group of the BTA moieties could play a major role in ion channel assembly and 
conductivity.  If this group had been replaced by a non-charged substituent (e.g. methyl 
group or hydrogen), the pore-formation activity, and potentially cytotoxic effect could be 
diminished.  If new design of these compounds can no longer form channels in the 
membranes and also provide a minimal cytotoxic effect, while retaining the protective 
effects of reducing pore formation induced by Aβ and reducing production of reactive 
oxygen species (ROS) induced by Aβ, these molecules could be promising drug 
candidates for AD treatment. 
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